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Mechanisms of Interaction of Non-Thermal Plasma with Living Cells 
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Thermal plasmas and lasers have been widely used in medicine to cut, ablate and 
cauterize tissues through heating; in contrast, non-thermal plasma produces various 
highly active molecules and atoms without heat. As a result, its effects on living cells and 
tissues could be selective and tunable. This makes non-thermal plasma very attractive for 
medical applications. However, despite several interesting demonstrations of non-thermal 
plasma in blood coagulation and tissue sterilization, the biological and physical 
mechanisms of its interaction with living cells are still poorly understood impeding 
further development of non-thermal plasma as a clinical tool. Although several possible 
mechanisms of interaction have been suggested, no systematic experimental work has 
been performed to verify these hypotheses.  
Using cells in culture, it is shown in this work that non-thermal plasma created by 
dielectric barrier discharge (DBD) has dose-dependent effects ranging from increasing 
cell proliferation to inducing apoptosis which are consistent with the effects of oxidative 
stress. DNA damage is chosen as a marker to assess the effects of oxidative stress in a 
quantitative manner. It is demonstrated here that plasma induced DNA damage as well as 
other effects ranging from cell proliferation to apoptosis are indeed due to production of 
intracellular reactive oxygen species (ROS).  We found that DNA damage is initiated 
primarily by plasma generated active neutral species which cannot be attributed to ozone 
alone. Moreover, it is found that extracellular media and its components play a critical 
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role in the transfer of the non-thermal plasma initiated oxidative stress into cells. 
Specifically, it is found that the peroxidation efficiency of amino acids is the sole 
predictor of the ability of the medium to transfer the oxidative stress induced by non-
thermal plasma.  
Phosphorylation of H2AX, a DNA damage marker, following plasma treatment is 
found to be ATR dependent and ATM independent, suggesting that non-thermal plasma 
may induce formation of bulky lesions unlike ionizing radiation (IR) or H2O2 which 
primarily produce DNA double strand breaks. Moreover, it is found that the pathway by 
which plasma generated oxidative stress is transferred across cellular membranes does 
not involve lipid peroxidation by-products, although lipid peroxidation does occur. 
 . 
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Chapter 1. Introduction 
 
1.1. Plasma 
Plasma is a partially ionized medium. Plasma will refer here to a partially ionized 
gas.  It is characterized by a mixture of electrons, ions and neutral particles that, on 
average, is electrically neutral. Plasma can be created in several different ways. Heating 
is one of them. Electric field driven ionization is another. The term plasma was most 
likely coined by Irving Langmuir, because the multi-component, ionized gas reminded 
him of blood plasma in medicine [1]. This term is likely to create some confusion 
particularly in medical applications and especially during the process of plasma (the 
ionized gas) assisted blood coagulation. When necessary, the plasma in the form of 
ionized gas will be referred to as electrical plasma or non-thermal plasma to avoid the 
confusion. 
Plasma occurs naturally and can also be man-made. Examples of natural plasma 
include solar corona, the Earth‘s ionosphere, lightning (Figure 1A) and Aurora Borealis 
(Figure 1B). Man-made plasma is employed in semiconductor electronics manufacturing, 
lighting, treatment of synthetic fabrics, plasma TVs, and many other areas including 
Plasma Medicine. Most man-made plasmas are created electrically. They are primarily 
used (1) to generate high temperature in gas phase; (2) to create electrically conducting 
gas medium; (3) to produce charged particles (ions or electrons) and, possibly, control 
their directed motion; (4) to create electronically excited molecules such as excited 
nitrogen or singlet oxygen 
1
O2 for various purposes including generation of light and (5) 
2 
 
 
to produce radicals and other chemically active species such as ozone, molecular oxygen, 
OH

 radicals, nitric oxide (NO), and others. 
 
Figure 1. Plasmas in Nature. Examples of (A) Thermal and (B) Non-thermal plasmas. 
For the purpose of this discussion it is convenient to classify all plasmas as low or 
atmospheric pressure. Low pressure plasmas are employed in electronics manufacture 
and lighting, for example. In this work, however, atmospheric pressure plasma will be the 
entire focus and we will not discuss anything related to low pressure plasmas. Another 
important characteristic of plasma in medical applications is its temperature. Most of the 
known uses of electrical plasma in medicine are based on the high temperatures 
generated on or within tissues by electrical discharges.  Electrocautery [2, 3] and Argon 
Plasma Coagulator [4, 5], are widely used in medicine today to rapidly coagulate blood 
and ablate tissue [2, 3, 5-11] . However, they lead to significant thermal tissue damage.  
For these reasons, non-thermal room temperature electrical discharges, where thermal 
damage is eliminated and specific biochemical reactions can be initiated, are being 
sought [12-14]. It is such non-thermal discharges and their mechanisms of interaction 
with living tissues that are the sole focus of this work. 
 Different physical mechanisms of creating non-thermal plasma in electrical 
discharges are based on some common principles. In the very beginning of the electrical 
discharge most of the energy goes to electrons, rather than ions, because electrons are 
A. B. 
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much lighter and accept this energy faster. As a result, the temperature of electrons in 
plasma will rise quickly to around 10,000 K. Ions and neutral molecules, however, can 
remain at nearly room temperature for a short time. The resulting plasma is often called 
non-equilibrium because of the dramatically different temperatures of the electrons on the 
on hand and ions and neutral species on the other.  Over time, however, heat is 
transferred from the electrons to ions and neutral species. Given the opportunity, 
temperature of heavier components of plasma can reach the same order of magnitude as 
the electron temperature. Such thermal plasmas are sometimes called equilibrium because 
of the temperature equilibration. Non-equilibrium or non-thermal plasma can, therefore, 
be maintained by not giving the opportunity for heat to transfer from electrons to ions and 
neutral species. This, in turn, can be accomplished in several ways. One is to limit the 
time average electrical current or equivalently the amount of time over which sufficient 
electric field is applied. Another is to transfer heat from the plasma region by limiting 
plasma volume and increasing heat transferring surface area around it. 
  
Figure 2. Floating electrode dielectric barrier discharge (FE-DBD) plasma. (a) Non-
thermal plasma is safe to apply on living tissue. (b) The human body with its high 
dielectric capacity functions as the second electrode (floating electrode) [12]. 
 
 
A. B. 
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1.2. Non-Thermal Dielectric Barrier Discharge Plasma 
   Non-thermal atmospheric pressure dielectric barrier discharge (DBD) plasma has 
recently emerged as a novel tool in medicine. The operating principle of this plasma 
discharge is similar to the Dielectric Barrier Discharge introduced by Siemens in 1862 
[15]. Non-Thermal plasma occurs at atmospheric pressure in air or other gases when high 
voltage of sinusoidal waveform or short duration pulses is applied between two 
electrodes, with at least one electrode being insulated [16]. The insulator prevents build-
up of current between the electrodes, creating electrically safe plasma without substantial 
gas heating. This approach allows direct treatment of living tissue (Figure 2) and 
biological systems without thermal damage observed in more conventional thermal 
plasma [5, 12].  
   In the case of direct application to a living tissue, the dielectric barrier discharge 
system (called Floating Electrode DBD or FE-DBD) is constructed similarly to 
conventional dielectric barrier discharge described above and is inherently non-thermal – 
it is able to operate at room temperature and atmospheric pressure [12, 15, 16]. Plasma 
operates under conditions where one of the electrodes is an insulated high voltage 
electrode and the second active electrode is human (Figure 2) or animal tissue or organ 
[12]. Plasma treatment exposes cells or the tissue surface to active short and long lived 
neutral atoms and molecules, including ozone (O3), NO, OH radicals, and singlet oxygen 
(O2 
1Δg), and a significant flux of charged particles, including both electrons and positive 
and negative ions like super oxide radicals. Non-thermal plasma density, temperature, 
and composition can be changed to control plasma products to some extent [17].  
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Figure 3. Non-thermal dielectric barrier discharge plasma treatment setup 
For most of the work reported here, non-thermal atmospheric pressure dielectric barrier 
discharge plasma was produced using an experimental setup similar to one previously 
described [12] and schematically illustrated in Figure 3 and the actual setup itself is as 
shown in Figure 4.  
 
Figure 4. Non-thermal DBD plasma power supply, electrode and setup used for in vitro 
treatment of mammalian cells. 
High Voltage Power Supply 
Sample Holder 
Electrode 
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Non-thermal plasma was generated by applying alternating polarity microsecond 
pulsed  voltage between the insulated high voltage electrode and the sample undergoing 
treatment using a variable voltage and variable frequency power supply (Quinta, Russia). 
1 mm thick, polished clear fused quartz was used as an insulating dielectric barrier 
covering the 2.5 cm diameter copper electrode. The discharge gap between the bottom of 
the quartz and the treated sample surface was fixed at 2 mm. Discharge power density 
was measured to be roughly 0.13 Watts/cm
2 
(at 500Hz) and 0.31 Watts/cm
2
 (at 2 kHz) 
using both electrical characterization and a specially designed calorimetric system [18]. 
The values for typical discharge parameters are provided in Table 1.  
Table 1. Operating parameters for the non-thermal atmospheric pressure dielectric barrier 
discharge (DBD) plasma used for all the studies in this dissertation 
Parameter Value 
Excitation Microsecond pulsed 
Voltage 20 kV p-p 
Rise Time 5V/ns 
Pulsed Width (FWHM) 1.65 sec 
Frequency 0.5 – 1.5 kHz 
Power Density 0.1 – 1 W/cm
2
 
Rotational Temperature 300 – 350 K 
Vibrational Temperature 3000 – 4000 K 
The plasma treatment dose in J/cm
2
 is calculated by multiplying the plasma discharge 
power density by the plasma treatment duration. Non-thermal DBD plasma has a g-factor 
(number of ROS generated per electron volt or eV) between 0.3 and 0.5 [19]. For a 
plasma dose of 3.9 Joules cm
-2
, 7.32 – 12.2 x 1016/cm3 ROS are generated in the gas 
phase. Table 2 shows typical densities of various active species generated by non-thermal 
dielectric barrier discharge plasma in gas phase [17, 20-22]. It is important to note that 
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DBD plasma at room temperature generates about 2 – 3 orders of magnitude more ozone 
than nitric oxide. 
Table 2. Typical range of densities of various active species generated by non-thermal 
dielectric barrier discharge plasma in gas phase. (e
-
: electrons; M
+
: positive ions) 
Plasma Generated Species Density (cm
-3
) 
Superoxide (O2
-
) 10
10
 - 10
12
 
Hydroxyl (OH

) 10
15
 - 10
17
 
Hydrogen Peroxide (H2O2) 10
14
 - 10
16
 
Singlet Oxygen (
1
O2) 10
14
 - 10
16 
Ozone (O3) 10
15
 - 10
17 
Nitric Oxide (NO) 10
13
 - 10
14 
Electrons (e
-
) 10
9
 - 10
11 
Positive Ions (M
+
) 10
10
 - 10
12 
 
1.3. Plasma Medicine 
Plasma technology has been employed for some time in controlling microbial 
contamination. In fact, generation of UV light often employs lower pressure plasma 
discharges. Ozone which has been widely used as a disinfectant for water is typically 
generated by non-thermal plasma. However, broader spectrum of applications of non-
thermal atmospheric pressure plasma for surface sterilization of inanimate substrates and 
modulation of inanimate surfaces for the purposes of cell attachment has been discovered 
relatively recently. In fact, the past ten years have resulted in significant developments of 
non-thermal plasma for various applications in medicine, where investigations are being 
carried out mostly at academic institutions and research centers on treatment of living 
tissues for the purpose of killing microbes on wounds, burns, within intestines and teeth, 
enhancing wound healing, coagulating blood without damage of surrounding tissue, and 
even treatment of malignancies. The most important finding so far is that non-thermal 
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plasma can be somewhat selective in killing microbes, while showing relatively little or 
no damage to surrounding living tissues. The reasons for this are not yet completely clear.  
What are the reasons for only recent emergence of applications of non-thermal plasma in 
life sciences? Some of the reasons can be related to only recent (past twenty years) 
emergence of power electronics technology which makes control of non-thermal plasma 
inexpensive. We can now make relatively small power supplies that control non-thermal 
air plasmas relatively cheaply. However, the main reason is probably socio-economic. 
Throughout 1970s, 80s and 90s plasma was being developed as one of the key 
technological tools for semiconductor industry. Many plasma scientists and engineers 
were focusing on electronics production at that time. These tools are now relatively well-
developed. Moreover, there is a sense that the peak of electronics revolution has passed. 
For this reason many of the same scientists and engineers are seeking new applications 
for plasma. Applications of non-thermal plasma in medicine also pose a challenge 
because of their highly interdisciplinary nature. 
 
1.3.1. Overview 
Some of the earlier applications of plasma in medicine relied mainly on the 
thermal effects of plasma. Heat and high temperature have been exploited in medicine for 
a long time for the purpose of tissue removal, sterilization, and cauterization. 
Electrocautery is a more modern technique which applies controlled heat to surface layers 
of tissue by passing sufficiently high current through it [4]. However, contact of tissue 
with metal surface of a cautery device often results in adhesion of charred tissue to the 
metal. Some of the earlier applications of plasma in medicine provided an alternative to 
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metal contact electrocautery. In argon plasma coagulation (APC, also sometimes called 
argon beam coagulation), highly conductive plasma replaced the metal contacts in order 
to pass current through tissue avoiding the difficulties with tissue adhesion. Hot plasma is 
also being employed to cut tissue, [3, 5–8] although the exact mechanism by which this 
cutting occurs remains unclear. What differentiates more recent research on applications 
of plasma in medicine is the exploitation of non-thermal effects. Why are non-thermal 
effects of plasma so interesting and promising? The main reason is that non-thermal 
plasma can potentially be tuned to achieve various sub-lethal effects, not just 
indiscriminant tissue destruction. 
 
1.3.2. Clinical Applications of Non-Thermal Plasma 
Non-thermal plasma has been widely studied for sterilization of inert surfaces [12, 
17, 20, 23-28] and treatment of inert substrates with the purpose of modulating cell 
attachment [14, 29]. Only recently it has been shown that non-thermal plasma can be 
applied to cells in sub-lethal doses to elicit specific biological effects, including gene 
transfection [30-32], cell detachment [14, 29, 33, 34], induction of apoptosis [35], cell 
proliferation [36] and wound healing [12, 13, 37-39]. Non-thermal plasma can even have 
selective effects. In recent studies on plasma initiated blood coagulation [12, 13], skin 
sterilization [12, 28] and tissue toxicity after plasma treatment [40, 41], plasma did not 
demonstrate effects visible to the eye. 
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1.3.2.1. Blood Coagulation   
 One of the areas where the use of plasma is being investigated is in blood 
coagulation to stop bleeding in critical life threatening situations. For example, 
coagulation is a vital issue in severely injured individuals in situations involving accident 
victims. Methods of inducing coagulation rapidly in such cases are critical for emergency 
medical responders to treat victims at the scene of an incident. Non-thermal plasma 
provides this opportunity to induce coagulation in a safe manner both at the accident site 
and in hospital emergency rooms [12, 13], particularly for slow bleeding. Similar 
applications might exist in brain surgeries, bleeding of vocal chords and other similar 
situations.  
 
1.3.2.2. Sterilization 
Another important area where the non-thermal plasma may have a significant 
impact on healthcare is related to the prevention of infection in skin wounds including 
burns and ulcerations that occur, for example, in patients with diabetes. The use of 
plasma has been demonstrated to have the capacity to kill bacteria that cause infections in 
such wounds without having an adverse affect on human tissues [12, 28, 38]. Such 
infections are often difficult to treat with conventional antibiotic treatment. Plasma 
treatment could potentially be used continuously in cases of severe burns as an adjunct to 
antibiotic therapy to attain sterilization of the affected areas thus preventing infections.  
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1.3.2.3. Cancer Therapy 
Non atmospheric plasma is also being developed as a novel clinical tool for 
anticancer therapy. Non-thermal plasma has been tested for its ability to effectively treat 
melanoma, a cancer of the skin, by selectively killing cancer cells while leaving normal 
skin tissue unharmed. Experiments identified a dose of plasma that caused minimal 
immediate toxicity, but then went on to stimulate apoptosis in a melanoma cancer cell 
line [42]. In another study, Vandamme, et. al. at GREMI, University de‘ Orleans, France, 
demonstrated a marked antitumor effect of plasma treatment of human U87 malignant 
glioma xenografts in mice. They reported a tumor volume decrease of 56% for treated 
mice and also showed that the tumor volume reduction translated into an increase of 
mouse lifespan of 60% [43]. 
 
1.3.2.4. Wound Healing 
Recently there is evidence that endothelial cells (cells which line all blood 
carrying vessels of our body) exposed to short duration (15 s – 30 s) of low power (~ 0.2 
W/cm
2
) non-thermal plasma treatment exhibit enhanced proliferation which may be due 
to observed release of Fibroblast Growth Factor (FGF) from plasma treated cells. 
Endothelial cells play a guiding role in angiogenesis, the growth of new blood vessels 
from existing vessels. In varied disease conditions, healing may result from promoting or 
inhibiting angiogenesis. This has further application to the effect of non-thermal plasma 
on the vasculature, which is exposed during plasma treatment of many tissues [44].  
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1.3.2.5. Modulation of Cell Transfection 
 Recent studies have investigated the role of non-thermal plasma treatment for 
gene therapy and researchers have come up with novel transfection methods for 
mammalian cells using gas plasmas. Introduction of foreign genes into target cells is a 
crucial step for achievement of gene therapy. Using an electric pulse-activated gas 
plasma generator one day after the 1–3 s plasma exposures with DNA concentration at 
0.5 μg/μl, favorable transfection efficiencies (17.8–21.6%) and relatively low mortalities 
(0.65–2.86%) were obtained for HeLa-S3, HT-1080 and MCF-7 cells. The recipient cells 
became transiently permeable for plasmid DNA during the plasma exposure, suggesting 
that plasma-mediated transfection may involve similar mechanisms that accounts for 
electroporation [45]. In another study atmospheric pressure glow discharge torch (APGD-
t), a miniature pulsed RF (13.56 MHz) plasma source was specifically designed to 
efficiently produce and transport reactive species to and interact with biological samples. 
Results showed that APGDt was capable of creating pores between 4.8 and 6.5 nm in 
radius in the cell membrane. Transfection of the plasmids in HeLa cells was possible with 
the APGDt and local efficiencies up to 35% were observed with low mortalities [46].  
 
1.3.2.6. Skin Diseases 
One example of plasma use in treatment of skin diseases is Cutaneous 
Leishmaniasis (CL, caused by the Leishmania parasite) which results from the bite of an 
infected sand fly when it injects the promastigote form of the disease into the host while 
feeding. There, the parasites are phagocytosed by the host macrophages, change into 
amastigote form, and break the host cell continuing the infection. A series of in-vitro 
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experiments comparing the effect of plasma on human macrophages and on the 
promastigote form of Leishmania parasite were conducted by Fridman et. al. [47]. 
Following plasma, 20% of macrophages are inactivated while 100% promastigotes 
appear inactive as observed through a phase contrast microscope with trypan blue 
exclusion test for macrophages and simple observation for the protozoa (they stop 
moving the flagellum and begin to disintegrate which takes about 48 h; the organisms do 
not appear to re-activate following treatment) [47]. 
 
1.4. Motivation For this Work 
Although electrical discharges that generate non-thermal plasma (with gas near 
room temperature) have been known for a long time, their clinical potential has been 
largely ignored. Possible medical applications described above emerged only within the 
last 10-15 years. However, there is still a substantial lack of understanding of 
mechanisms by which non-thermal plasma could interact with living cells and tissues 
which limits further development of its clinical applications. The group of Eva Stoffels 
[14, 29, 33, 34, 48-52] did some pioneering work in trying to understand the effects of 
plasma on cells and they discussed the possible role of reactive oxygen species (ROS) 
and/or charged species in mediating the effects of plasma. However they have provided 
no direct evidence of ROS or the role of oxidative stress in any of their papers.  
Moreover, prior studies related to mechanisms of interactions focused mainly on bacteria. 
It is demonstrated here that, not only can non-thermal DBD plasma induce a variety of 
effects on mammalian cells ranging from increased cell proliferation to apoptosis, but 
also that oxidative stress is the primary mechanism of interaction between non-thermal 
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plasma and mammalian cells. This suggests that non-thermal plasma can be used to 
extend the list of medical tools, such as IR, photodynamic therapy, and various drugs, 
whose primary effects are mediated by Reactive Oxygen Species (ROS). It also raises 
questions about possible differences between oxidative effects created by plasma in 
comparison to IR, UV and hydrogen peroxide (H2O2).  
 
 
1.5. Dissertation Overview and Organization 
 
It is hypothesized that non-thermal plasma interacts with living cells via 
production of reactive oxygen species and resultant modulation of the oxidative state of 
the cells. The goal of this dissertation is to test this hypothesis and understand the 
mechanisms of interaction of non-thermal atmospheric pressure dielectric barrier 
discharge plasma with living cells. This involves investigating the effects of non-thermal 
plasma on living cells and cellular membranes when the cells are in a wet environment 
under various different mediums by carrying out a series of rigorous in vitro experiments. 
Non-thermal plasma treatment is essentially a surface phenomenon, unlike ionizing 
radiation, which penetrates through the volume of tissue or fluid being treated, but results 
have shown that non-thermal plasma treatment of mammalian cells induced DNA double 
strand breaks inside the cellular nucleus while the cell membrane appears to be intact. 
This leads to an interesting question, whether plasma has some subtle effects and 
somehow these effects are able to penetrate the cells? The objective of this dissertation is 
to investigate this very question and try to present a few potential mechanisms. The 
outline of the thesis is as follows:  
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Chapter 2 aims to provide a background on oxidative stress phenomena, effects 
of oxidative stress on various cellular components including DNA, lipids and proteins, 
antioxidant defense systems in the body, biological and clinical effects of oxidative 
stress, the role of oxidative stress in common diseases including diabetes, atherosclerosis, 
Alzheimers disease, etc. Commonalities between different clinical treatment modalities 
including, ionizing radiation, UV and hydrogen peroxide, which are known to interact 
with cells and tissue via the induction of and/or modulation of oxidative stress.  
Since plasma is essentially a surface phenomenon, the effects of plasma are more 
likely to interact first with the cell membranes than DNA, we try to understand effects of 
plasma treatment on cell membranes of endothelial cells by analyzing the toxicity of non-
thermal plasma and release of membrane bound growth factors. Further, low levels of 
oxidative stress are known to enhance cell proliferation. With the knowledge that non-
thermal plasma produces reactive oxygen species in liquid medium, we tested the effects 
of low dose non-thermal plasma treatment on mammalian cells. The remarkable result 
that low dose non-thermal plasma enhances proliferation of endothelial cells in vitro 
forms the basis of Chapter 3. In this chapter we further try to understand the mechanism 
of low dose non-thermal plasma induced enhancement of proliferation of endothelial 
cells. Results indicate that low dose plasma induced oxidative stress may induce cell 
proliferation via release of FGF. In Chapter 3 we also present results on in vivo studies 
performed on animals to test the toxicity of low dose non-thermal plasma treatment on 
intact skin and wounded tissue. We were also interested in analyzing how deep do the 
effects of non-thermal plasma penetrate. This would be an important consideration when 
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non-thermal plasma would be developed as a clinical tool for skin sterilization and 
wound healing. 
In Chapter 4 we investigate the effects of high dose non-thermal plasma on 
mammalian cells. Initiation of apoptosis is an important issue in cancer treatment as 
cancer cells frequently have acquired the ability to block apoptosis and thus are more 
resistant to chemotherapeutic drugs. Targeted and selective destruction of cancer cells is 
desirable for many reasons, ranging from the enhancement of or aid to current cancer 
therapy modalities like IR and chemotherapy to problems currently lacking a solution, 
e.g., lung cancer. High level of oxidative stress is known to be detrimental to cell survival 
and in many cases leads to induction of apoptosis. We demonstrate the induction of 
apoptosis in a human melanoma cell line in vitro by exposure to high dose of non-thermal 
atmospheric pressure plasma. Our results show that exposure of tissue culture to 
atmospheric pressure non-thermal plasma induces apoptosis and this effect is likely 
related to production of ROS by non-thermal plasma.   
Non-thermal atmospheric pressure dielectric barrier discharge plasma applied 
directly to living tissues is now being widely considered for various clinical applications.  
One of the key questions that arise in this type of topical treatment is if the skin or tissue 
remains undamaged after non-thermal plasma treatment. In Chapter 5 we present results 
related to the in vivo studies aimed at investigating the toxicity of non-thermal plasma 
treatment of intact porcine skin and wounded porcine tissue. 
In Chapter 6, we finally investigate and present results that elucidate some of the 
possible mechanisms of interaction of non-thermal plasma with living cells. To determine 
whether DBD plasma treatment of cells could induce DNA damage, we looked at 
17 
 
 
phosphorylation of H2AX, a histone variant that is phosphorylated in response to DNA 
damage [53]. Western blot with an antibody that detects H2AX phosphorylated at Ser139 
(-H2AX) revealed that treatment of cells with DBD plasma induces a dose-dependent 
increase in -H2AX. Neutral active species play a major role in the interaction of non-
thermal plasma with living cells and not charged particles. ROS produced by plasma in 
the medium mediate the interaction of plasma with living cells via production of organic 
hydroperoxides. These hydroperoxides may lead to lipid peroxidation and the byproducts 
of lipid peroxidation may bind to receptors on cell membranes and activate intracellular 
signaling pathways which may lead to subsequent DNA damage. We also show that 
phosphorylation of H2AX after non-thermal plasma treatment of MCF10A cells is 
primarily through ATR, in contrast to the ATM-dependent phosphorylation of H2AX 
after treatment of cells with IR or hydrogen peroxide. Our studies suggest that oxidative 
stress induced by non-thermal plasma treatment of cells leads to activation of ATR, 
suggesting that unlike IR and H2O2, non-thermal plasma primarily induces bulky lesions 
and stalled replication forks. 
Chapter 7 concludes the thesis by summarizing the results elucidating some of 
the mechanisms of interaction of non-thermal plasma with mammalian cells and provides 
brief remarks on the future directions for this work. 
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1.6. Dissertation Contributions 
 
Specific novel and useful contributions of the work described in this thesis are: 
 Experimental confirmation that non-thermal DBD plasma affects genetic material 
within cells despite the fact that it is a non-penetrating form of treatment. This is 
important because most of cellular behavior as well as possible cellular 
transformation are controlled through DNA. 
 Definitive test of the hypothesis that the primary agents of interaction between non-
thermal DBD plasma and DNA within mammalian cells are reactive oxygen species. 
 Experimental demonstration that non-thermal plasma created by DBD has dose-
dependent effects ranging from increasing cell proliferation to inducing apoptosis 
which are consistent with the effects of oxidative stress. 
 Discovery that neutral species produced in non-thermal DBD plasma are the primary 
plasma species which lead to oxidative stress and subsequent effects on DNA. Proof 
that these neutral species act very differently than ozone alone, although ozone is the 
major constituent of plasma produced neutral species in gas phase. 
 Demonstration that specific composition of the extracellular medium plays the 
determining role in passing the oxidative stress between gas phase plasma species and 
cells. 
 Proof that non-thermal DBD plasma may induce formation of bulky lesions unlike 
ionizing radiation (IR) or hydrogen peroxide (H2O2) which primarily induce DNA 
double strand breaks. 
 Finally, initial results showing that mechanism by which oxidative stress passes 
through cell membrane does not require lipid peroxidation.  
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Chapter 2. Effects Of Oxidative Stress On Mammalian Cells 
 
2.1. Overview 
 All organisms, except for some anaerobic and aerotolerant species, need O2 for 
efficient production of energy by the use of electron transport chains that ultimately 
donate electrons to O2. In the biosphere, molecular oxygen is the most important electron 
acceptor. By virtue of its biradical nature, molecular oxygen readily accepts unpaired 
electrons to give rise to a series of partially reduced species collectively known as 
reactive oxygen species (ROS) [54]. These include superoxide radical (O2
-
), hydrogen 
peroxide (H2O2), hydroxyl radical (OH

), singlet oxygen (
1
O2), peroxyl (ROO

) and 
alkoxyl (RO

) radicals which are involved in initiation and propagation of free radical 
chain reactions and are potentially highly damaging to cellular targets including DNA, 
lipids and proteins [54, 55]. In healthy aerobes, production of ROS is approximately 
balanced with antioxidant defense systems. This balance is not perfect, however, so some 
ROS-mediated damage occurs continuously. Antioxidant defenses control levels of ROS 
rather than eliminate them. Although some ROS perform useful functions, the production 
of ROS exceeding the ability of an organism to mount an antioxidant defense results in 
oxidative stress. Having too many ROS in relation to the available antioxidants is often 
said to be a state of oxidative stress [54]. Oxidative stress can be defined as the imbalance 
between cellular oxidant species production and antioxidant capability[56]. In a state of 
cellular imbalance, in which the levels of oxidants outweigh the levels of antioxidants, 
damage is caused to nuclear and mitochondrial DNA, proteins, and lipids. ROS are 
involved in a variety of different cellular processes ranging from proliferation, cellular 
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injury, apoptosis, necrosis, mutagenesis, and carcinogenesis, accelerated senescence and 
cell death. Oxidative stress is implicated in various diseases including some allergic and 
inflammatory skin diseases, Alzheimer‘s, atherosclerosis in diabetes patients, and Lou 
Gehrig disease. Cells are exposed to a large variety of ROS from endogenous sources like 
ROS enzymes, phagocytic cells, cellular metabolism and various diseases and from 
exogenous sources like radiation, UV radiation, electrophysical phenomena including 
non-thermal plasma and photodynamic therapy, food, drugs, pollutants and xenobiotics. 
This review aims to provide a background on oxidative stress phenomena, effects of ROS 
on various cellular components, biological and medical effects of ROS, differences and 
commonalities of different clinical treatments including, ionizing radiation, UV and 
hydrogen peroxide, which interact with cells and tissue via the induction of oxidative 
stress.  
 
2.2. Reactive Oxygen Species (ROS) 
Oxidative stress describes cell damage caused by an overabundance of oxidants, 
including ROS (ROS, e.g., oxygen ions, free radicals, and peroxide). ROS and other 
radicals are involved in a variety of biological phenomena, such as mutation, 
carcinogenesis, degenerative and other diseases, in inflammation, aging, and 
development. ROS are well recognized for playing a dual role as deleterious and 
beneficial species. ROS are harmful in excess, but some level of them is necessary for 
important cellular functions. Some cells produce ROS to kill invading microbes, and 
ROS are involved in cell signaling [55, 57]. Also, oxidative stress plays a role in cellular 
processes, such as aging and apoptosis. Oxidative stress can be defined as the imbalance 
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between cellular oxidant species production and antioxidant capability. ROS are involved 
in a variety of different cellular processes ranging from apoptosis and necrosis to cell 
proliferation and carcinogenesis. In fact, molecular events, such as induction of cell 
proliferation, decreased apoptosis, and oxidative DNA damage have been proposed to be 
critically involved in carcinogenesis. Carcinogenicity and aging are characterized by a set 
of complex endpoints, which appear as a series of molecular reactions. ROS can modify 
many intracellular signaling pathways including protein phosphatases, protein kinases, 
and transcription factors, suggesting that the majority of the effects of ROS are through 
their actions on signaling pathways rather than via non-specific damage of 
macromolecules; however, exact mechanisms by which redox status induces cells to 
proliferate or to die, and how oxidative stress can lead to processes evoking tumor 
formation are still under investigation [54, 55]. 
In a balanced cell state, ROS are produced as a byproduct of metabolic processes 
and the level of ROS can be controlled with antioxidants, such as small molecular weight 
dietary supplements, including vitamin E and vitamin C; small molecular weight peptides 
and cofactors, including glutathione and pyruvate; and enzymes, including superoxide 
dismutase and catalase [58]. In a state of cellular imbalance, in which the levels of 
oxidants outweigh the levels of antioxidants, damage is caused to nuclear and 
mitochondrial DNA, proteins, and lipids. If this damage is irreparable, then injury, 
mutagenesis, carcinogenesis, accelerated senescence, and cell death can occur [58]. 
Oxidative stress has been linked to diseases, including some allergic and inflammatory 
skin diseases [59], Alzheimer‘s [60] and atherosclerosis in diabetes patients [61]. 
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2.2.1. Biologically Relevant Reactive Oxygen Species 
Although molecular oxygen is a relatively stable radical, certain oxygen species 
are significantly more reactive. The different ROS present in the cell exhibit different 
chemical reactivities. Molecular oxygen exists in the triplet state; two of its valence 
electron unpaired in separate orbitals and having parallel spins. Ground state oxygen is 
not very reactive due to the inertness of its orbital structure: it would have to accept a pair 
of electrons with parallel spins to fill the vacancies of its orbitals. This is unlikely to 
occur since a pair of electrons in an atom or molecule usually have antiparallel spins [62]. 
In biological systems, this spin restriction can be accommodated by transition metal ions 
such as iron, manganese and copper. Transition metal ions undergo single-electron redox 
exchanges within their unoccupied 3d-orbitals [63]. Molecular oxygen can become more 
reactive when its outer valence electrons adopt antiparallel spins and occupy the same 
orbital. This state of molecular oxygen is known as the singlet state. Singlet oxygen (
1
O2) 
is the first excited state of molecular oxygen, and is commonly formed by absorption of 
light energy. Singlet oxygen is a powerful oxidant because the spin restriction is 
removed, which allows it to abstract electrons of either spin [62, 64]. The superoxide 
anion (O2
-
) is produced by a single electron reduction of molecular oxygen. Superoxide 
anion is both an oxidant and a reductant. It is more reactive than triplet state oxygen and 
tends to dismutate to hydrogen peroxide (H2O2) and molecular oxygen. This reaction can 
be catalyzed by superoxide dismutases such as Cu-Zn superoxide dismutases and Mn 
superoxide dismutase [62]. Hydrogen peroxide is not an oxygen radical because its 
valence orbitals become filled with a second electron. It is therefore more stable than any 
other reduction product of oxygen. Hydrogen peroxide can travel extensively into and 
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within the cell because of it inherent stability and because it may form hydrogen bound 
chelate structures with histidines and imidazole rings [65]. By itself hydrogen peroxide 
does not play a major role in cellular oxidative toxicity [66]. However in the presence of 
iron (Fe
2+
) or superoxide anion, hydrogen peroxide can transform into the OH radical 
(OH

), the most reactive chemical species produced in living organisms. It is the third 
product of the stepwise reduction of oxygen in the electron transport chain and is also 
generated with superoxide anion and hydrogen peroxide react in the Haber – Weiss 
reaction. Hydroxyl radical can be produced by the radiolysis (x – rays, gamma – rays) or 
photolysis (~350 nm) of water, or the photolysis (UV light) of hydrogen peroxide or by 
laser irradiation of photosensitizers or by non-thermal plasma treatment of atmospheric 
pressure air. Xenobiotics such as bleomycin facilitate the formation of hydroxyl radicals 
on DNA by intercalating DNA and complexing with metal ions, forming a site for the 
Fenton reaction. Because it is so reactive, the hydroxyl radical does not travel for before 
it oxidizes a substrate.  
Table 3. Radical and nonradical reactive oxygen species[55] 
Reactive Oxygen Species 
Oxygen Radicals Nonradical Oxygen Species 
Hydroxyl (OH

) Hydrogen Peroxide (H2O2) 
Superoxide (O2
-
) Ozone (O3) 
Peroxyl (ROO

) Singlet Oxygen (
1
O2) 
Alkoxyl (RO

) Peroxynitrite (ONOOH) 
Nitric Oxide (NO

) Hypochlorous Acid (HOCl) 
This review focuses on reactive oxygen species, which can cause damage to 
biological targets such as lipids, DNA, and proteins, and on the antioxidant defense 
systems of a cell. Reactive oxygen species (ROS) that can be classified into two groups 
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of compounds; radicals and nonradicals. The radical group, contains compounds such as 
nitric oxide radical (NO

), superoxide ion radical (O2
-
), hydroxyl radical (OH

), peroxyl 
(ROO

) and alkoxyl radicals (RO

), and one form of singlet oxygen (
1
O2) as shown in 
Table 3. [67]. These species are radicals, because they contain at least 1 unpaired electron 
in the shells around the atomic nucleus and are capable of independent existence [54]. 
The occurrence of one unpaired electron results in high reactivity of these species by their 
affinity to donate or obtain another electron to attain stability The group of nonradical 
compounds contains a large variety of substances, some of which are extremely reactive 
although not radical by definition. Among these compounds produced in high 
concentrations in the living cell are hypochlorous acid (HClO), hydrogen peroxide 
(H2O2), organic hydroperoxides, aldehydes, ozone (O3), and singlet oxygen as shown in 
Table 3. 
 
2.2.1.1. Hydroxyl Radical (OH) 
The reactivity of hydroxyl radicals is extremely high [54, 68, 69]. In contrast to 
superoxide radicals that are considered relatively stable and have constant, relatively low 
reaction rates with biological components, hydroxyl radicals are short-lived species 
possessing high affinity toward other molecules. Hydroxyl radical can be generated by 
reaction of meal ions with H2O2, or by UV induced hemolytic fission of the O – O bond 
in H2O2. Hydroxyl radicals can also be generated from ozone and peroxynitrite. Since the 
major constituent of cells is water, exposure to high energy radiation such as -rays will 
result in OH

 production by hemolytic fission of water. Sonication of aqueous solutions 
also produces OH

 radicals. OH

 is a powerful oxidizing agent that can react at a high 
rate with most organic and inorganic molecules in the cell, including DNA, proteins, 
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lipids, amino acids, sugars, and metals. OH

 radicals are responsible for much of the 
damage done to cellular DNA, proteins and lipids. If two OH

 radicals react, they can 
form H2O2. Although this reaction has a high rate contant and occurs in spurs during 
radiolysis, it is unlikely to occur in vivo because the steady state concentration of OH

 
radicals is effectively zero. The three main chemical reactions of hydroxyl radicals 
include hydrogen abstraction, addition, and electron transfer [54]. OH

 is considered the 
most reactive radical in biological systems; due to its high reactivity, it interacts at the 
site of its production with the molecules closely surrounding it [68].  
 
2.2.1.2. Superoxide Anion (O2
-
) 
This species possesses different properties depending on the environment and pH. 
Superoxide is far less reactive than OH

 and does not react at all with most biological 
molecules in aqueous solutions. It does react quickly with other radicals such as NO

, 
iron sulfur clusters in certain enzymes and some phenoxyl radicals. Due to its pKa of 4.8, 
superoxide can exist in the form of either O2
-
 or, at low pH, hydroperoxyl (HO2

) [54, 
69, 70]. The latter can more easily penetrate biological membranes than the charged 
form. Hydroperoxyl can therefore be considered an important species, although under 
physiological pH most of the superoxide is in the charged form. In general, superoxide 
does not readily cross membranes, although it can pass through the anion exchange 
proteins present in some cells, for example erythrocytes and lung. The most important 
reaction of superoxide radicals is dismutation; in this reaction, superoxide radical reacts 
with another superoxide radical. One is oxidized to oxygen, and the other is reduced to 
hydrogen peroxide [71]. Although the rate constant at physiological conditions for this 
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spontaneous reaction is low, it can become much higher in acidic pH where the 
hydroperoxyl radical is formed [68, 69, 72]. 
In a hydrophilic environment both the O2
-
 and HO2

 can act as reducing agents 
capable, for example, of reducing ferric (Fe
3+
) ions to ferrous (Fe
2+
) ions; however, the 
reducing capacity of HO2

 is higher. O2
-
 also acts as a powerful nucleophile, capable of 
attacking positively charged centers, and as an oxidizing agent that can react with 
compounds capable of donating H
+
 ions (e.g., ascorbate and a-tocopherol). In organic 
solvents the solubility of O2
-
 is higher, and its ability to act as a reducing agent is 
increased. In general, however, in aqueous environments at physiological pH, superoxide 
is not highly reactive. Its rates of reaction with DNA, amino acids and most other 
biomolecules are low, or zero. Biological damage by O2
-
 is highly selective and usually 
involves its reactions with other radicals, for example NO
 
[68, 69, 72, 73]. 
2.2.1.3. Hydrogen Peroxide (H2O2) 
The result of the dismutation of superoxide radicals is the production of H2O2. 
There are some enzymes that can produce H2O2 directly or indirectly. Although H2O2 
molecules are considered reactive oxygen metabolites, they are not radical by definition; 
they can, however, cause damage to the cell at a relatively low concentration (10 M). 
H2O2 freely dissolved in aqueous solution and can easily penetrate biological membranes. 
Their deleterious chemical effects can be divided into the categories of direct activity, 
originating from their oxidizing properties, and indirect activity in which they serve as a 
source for more deleterious species, such as OH

 or HClO. Direct activities of H2O2 
include degradation of haem proteins; release of iron; inactivation of enzymes; and 
oxidation of DNA, lipids, SH groups, and keto acids [54, 74, 75]. 
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2.2.1.4. Singlet Oxygen (1O2) 
   Molecular oxygen can become more reactive when its outer valence electrons 
adopt antiparallel spins and occupy the same orbital. This state of molecular oxygen is 
known as the singlet state. Singlet oxygen (
1
O2) is the first excited state of molecular 
oxygen, and is commonly generated by photosensitization reactions. Singlet oxygen 
1
O2 
is not a radical; there are no unpaired electrons.  Singlet oxygen is a powerful oxidant 
because the spin restriction is removed, which allows it to abstract electrons of either 
spin [54, 62, 64]. Singlet oxygen generated by photoexcitation and by chemiexcitation 
selectively reacts with the guanine moiety in nucleosides and in DNA. The oxidation 
products include 8-oxo-7-hydro-deoxyguanosine (8-oxodG) and 2, 6-diamino-4-
hydroxy-5-formamidopyrimidine (FapyGua). Singlet oxygen also causes alkali-labile 
sites and single-strand breaks in DNA. The biological consequences include a loss of 
transforming activity and mutagenicity and genotoxicity [76]. Singlet oxygen is also 
involved in inducing lipid peroxidation [77] and protein oxidation [78] 
 
2.2.1.5. Peroxyl (ROO) and Alkoxyl Radicals (RO) 
  Peroxyl (ROO

) and alkoxyl (RO

) radicals are usually very good oxidizing agents. 
HO2

, protonated O2
-
, can be regarded as the simplest peroxyl radical. For example, 
peroxyl (ROO

) radicals oxidize ascorbate and NADH, the latter leading to O2
-
 
formation in the presence of O2. Peroxyl and alkoxyl radicals can abstract H from other 
molecules, a reaction important in lipid peroxidation. Peroxyl radicals can react with each 
other, for example by the Russell mechanisms to generate 
1
O2. Carbon centered radicals 
react with O2 to form ROO

 radicals. Decomposition of organic peroxides (ROOH) 
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generates both ROO

 and RO

 radicals.  
Most peroxides are stable at room temperature, but they can be decomposed by heating, 
exposure to UV light or by addition of transition metal ions [54, 68]. 
ROOH + Fe (III)  ROO + Fe2+ + H+                                                                             (1)                                                                   
ROOH + Fe
2+
  RO + OH- + Fe (III)                                                                             (2)                                                                    
Reactions shown in Equation (1) and Equation (2) account for much of the stimulation of 
lipid peroxidation by iron. Lipid peroxides also react with HO2

 to form ROO
 
as shown 
in Equation (3)
 
[68] 
HO2

 + ROOH  ROO + H2O2                                                                                       (3) 
2.2.1.6. Nitric Oxide (NO) and Peroxynitrite (ONOO-) 
 The nitric oxide, or nitrogen monoxide, radical (NO

) is produced by the 
oxidation of one of the terminal guanido nitrogen atoms of L-arginine. In this reaction, 
catalyzed by the group of enzymes called nitric oxide synthase (NOS)s, L-arginine is 
converted to nitric oxide and L-citrulline. Three types of the enzyme exist: neuronal 
NOS, endothelial NOS (eNOS), and inducible NOS (iNOS). One-electron oxidation 
results in the production of nitrosonium cation (NO
+
), while one-electron reduction leads 
to nitroxyl anion (NO

), which can undergo further reactions, such as interacting with 
NO

 to yield N2O and OH

. The half-life of the nitric oxide radical depends on the square 
of the radical concentration. NO

 can react with a variety of radicals and substances. One 
of the most important reactions under physiological conditions is that of superoxide and 
nitric oxide radicals resulting in peroxynitrite as shown in Equation (4). This reaction 
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helps to maintain the balance of superoxide radicals and other ROS and is also important 
in redox regulation [79, 80].  
NO

 + O2

  ONOO  k > 109 M-1s-1                       (4) 
The protonated form of peroxynitrite (ONOOH) is a powerful oxidizing agent that 
might cause depletion of sulfhydryl (SH) groups and oxidation of many molecules 
causing damage similar to that observed when OH

 is involved. It can also cause DNA 
damage such as breaks, protein oxidation, and nitration of aromatic amino acid residues 
in proteins. Under physiological conditions, ONOOH can react with other components 
present in high concentrations, such as H2O2 or CO2, to form an adduct that might be 
responsible for many of the deleterious effects seen in biological sites [54, 75, 79-81]. 
 
2.2.2. Sources of ROS 
  The cell is exposed to a large variety of reactive oxygen and nitrogen species from 
both exogenous and endogenous sources (Figure 5) [82]. The former include oxygen, 
gamma irradiation, UV irradiation, ultrasound, food, drugs and Xenobiotics, ozone etc 
while the later include phagocytic cells, enzymes, metabolism and diseases. Although the 
exposure of organism to ROS is extremely high from exogenous sources, the exposure to 
endogenous sources is much more important and extensive, because it is a continuous 
process during the life span of every cell in the organism. 
 
 
 
 
30 
 
 
2.2.2.1.Exogenous Sources 
Oxygen and Ozone 
The toxicity of the oxygen molecule itself is sometimes beneficial and used as a 
therapeutic aid as, for example, in hyperbaric oxygen therapy [83]. Ozone (O3) is 
essential in scavenging deleterious UV-C irradiation and extremely important with its 
presence in the upper atmosphere. On the other hand, it acts as a damaging species to 
biological tissues [84, 85]. Ozone is not a radical like oxygen, is characterized by its 
sharp odor, can damage lungs, and can serve as a powerful oxidizing agent that can 
oxidize biological components directly [86]. 
Radiation and Pollutants 
Exposure of living organisms to ionizing and non-ionizing irradiation constitutes 
a major exogenous source of reactive species [87, 88]. Exposure of the cells to -radiation 
results in the production of a whole range of radical and non-radical species from the 
ionization of intracellular water (e.g., aqueous electron, OH

, H2O2). Even exposure to 
non-ionizing irradiation such as UV-C (< 290 nm), UV-B (290–320 nm), and UV-A 
(320–400 nm) can indirectly produce a variety of ROS including 1O2, H2O2, and O2
-
 
radicals; hemolytic cleavage of H2O2 by UV radiation yields OH

 radicals. Air pollutants 
such as car exhaust, cigarette smoke, and industrial contaminants encompassing many 
types of NO derivatives constitute major sources of ROS that attack and damage the 
organism either by direct interaction with skin or following inhalation into the lung [89, 
90].  
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Drugs 
Drugs are also a major source of ROS [91, 92]. There are drugs, such as bleomycin and 
adreamicine, whose mechanism of activity is mediated via production of ROS, those like 
nitroglycerine that are NO

 donors and those that produce ROS indirectly. Narcotic drugs 
and anesthetizing gases are considered major contributors to the production of ROS [93]. 
A large variety of Xenobiotics (e.g., toxins, pesticides, and herbicides such as paraquat) 
and chemicals (e.g., mustard gas, alcohol) [94-97] produce ROS as a by-product of their 
metabolism in vivo. The invasion of pathogens, bacteria, and viruses might result in the 
production of many ROS species by direct release from the invaders or an endogenous 
response induced by phagocytes and neutrophills. 
Figure 5. Sources of reactive oxygen species 
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Reactive Oxygen Species 
 -irradiation 
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Food 
   One of the major sources of oxidants is food [98-100], for a large portion of the 
food we consume is oxidized to a large degree and contains different kinds of oxidants 
such as peroxides, aldehydes, oxidized fatty acids, and transition metals [100]. Food 
debris that reaches the intestinal tract places an enormous oxidative pressure on the 
intestinal-tract mucosa [101]. 
 
2.2.2.2.Endogenous Sources  
Enzymatic ROS Production 
Enzymes comprise another endogenous source of ROS. While most enzymes 
produce ROS as a by-product of their activity, exemplified by the formation of 
superoxide radicals by xanthine oxidase, there are some enzymes designed to produce 
ROS, such as nitric oxide synthase that yields NO

 radicals, those that produce H2O2, and 
those responsible for hydroxylation [102-104]. White blood cells, including neutrophills, 
eosinophils, basophils, and mononuclear cells (monocytes), and lymphocytes, with their 
mechanisms to combat bacteria and other invaders [105, 106], are major producers of 
endogenous ROS and other factors that act synergistically with ROS [107, 108]. 
Following stimulation, these cells undergo a respiratory burst characterized by a 20-fold 
increase in oxygen consumption, which is accompanied by an increase in glucose 
utilization and production of reduced nicotinamide phosphate dinucleotide (NADPH) by 
the pentose phosphate pathway [109]. NADPH serves as a donor of electrons to an 
activated enzymatic complex in the plasma membrane. This NADPHoxidase complex 
utilizes electrons to produce superoxide radicals from the oxygen molecule. Following 
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dismutation, the production of H2O2 leads to the formation of OH. by the metal-
mediated, Haber-Weiss reaction. The presence of the enzyme myaloperoxidase leads to 
the production of HClO by interaction between hydrogen peroxides and chlorides [110, 
111] 
ROS are also generated by cellular oxidase reactions catalyzed by enzymes such 
as NADPH oxidase, monoamine oxidase, and xanthine oxidase. NADPH oxidase 
functions in the cell membrane of neutrophills and other phagocytic cells to produce 
superoxide anion as part of a bactericidal mechanism known as the inflammatory burst 
[112]. Chronic granulomatous disease is an inherited disorder in which a component of 
the inflammatory burst is defective. Individuals with this disease suffer chronic infections 
due to the inability of neutrophills to kill microbes [113]. In addition to using ROS to 
protect the organism, ROS are generated as byproducts of other oxidase reactions. 
Monoamine oxidases catalyze deamination reactions, which are necessary to digest 
nitrogen containing compounds such as serotonin, tryptamine and 2-phenylethlyamine, as 
well as to inactive catecholamine-containing neurotransmitters such as dopamine, 
epinephrine, norepinephrine and histamine. In this process another ROS, hydrogen 
peroxide is generated [114]. Xanthine oxidoreductase catalyzes the oxidation of 
hypoxanthine to xanthine and the oxidation of xanthine to uric acid. By-products of this 
reaction also include the ROS superoxide anion and hydrogen peroxide. Xanthine oxidase 
is implicated in the ischemia-reperfusion injury, which generated high levels of ROS. 
During ischemia, the cell loses its ability to maintaining ATP levels, resulting in the 
breakdown of transmembrane ion gradients and increased intracellular calcium levels. In 
addition, ATP catabolizes hypoxanthine, which accumulated along with xanthine 
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oxidase. Upon reperfusion, levels of oxygen increase, and the primed xanthine 
oxidase/hypoxanthine reaction reduces oxygen, generating high levels of superoxide and 
hydrogen peroxide. These ROS can form highly reactive hydroxyl radicals which cause 
injury to surrounding tissue. 
Metabolism 
Although the exposure of the organism to ROS is extremely high from exogenous 
sources, the exposure to endogenous sources is much more important and extensive, 
because it is a continuous process during the life span of every cell in the organism [84]. 
The reduction of oxygen to water in the mitochondria for ATP production occurs through 
the donation of 4 electrons to oxygen to produce water [115]. A major source of ROS 
(ROS) is generated during cellular respiration, when a molecule of oxygen accepts four 
electrons from reduced NADH and FADH2 generated by the glycolytic pathway and 
citric acid cycle, eventually forming H2O. The free energy generated by this process 
drives the synthesis of adenosine triphosphate (ATP). The mitochondria regulate the 
stepwise transfer of electrons to oxygen by a series of electron carriers. The incomplete 
transfer of electrons to oxygen generates reactive intermediates that may oxidize lipid, 
proteins and nucleic acids. The reactive intermediates include superoxide anion (), 
hydrogen peroxide, or hydroxyl radical in order of the stepwise reduction of oxygen to 
water. During this process several major oxygen derivatives are formed [116]. In many 
cases there is a leakage of ROS from the mitochondria into the intracellular environment 
[116]. The mitochondrion serves as the major organelle responsible for ROS production 
and many events throughout the cell cycle [117]. The massive production of 
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mitochondrial ROS is increased further in the aging cell where the function of the 
mitochondrion is impaired and its membrane integrity damaged [118]. 
Diseases 
Numerous pathologies and disease states serve as sources for the continuous 
production of ROS [119-128]. Many clinical disorders have been described in the 
literature in which ROS were important for the initiation stage of a disease or are 
produced during the course of a disease. ROS may be important initiators and mediators 
in many types of cancer [124, 129-132], heart diseases, endothelial dysfunction [133, 
134], atherosclerosis and other cardiovascular disorders, inflammation and chronic 
inflammation [135], burns [136], brain degenerative impairments [137, 138], diabetes 
[131, 139, 140], eye diseases [141], and ischemic and post ischemic (e.g., damage to skin, 
heart, brain, kidney, liver, and intestinal tract) pathologies [104, 142]. In several normal 
conditions ROS are produced and play a role in the pathogenesis of the physiological 
condition.  
 
2.2.3. ROS signaling 
ROS are generated following ligand-receptor interactions and function as specific 
second messengers in signaling cascades involved in cell proliferation and differentiation. 
Although ROS are generated intracellularly by several sources, including mitochondria, 
the primary sources of ROS involved in receptor-mediated signaling cascades are plasma 
membrane oxidases, preferentially NADPH oxidases, with a rapid kinetics of activation 
and inactivation. This allows a tight up- and downregulation of intracellular ROS levels 
within the short time required for the transduction of signals from the plasma membrane 
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to the cell nucleus. The mode of action of ROS may involve direct interaction with 
specific receptors, and/or redox-activation of members of signaling pathways such as 
protein kinases, protein phosphatases, and transcription factors. Furthermore, ROS act in 
concert with intracellular Ca
2+
 in signaling pathways which regulate the balance of cell 
proliferation versus cell cycle arrest and cell death. The delicate intracellular interplay 
between oxidizing and reducing equivalents allows ROS to function as second 
messengers in the control of cell proliferation and differentiation [143]. 
Extracellular factors including ROS draw out a variety of responses, such as cell 
proliferation or cell death, through the cellular signaling system. Binding of growth 
factors to the receptors leads to the activation of receptor tyrosine kinases, which in turn 
stimulate downstream signaling systems such as mitogen-activated protein (MAP) 
kinases, phospholipase C gamma (PLCgamma) and phosphatidylinositol 3-kinase. These 
biochemical reactions finally reach the nucleus, resulting in gene expression mediated by 
the activation of several transcription factors. Various studies have revealed that cellular 
signaling pathways are regulated by the intracellular redox state. Generation of ROS, 
such as H2O2, leads to the activation of protein tyrosine kinases followed by the 
stimulation of downstream signaling systems. Cellular signaling pathways are generally 
subjected to dual redox regulation in which redox has opposite effects on upstream 
signaling systems and downstream transcription factors. Not only are the cellular 
signaling pathways subjected to redox regulation, but also the signaling systems regulate 
the cellular redox state. When cells are activated by extracellular stimuli, the cells 
produce ROS, which in turn stimulate other cellular signaling pathways, indicating that 
ROS act as second messengers. It is thus evident that there is cross talk between the 
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cellular signaling system and the cellular redox state. Cell death and life also are 
subjected to such dual redox regulation and cross talk. Death signals induce apoptosis 
through the activation of caspases in the cells. Oxidative radical stress induces the 
activation of caspases, whereas the oxidation of caspases results in their inactivation. 
Furthermore, some cell-death signals induce the production of ROS in the cells, and the 
ROS produced in turn stimulate the cell-death machinery. All this evidence shows that 
the cell's fate is determined by cross talk between the cellular signaling pathways and the 
cellular redox state through a complicated regulation mechanism [144]. 
 
2.2.4. Antioxidant Systems  
Given that the cell is exposed to potentially dangerous ROS generated by aerobic 
respiration and by the enzymatic activity of oxidases, antioxidant systems are in place to 
neutralize the ROS. Redox homeostasis involves balancing cellular ROS with the 
antioxidants that neutralizes them. Antioxidants donate electrons to ROS safely, 
neutralizing them before they abstract electrons from sensitive targets such as lipids or 
DNA. Antioxidants include the enzymes superoxide dismutase, catalase, glutathione 
peroxidases, quinine reductase, heme oxygenase, thioredoxin and glutathione reductase, 
in addition to non-enzymatic compounds vitamin E (-tocopherol), carotenoids, vitamin 
C (ascorbic acid) and glutathione. Glutathione is a tripeptide composed of glutamate, 
cysteine and glycine. It is present in high levels (5 – 10 mM) and serves as a cellular 
antioxidant buffer. The thiol groups in this cysteine containing peptide and other proteins 
such as thioredoxin act as basal reducing factors by undergoing reversible disulfide bond 
formation. The superoxide dismutase enzymes convert 𝑂2
− to the non-radical reactive 
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species hydrogen peroxide, and the catalase enzyme converts peroxide into water. In the 
presence of reduced iron however, hydrogen peroxide can be converted in highly reactive 
hydroxyl radical. Superoxide radicals can also react with nitric oxide (NO) to generate 
cytotoxic peroxynitirite anions (ONOO
-
). When the cell cannot maintain a balance 
between the production of ROS and the neutralization of ROS by antioxidant mechanism, 
the cell is considered to be in a state of oxidative stress [54, 55, 131, 145-148]. 
 
2.3. Effects of Oxidative Stress  
When the cell cannot maintain a balance between the production of ROS and the 
neutralization of ROS by antioxidant mechanisms, the cell is considered to be in a state of 
oxidative stress. Having too many ROS in relation to the available antioxidants is often 
said to be a state of oxidative stress [56, 74]. The term oxidative stress is widely used in 
free radical literature, but is not clearly defined. In 1991 Sies, H. defined oxidative stress 
as a disturbance in the prooxidant-antioxidant balance in favor of the former, leading to 
potential damage. Such damage is often called oxidative damage. Halliwell and 
Gutteridge define oxidative damage as the biomolecular damage caused by attack of ROS 
upon the constituents of living organisms [54]. Increased oxidative damage can result not 
only from more oxidative stress, but also from more failure of repair or replacement 
systems. Consequences of oxidative stress can include any, or any combination of, the 
following to an extent that depends on the cell type and the severity of oxidative stress. 
Many cells respond to mild oxidative stress by proliferating. Cells may adapt to the 
oxidative stress by upregulation of defense systems, which may (a) completely protect 
against damage; (b) protect against damage to some extent or (c) overprotect the cells, 
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thereby making them resistant to oxidative stress imposed subsequently. Moderate levels 
of oxidative stress may lead to cellular injury. This involves damage to some or all 
molecular targets: lipids, DNA, proteins, carbohydrates etc. Such damage can sometimes 
be the trigger leading to cellular adaptations. At higher levels of oxidative stress, cells 
may enter a state of senescence, in which the cell survives but cannot divide. After 
cellular injury due to oxidative stress the cell may: (a) recover from the oxidative damage 
by repairing it or replacing the damaged molecules; or (b) it may survive with persistent 
oxidative damage; or (c) oxidative damage, especially to DNA, may trigger death by 
apoptosis, necrosis, or cell death [54]. Finally, chronic elevation in the ROS may play a 
role in the pathogenesis of cancer  [124], diabetes [139], atherosclerosis [119, 126], 
neurodegeneration [120, 137, 138], ischemia/reperfusion injury [104, 134, 142] and other 
diseases. In the next section we elaborate the biological effects of oxidative stress. 
 
2.3.1. Biological Effects of Oxidative Stress 
  The continuous efflux of ROS from endogenous and exogenous sources results in 
continuous and accumulative oxidative damage to cellular components [149] and alters 
many cellular functions [150]. Among the biological targets most vulnerable to oxidative 
damage are enzymes [54, 151], lipid membranes [54, 152], and DNA [54, 153] (see 
Figure 6). Our understanding of the chemistry of radicals clarifies the interaction of these 
species in the locations at which they are being produced. For example, hydroxyl 
radicals, produced in mitochondrial compartments, are responsible for damage occurring 
in the mitochondrion but not the nucleus. Their high reactivity with biological molecules, 
which leads to their extremely short life span, does not permit their distribution within 
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the intracellular environment and limits their ability to cause damage a long distance 
from their site of formation. On the other hand, oxygen metabolites those are not 
extremely reactive, such as HO2 may exist in the intracellular environment for longer 
periods of time and reach locations far from their production site. For example, H2O2 
produced in mitochondria may interact elsewhere in the cytoplasm or in the nucleolus. 
 
Figure 6. Oxidative damage induced by reactive oxygen species [55] 
Although paradoxical, the oxidative stress phenomenon, while associated with 
deleterious processes and harmful events, is essential to the existence and development of 
the cell [131]. Oxidative conditions are the stimulating force for biochemical processes 
and events during the life span of the cell. While the resting-cell environment is highly 
reduced, it becomes more and more oxidized during proliferation and activation of 
cellular biochemical pathways until apoptosis and necrosis occur. In these latter stages 
the cellular environment becomes highly oxidized [154]. ROS and RNS play crucial roles 
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in gene activation [155, 156], cellular growth [157], and modulation of chemical 
reactions in the cell [158, 159] and function as major components of the defense against 
bacteria and viruses provided by neutrophills (phagocytes) and as agents responsible for 
dilation of blood vessels (e.g., NO) [160]. They also participate in blood pressure control 
[161]; are important mediators in the biosynthesis of other molecules, such as 
prostaglandins [162]; function in embryonic development [163]; and act as signaling 
molecules within the individual cell and among cells during their life spans [164]. 
 
2.3.2. Cell Proliferation 
 Low level oxidative stress (e. g. by adding small amounts of H2O2 [148], low dose 
non-thermal plasma [44], or exposure of cells to centrigray level doses of ionizing 
radiation [165-167] ) stimulates the proliferation of several cell types in culture. The 
arrest of growth induced by cell confluence has been suggested by some to be related to a 
decrease in intracellular ROS and consequent loss of pro-proliferative stimuli[168]. 
Studies have further demonstrated that even exogenous ROS at sub-lethal levels can 
mimic certain growth factors to regulate, and activate the mitogenic-associated signal 
transduction pathways in the cells. It is now recognized that ROS at low concentrations 
are ubiquitous intracellular messengers. Recently a new physiological role of ROS was 
identified in several non-phagocytic cells, in which ROS generation was associated with 
the mitogenic stimulus action of growth factors [169]. A role for ROS production and 
oxidative stress has been proposed for the stimulation of cell proliferation. The effects of 
ROS and oxidative stress within cells appear to be cell specific and dependent upon the 
form as well as the intercellular concentration of ROS. ROS function to induce cell 
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proliferation during the tumor promotion stage of carcinogenesis (100). Both H2O2 and 
superoxide anion (O2
-
) induce mitogenesis and cell proliferation in several mammalian 
cell types (101). Furthermore, a reduction in cellular oxidants via supplementation with 
antioxidants such as superoxide dismutase, catalase, -carotene, and flavenoids inhibits 
cell proliferation in vitro (102. Although no single mechanism explains the increased cell 
proliferation and/or inhibition of apoptosis observed following conditions that favor 
increased cellular oxidants, mounting evidence is emerging that links ROS with altered 
expression of growth regulatory genes [124]. Diminishing ROS levels can decrease cell 
proliferation; for example overexpression of catalase in rat aortic smooth muscle cells 
lowered H2O2 levels and blocked their proliferation. Pro-Proliferative effects of ROS may 
contribute to atherosclerosis, angiogenesis, rheumatoid arthritis and to fibrosis in several 
human diseases [168]. 
 
2.3.3. Cellular Adaptation 
Oxidative stress involves responses to oxidants or agents that cause oxidation via 
intracellular redox reactions. As described earlier, a wide variety of agents and 
compounds, including oxygen itself, can cause oxidative stress if present in sufficient 
concentration. Severe oxidative stress can result in compromise of vital cell or 
organismal functions or even loss of viability. Cells usually tolerate mild to moderate 
oxidative stress, which often results in increased synthesis of antioxidant defences in an 
attempt to restore the oxidant/antioxidant balance. In many cases, mild oxidative stress 
can elevate defenses sufficiently to protect cells against more severe oxidative stress 
applied subsequently [168]. Studies have shown that cells can adapt to withstand 
extremely high levels of oxidative stress is first applied. Davies, K. J. A. et. al. have 
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reported a transient adaptation to the oxidative stress of hydrogen peroxide (H2O2) 
exposure in several mammalian cell lines including Chinese hamster ovary fibroblast 
cells, embryonic mouse fibroblasts, etc. They showed that very low concentrations of 
H2O2 from 3 – 15 M result in 25 – 40% stimulation of cell growth while low H2O2 
concentrations of 120 – 150 M induced a temporary growth arrest and marked adaptive 
increase in H2O2 resistance, whereas higher H2O2 concentrations were strongly cytotoxic. 
They discovered that if the cells were pretreated with H2O2, however, the toxicity of 
subsequent H2O2 exposure was significantly reduced. The observed adaptation, though, 
comes at the cost of compromised replicative or divisional competence rather than gross 
destruction of cells. The adaptation may be explained by the fact that pretreatment with 
H2O2 induced the overexpression of antioxidants, such as catalases or glutathione 
peroxidases, which are capable of neutralizing the effects of H2O2. It is possible that 
mammalian cells normally adapt to fluctuating oxidative stress levels in vivo by 
transiently overexpressing a series of both antioxidant and non-antioxidant genes [148].  
 
2.3.4. Cell Injury  
All aerobic cells generate, enzymatically or non-enzymatically, a constitutive flux 
of O2
-
, H2O2, and possibly OH

. At the same time, the abundant antioxidant defenses of 
most cells, again both enzymatic and nonenzymatic, prevent these species from causing 
cell injury. Nevertheless, there are situations in which the rate of formation of partially 
reduced oxygen species is increased and/or the antioxidant defenses of the cells are 
weakened. In either case, oxidative cell injury may result [170].   
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2.3.4.1. Effects on Lipid Membranes 
All cellular membranes are especially vulnerable to oxidation due to their high 
concentrations of unsaturated fatty acid. The damage to lipids, usually called lipid 
peroxidation, occurs in 3 stages. The first stage, initiation, involves the attack of a 
reactive oxygen metabolite capable of abstracting a hydrogen atom from a methylene 
group in the lipid. The presence of a double bond adjacent the methylene group weakens 
the bond between the hydrogen and carbon atoms so that it can easily be removed from 
the molecule. Following hydrogen abstraction, the remaining fatty acid radical retains 1 
electron and is stabilized by rearrangement of the molecular structure to form a 
conjugated diene. When oxygen is in sufficient concentration in the surroundings, the 
fatty acid radical will react with it to form ROO

 during the propagation stage. These 
radicals themselves are capable of abstracting another hydrogen atom from a neighboring 
fatty acid molecule, which leads again to the production of fatty acid radicals that 
undergo the same reactions—rearrangement and interaction with oxygen. The ROO 
radical becomes a lipid hydroperoxide that can further decompose to an aldehyde or form 
cyclic endoperoxide, isoprotans, and hydrocarbons. The propagation stage allows the 
reaction to continue. A single initiation can lead to a chain reaction resulting in 
peroxidation of the entire unsaturated lipid in the membrane. An antioxidant that can stop 
this process is therefore defined as a chain-breaking antioxidant. Fatty acids with no 
double bonds or with 1 double bond can undergo oxidation but not a chain lipid 
peroxidation process; for example, oleic acid with 18 carbon atoms and 1 double bond 
(18:1) cannot undergo the lipid peroxidation process. The last stage, chain termination, 
occurs following interaction of one ROO

 with another radical or antioxidants [54, 171]. 
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2.3.4.2. Effects on DNA 
Although DNA is a stable, well-protected molecule, ROS can interact with it and 
cause several types of damage: modification of DNA bases, single- and double-DNA 
breaks, loss of purines (apurinic sites), damage to the deoxyribose sugar, DNA-protein 
cross-linkage, and damage to the DNA repair system. Not all ROS can cause damage; 
most is attributable to hydroxyl radicals. For example, following exposure of DNA to 
hydroxyl radicals, like those induced by ionizing irradiation, a variety of adducts are 
formed. The OH

 radical can attack guanine at its C-8 position to yield an oxidation 
product, 8- hydroxydeoxyguanosine (8-OHdG) [172]. Other positions could be attacked, 
and other possible products could be formed. Hydroxyl radicals can also attack other 
bases like adenine to yield 8 (or 4-, 5- ) - hydroxyadenine. Other products are the result of 
interactions between pyrimidines and hydroxyl radicals leading to the formation of 
thymine peroxide, thymine glycols, 5- (hydroxymethyl) uracyl, and other such products. 
The direct interaction of DNA with other less reactive ROS, such as O2
-
 and H2O2, does 
not lead to damage at their physiological concentrations; however, these species serve as 
sources for other reactive intermediates that can easily attack and cause damage. For 
example, H2O2 and superoxide might lead to the production of the OH. via the Haber-
Weiss reaction, and NO and O2
-
 might lead to the formation of ONOO
-
 that can easily 
cause DNA damage similar to that obtained when hydroxyl radicals are involved. 
Transition metals like iron that possess high-binding affinity to DNA sites can catalyze 
the production of OH

 in close proximity to the DNA molecule, thus ensuring repeated 
attack upon the DNA by an efflux of hydroxyl radicals [173-176]. 
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The primary source of DNA oxidation is the hydroxyl radical. The hydroxyl 
radical abstract hydrogens from a base or sugar component of DNA, generating water and 
a carbon-centered radical. The carbon centered radical eventually becomes a 
hydroxylated carbon that may be further modified, generating a variety of products. 
Hydroxyl radical attack causes the degradation of bases, and breakage of the sugar-
phosphate backbone either directly through oxidative degradation of the deoxyribosyl 
group or indirectly through the creation of an abasic site followed by a beta-elimination 
reaction [62]. If not repaired, DNA breaks can cause chromosomal aberrations or even 
cell death. DNA strand breaks may also indirectly cause cell death by depleting 
intracellular NAD+/NADH due to activation of the polyadenosine diphosphate (ADP) 
ribosyl transferase-dependent repair pathways [177]. The carbon-centered radicals may 
also react with amino acids residues in nuclear proteins bound to DNA, forming DNA 
protein crosslink‘s [62]. 
More than 50 different types of oxidatively modified purine and pyrimidine bases 
have been detected in nucleic acids exposed to ROS. Base modifications include addition 
of chemical groups such as hydroxyl groups and ring opening, which can lead to single 
base changes or base deletions [62]. Guanine is the most easily oxidized nucleotide, as it 
has the lowest redox potential among the DNA bases [178]. 8-oxo-7, dehydroguanine is 
the most abundant oxidative lesion of DNA [179]. 8-oxoguanin is formed when a 
hydroxyl radical abstracts an electron from the C8 position of guanine, generating a C8-
OH adduct radical. Loss of an electron and proton generates 8-oxoguanine, while gain of 
an electron and proton generates 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FaPy), 
the second major oxidation product of guanine [180]. Although 8-oxoguanine does not 
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block DNA synthesis, it can induce base mispairing during DNA synthesis because 8-
oxoguanine can pair with both cytosine and adenine. This mispairing can lead to G: C  
T: A transversions during DNA replication. In addition, oxidation of guanine can occur in 
the cellular pool of dGTP, forming 8-oxo-dGTO. This DNA substrate can be 
incorporated opposite adenine or cytosine residues of template DNA, resulting in A: T  
C: G and G: C  T: A transversions [181]. The most prevalent modification to 
pyrimidines is the formation of thymine glycol which, unlike 8-oxoguanine, creates a 
bulky lesion on DNA that blocks replication and transcription. Hydroxyl radical 
abstraction at the C5=C6 double bond can result in the formation of C5-OH adduct 
radicals of thymine. Addition of OH
-
 or addition of water followed by deprotonation 
generates thymine glycol [179]. Also, oxidation of 5-methylcytosine (m
5
C) results in the 
formation of thymine glycol [182]. 
 
2.3.4.3. Effects on Proteins 
Proteins, also major constituents of membranes, can serve as possible targets for 
attack by ROS. Among the various ROS, the OH

 radical, RO

 radical, and nitrogen-
reactive radicals predominantly cause protein damage. Hydrogen peroxide itself and 
superoxide radicals in physiological concentrations exert weak effects on proteins; those 
containing SH groups, however, can undergo oxidation following interaction with H2O2. 
Proteins can undergo direct and indirect damage following interaction with ROS, 
including peroxidation, damage to specific amino-acid residues, changes in their tertiary 
structure, degradation, and fragmentation. The consequences of protein damage as a 
response mechanism to oxidative stress are loss of enzymatic activity, altered cellular 
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functions such as energy production, interference with the creation of membrane 
potentials, and changes in the type and level of cellular proteins. Protein oxidation 
products are usually aldehydes, ketocompounds, and carbonyls. One of the major adducts 
that can easily be detected and serve therefore as a marker for protein oxidative damage 
is 3-nitrotyrosine. This adduct is produced following the interaction between ONOO

 and 
other nitrogen reactive radicals with the amino acid tyrosine. Following OH

 radical 
attack, a series of compounds can be formed, including hydroxyproline, glutamyl 
semialdehyde, and others. Following protein oxidation, modified proteins are susceptible 
to many changes in their function. These include chemical fragmentation, inactivation, 
and increased proteolytic degradation [152, 183-185]. 
 
2.3.5. Cellular Senescence 
 High levels of oxidative stress may induce a permanent state of non-division, 
known as senescence. For example human fibroblasts exposed to 100 – 300 M H2O2 in 
culture developed a senescent phenotype, showing increased expression of proteins that 
inhibit the cell cycle. Senescence after prolonged cell culture is in part due to the 
oxidative stress of the culture process [54].  
After a finite number of divisions, primary cell cultures enter a state of replicative 
senescence in which they are growth-arrested and refractory to further mitogenic 
stimulation. Although the relevance of in vitro senescence to organismal ageing remains 
controversial, several studies indicate that oxidants are important in the development of 
the senescent phenotype. Early studies with human diploid fibroblasts revealed that cells 
grown in low oxygen tension exhibit a prolonged life span. In contrast, cells grown in the 
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presence of high oxygen concentrations have a reduced life span and show an accelerated 
rate of telomere shortening per population doubling. Similarly, treatment of cultures of 
primary fibroblasts with moderate, non-lethal doses of exogenous hydrogen peroxide 
activates a rapid, senescence-like growth arrest [186].  
The role of oxidants in cellular senescence was further underscored by recent 
observations that overexpression of an activated Ras gene can also induce a senescence-
like state in human diploid fibroblasts. Subsequent analysis demonstrated that expression 
of activated Ras in diploid fibroblasts resulted in an increase in oxidant levels [187]. In 
addition, although expression of activated Ras in human diploid fibroblasts produced 
growth arrest, this arrest could be reversed either by reducing ambient oxygen or by 
treatment with a cell-permeable antioxidant. As such, these results raise the possibility 
that a moderate, sustained rise in oxidants may function as a common trigger for 
activation of the senescence program [188]. 
 
2.3.6. Cell Death 
A cell exposed to severe oxidative stress may eventually die. Cell death can occur 
essentially by two mechanisms, necrosis and apoptosis, although death by mechanisms 
with features of both pathways is often seen (see Figure 7). Necrosis and apoptosis result 
from many causes, including oxidative stress. For example, in mammalian cells, adding 
mM levels of H2O2 can cause necrosis, whereas lower levels can trigger apoptosis [189]. 
H2O2 induces apoptosis via production of OH

 radicals [190]. Further there is evidence 
that intracellular H2O2 is an important mediator of the cytotoxic effects of several types 
of antineoplastic therapy including chemotherapy [191-193], ionizing radiation [194, 
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195], ultraviolet radiation [196, 197], and possibly photodynamic therapy [189, 198]. 
Lipid peroxides formed due to excessive oxidative stress are also known to trigger 
apoptosis [199]. Several observations suggest that ROS might mediate apoptosis. For 
example (a) the addition of ROS or the depletion of endogenous antioxidants can induce 
apoptosis. (b) apoptosis sometimes can be inhibited by endogenous or exogenous 
antioxidants; (c) apoptosis is sometimes associated with increases in intracellular ROS 
levels [200].  
 
Figure 7. Range of cellular oxidative stress responses [148] 
During necrotic cell death there is cell and organelle swelling, loss of integrity of 
mitochondrial, peroxisomal and lysosomal membranes and eventual rupture of the 
plasma membrane, releasing contents in to the surrounding area to affect adjacent cells 
[54]. In apoptosis, the cell‘s own intrinsic ‗suicide mechanism‘ is activated. Apoptosis is 
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characterized by membrane blebbing, outer membrane leaflet inversion and exposure of 
phosphatidyl serine, cytosolic condensation, breakdown of nuclear DNA and finally, at 
least in vitro, the formation of well enclosed, apoptotic bodies [201]. Apoptosis is usually 
considered to involve two phases; (a) an activation phase, consisting of intracellular 
signaling pathways and (b) an execution phase, consisting of molecular machinery 
necessary for apoptosis to be completed. ROS have been shown to play an important role 
in the activation phase while not so much in the execution phase. In pathological 
circumstances ROS might trigger apoptosis by activating signaling pathways responsive 
to ROS themselves or damage caused by ROS [200]. 
One of the major insults that trigger apoptosis is oxidative stress, though higher 
levels of oxidative stress may also induce necrosis. Endogenously produced ROS play a 
key role in programmed cell death pathways of many cell types [201]. ROS and oxidative 
damage have been implicated in the induction of apoptosis.  On the other hand, apoptosis 
triggered by mechanisms like ligand binding to death receptors is accompanied by 
oxidative stress. Releases of cytochrome c and caspase cleavage disrupt the 
mitochondrial electron transport chain, causing an excessive production of superoxide 
(O2
-
). Studies have shown that in many cases antioxidants slow down apoptosis induced 
via oxidative stress by a range of insults which include ionizing radiation, UV, hydrogen 
peroxide and more recently non-thermal atmospheric pressure plasma. 
Generation of oxidative stress in response to various stimuli has also been 
implicated in the triggering of apoptosis. ROS and mitochondria play an important role in 
apoptosis induction under both physiologic and pathologic conditions. Cytochrome c 
release from mitochondria, that triggers caspase activation, appears to be largely 
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mediated by direct or indirect ROS action. Receptors of the tumor necrosis factor (TNF) 
family display various functions from cell growth to differentiation and cell death. A 
subset of this family, known as death receptors have been shown to induce apoptosis in 
some systems. Activation of these receptors by binding of TNF like ligands is sufficient 
and necessary to induce death via caspase dependent mechanisms. Interestingly studies 
have shown that N-acetylcysteine blocked the TNF-induced apoptosis suggesting a 
functional role of ROS in the process of apoptosis. Activation of the FAS receptor, which 
also belongs to the TNF receptor family, results in a signal transduction pathway that 
most likely uses ROS [202]. 
Necrotic cell death has long been considered an accidental and uncontrolled mode 
of cell death. But recently it has become clear that necrosis is a molecularly regulated 
event that is associated with numerous pathologies. Excessive oxidative stress can lead to 
necrosis via generation of intracellular ROS.  ROS initiate damage to lipids, proteins and 
DNA and consequently results in mitochondrial dysfunction, ion balance deregulation 
and loss of membrane integrity which eventually leads to necrotic cell death [203]. In 
many cases caspases which have exposed –SH groups can be inactivated due to attack by 
high levels of ROS like H2O2, HOCl, OH

 and ONOO

. These leads to a delay or halt in 
apoptosis and often cell death proceeds though the necrotic pathway [168]. ROS can 
initiate damage to proteins, nucleic acids and lipids [204, 205]. ROS can attack the 
disulfide bonds (-S-S-) and thiol groups (-SH) of proteins and thereby change their 
functions. Another effect of ROS during necrosis could be the modification of Ca'+ 
channels of the ER and plasma membrane [206]. Mitochondrial DNA is particularly 
susceptible to oxidative damage because of the absence of protective histones, limited 
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base excision repair mechanisms, and close proximity to the electron transport chain, all 
of which lead to mitochondrial genomic instability and consequent respiratory 
dysfunction followed by necrosis. Other important targets susceptible to ROS activity are 
the polyunsaturated fatty acids in the cellular membranes. Reactive aldehydes derived 
from lipid peroxidation can compromise the membrane function by interacting with both 
the protein and the lipid moieties in the membrane [207]. In mitochondria, the lipid 
peroxidation products negatively affect oxidative phosphorylation , inner membrane 
barrier properties, maintenance of mitochondrial membrane potential, and the 
mitochondrial Ca
2+
 buffering capacity, contributing in this way to necrosis [208]. Lipid 
peroxidation-mediated destabilization of both the plasma membrane and intracellular 
membranes, such as those of the lysosomes and the ER, results in leakage of proteases or 
efflux of Ca
2+
 into the cytosol, both of which participate in necrotic cell death processes 
[203]. 
 
2.3.7. Role of Oxidative Stress in Diseases 
 In the evolution of life on planet Earth was the acquisition of mitochondria, and 
thus of oxidative phosphorylation, by primordial cells. This achievement provided cells 
with larger amount of energy, which significantly contributed to the evolution of 
unicellular organisms into more complex and specialized living forms. However, this 
progress did not occur without any expenses. The use of oxygen in energy metabolism 
increased the production of energy as ATP, but toxic and potentially lethal substances 
were also produced, the ROS, which should be rapidly detoxified to prevent molecular 
and cellular damages. As a consequence, antioxidant systems developed to counteract the 
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negative effects of ROS, and living organisms adapted to strive by maintaining a specific 
redox state, i.e. a balance between ROS production and antioxidants‘ scavenger activity 
[123]  
 During the last two centuries, the life expectancy significantly increased, mostly 
because of improved nutrition, since medical advances contributed to this progress when 
mortality rates had already fallen substantially. However, longer life results in longer 
exposure to toxic agents, including ROS. Also, age- and/or disease-related inefficiency of 
antioxidant systems and reduced intake of antioxidants with the diet due to age- and/or 
disease-related anorexia increase oxidative stress, which in turn may promote molecular 
damages triggering the onset of degenerative diseases, worsening the clinical condition of 
patients and preventing healthy aging [123]. Chronic elevation in ROS may play a role in 
the pathogenesis of cancer, diabetes, atherosclerosis, neurodegenerative diseases 
including Alzheimers and Parkinson‘s, ischemia/reperfusion injury, and other diseases. 
Based on these premises, it is not surprising that considerable scientific efforts have been 
put into the investigation of the role of oxidative stress in various diseases, in aging 
process and in the pathogenesis of degenerative diseases. Leading researchers in their 
respective fields reviewed the available evidence to delineate the role of oxidative stress 
in cancer [124, 130], diabetes [209], atherosclerosis [119, 126], Alzheimer‘s [120] and 
Parkinson‘s diseases [125]. 
 A linkage between an increase in cellular reactive oxygen radicals and the 
pathogenesis of several chronic diseases including cancer has been established. Cellular 
oxidants (reactive oxygen and nitrogen species) can be generated from endogenous 
(normal physiological processes) as well as exogenous sources (xenobiotic interaction). 
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When the antioxidant control mechanisms are exhausted or overrun, the cellular redox 
potential shifts toward an oxidative stress, in turn, increasing the potential for damage to 
cellular nucleic acids, lipid, or protein. Unrepaired damage to DNA may result in 
mutation, provided cell replication ensues prior to repair of modified bases. Although 
importance has been established for the role of oxidative nuclear DNA damage in 
neoplasia, formation of mitochondrial DNA damage, mutation, and alteration of the 
mitochondrial genomic function also appear to contribute to the process of carcinogenesis 
Besides direct modification of nuclear and/or mitochondrial DNA, interference with 
oxidative DNA repair mechanisms (in both nuclear and mitochondrial compartments) 
contributes to an increase in mutation frequency and persistent oxidative DNA damage. 
Aside from a role of oxidants in the induction of mutation, it is apparent that ROS and 
cellular redox status mediate cell signaling pathways that are involved in cell growth 
regulatory pathways and, thus, the carcinogenesis process [124, 130]. 
In diabetes oxidative stress plays a key role in the pathogenesis of vascular 
complications, and an early step of such damage is considered the development of an 
endothelial dysfunction. Hyperglycemia directly promotes an endothelial dysfunction 
inducing process of overproduction of superoxide and consequently peroxynitrite that 
damages DNA and activates the nuclear enzyme poly (ADP-ribose) polymerase. This 
process, depleting NAD+, slowing glycolysis, ATP formation and electron transport, 
results in acute endothelial dysfunction in diabetic blood vessels and contributes to the 
development of diabetic complications [209]. 
 Oxidative stress seems to play a key-role in the pathogenesis of atherosclerosis. 
Intracellular ROS (ROS) have been increasingly appreciated to have a role in this 
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context. ROS seem to mediate various signaling pathways that underlie atherogenesis, 
from the initiation of fatty streak development through lesion progression to ultimate 
plaque rupture. Moreover enhanced oxidative stress has been found in many of the 
classical risk factors for cardiovascular disease [119, 126]. 
 Research has shown that oxidative stress mediates an important role in the 
pathogenesis of various neurodegenerative diseases including Alzheimer‘s disease (AD) 
and Parkinson‘s disease (PD). In recent years, there has been an increased awareness of 
the seminal role that both oxidative stress and redox-active transition metals play in AD 
as well as other neurodegenerative diseases. Examination of Alzheimer's disease brain 
has demonstrated a great deal of oxidative damage, associated with both hallmark 
pathologies (senile plaques and neurofibrillary tangles) as well as in normal appearing 
pyramidal neurons. The oxidative damage found in AD includes advanced glycation end 
products, nitration, lipid peroxidation adduction products, carbonyl-modified 
neurofilament protein and free carbonyls. Current evidence points to the fact that changes 
in the balance of redox transition metals, especially iron and copper, are key in the 
process. Both Fe and Cu are present at significantly elevated levels in AD neutrophil. 
Iron catalyzes the formation of OH

 from H2O2 as well as the formation of advanced 
glycation end products. Furthermore, aluminum, which also accumulates in NFT-
containing neurons, stimulates iron-induced lipid peroxidation. Advanced glycation end 
products in the presence of transition metals can undergo redox cycling with consequent 
production of ROS. Thus oxidative stress plays a major role in the pathogenesis of AD 
[120].  
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 Oxidative stress is also implicated in the pathogenesis of Parkinson‘s disease. 
Oxidative stress contributes to the cascade leading to dopamine cell degeneration in 
Parkinson‘s disease (PD). Oxidative stress is intimately linked to other components of the 
degenerative process, such as mitochondrial dysfunction, nitric oxide toxicity and 
inflammation Oxidative damage to lipids, proteins, and DNA occurs in PD, and toxic 
products of oxidative damage, such as 4-hydroxynonenal (HNE), can react with proteins 
to impair neuronal cell viability. The evidence for the occurrence of oxidative stress in 
PD is overwhelming, and there is little doubt that oxidative stress leads to an increase in 
oxidative damage in the brain cells [125]. 
 
2.4. Modalities Functioning via induction of Oxidative Stress 
 Currently various electrophysical effects like ionizing radiation, lasers, 
photodynamic therapy, pulsed electric fields and magnetic fields are being investigated or 
utilized in the treatment of various diseases and pathologies. Many of these devices are 
actually considered for similar types of medical applications. Non-thermal plasma and 
pulsed electric field, for example, are being viewed as potential treatments for cancer, an 
application where ionizing radiation has been employed for some time. In general, 
different electrophysical effects may have different advantages and disadvantages in a 
particular situation. However, exploiting advantages and circumventing disadvantages 
requires good understanding of biological mechanisms of interaction with cells and 
tissues. While such mechanisms are understood relatively well for modalities such as 
ionizing radiation, they remain poorly studied for non-thermal plasma, pulsed electric 
fields and to some extent for photodynamic therapy and laser treatment. In this section 
we consider the effects of and the mechanisms of interaction of three modalities of 
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treatment which are widely used in medicine; viz IR, H2O2 and UV, with cells and tissue, 
and all three of them are known to operate primarily via generation of intracellular 
oxidative stress. This section forms the basis of this thesis in trying to understand the 
mechanisms of interaction of non-thermal plasma with living cells. I specifically describe 
the commonalities and major differences between non-thermal plasma and IR/H2O2/UV 
later in this dissertation. 
 
2.4.1. Ionizing Radiation 
Ionizing radiation is a form of electromagnetic radiation that has the ability to 
create ions, directly or indirectly, as it passed through matter. Ionizing radiation is 
measured in units of Gray (Gy), a dosage value of 1 joule of energy absorbed by 1 kg of 
matter. Radiolysis, the breaking of one or more interatomic bond(s) due to exposure to 
high energy radiation, can occur in water to produce hydrogen peroxide, hydrogen atoms, 
hydrated electrons and hydroxyl radicals [210]. One of the important radiation-induced 
free-radical species is the hydroxyl radical which indiscriminately attacks neighboring 
molecules often at near diffusion-controlled rates. Hydroxyl radicals are generated by 
ionizing radiation either directly by oxidation of water, or indirectly by the formation of 
secondary partially ROS. These may be subsequently converted to hydroxyl radicals by 
further reduction (‗activation‘) by metabolic processes in the cell. Secondary radiation 
injury is therefore influenced by the cellular antioxidant status and the amount and 
availability of activating mechanisms. The biological response to radiation may be 
modulated by alterations in factors affecting these secondary mechanisms of cellular 
injury.  
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Ionizing radiation has been shown to generate ROS in a variety of cells [211]. 
When water, the most abundant intracellular material, is exposed to ionizing radiation, 
decomposition reactions occur, and a variety of ROS, including superoxide, hydroxyl 
radicals, singlet oxygen, and hydrogen peroxide, are generated [212]. The secondary 
radicals formed by the interaction of hydroxyl radicals with organic molecules may also 
be of importance [211, 212]. These ROS have the potential to damage critical cellular 
components such as DNA, proteins, and lipids and eventually result in physical and 
chemical damage to tissues that may lead to cell death or neoplastic transformation [213]. 
In many cases, ionizing radiation-induced cell death has been identified as apoptosis 
[214]. 
 
2.4.1.1. Biological Effects of Ionizing Radiation 
 Ionizing radiation (IR) is an invaluable diagnostic and therapeutic tool that is 
widely used in medicine. Human beings are constantly exposed to low levels of natural 
background radiations. In addition, exposure to low dose ionizing radiation (LDIR) from 
medical and industrial sources is becoming a worldwide problem. The cellular response 
to LDR is quite complex; the balance between death, arrest, and survival is tipped by the 
presence or absence of signaling through specific pathways, the identities of which are 
not yet clear. The biological effects of LDIR have attracted a lot of attention, but the 
biological mechanisms of the effects of LDIR still remain unclear. In this section we 
provide an overview of the current understanding of the biological effects of ionizing 
radiation and focus on the IR induced oxidative stress in mammalian cells.  
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2.4.1.2. Cell Proliferation 
While it has long been known that radiation leads to cell death, it has only 
recently become accepted that radiation has some potential to enhance proliferation in the 
surviving fraction of cells. Suzuki, et. al demonstrated that LDR stimulates the 
proliferation of normal human diploid cells. This effect was also observed in low-dose 
irradiated cells such as Raji lymphoma, Chinese hamster fibroblasts, and normal human 
diploid cells [165-167]. Exposure of cells to LDIR has been found to stimulate the 
activity of cell metabolism and enhancing cell growth. Irradiation at low doses of 
between 0.02 and 0.05 Gy caused stimulated proliferation of normal human diploid cells. 
Exposure to 0.5 Gy of IR stimulated induction of cell proliferation in mouse 
hematopoietic cells. 0.05 Gy of ionizing radiation enhances cell proliferation through the 
activation of ERK1/2 and p38 in normal human lung fibroblasts [165-167]. Suzuki, et. al. 
also found that 0.05 Gy of ionizing radiation enhanced cell proliferation and did not 
change the progression of the cell cycle. However, 2 Gy of ionizing radiation induced cell 
cycle arrest, phosphorylation of p53, and expression of p53 and p21 [167]. Thus low dose 
ionizing radiation enhances cell proliferation in various cell lines and it is possible that it 
does so by generating low concentration of ROS that may activate certain mitotic signal 
transduction pathways [165-167]. 
 
 
 
2.4.1.3. Cell Injury 
2.4.1.3.1. Effects on Lipids 
The interaction of ionizing radiation with biological matter induces complex and 
interconnected events. The excitation and ionization of atoms and molecules along 
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particle tracks result in physico-chemical reactions, initiating primarily hydroxyl and 
superoxide radicals [215]. For the past 30 years, the DNA molecule has been considered 
to be the essential target of ionizing radiation in the cell [216]. Less attention has been 
paid to biological membranes. The patho-physiological consequences of the exposure of 
biological tissue to ionizing radiation have usually been investigated in terms of cell 
death, with each cell considered as an independent entity. New concepts, however, 
increasingly take into account the importance of intercellular communication in 
determining the effects of radiation [217].  
Ionizing radiation induces oxidative damage in phospholipids [218, 219], initiated 
mainly by OH

 and O2
-
 radical products and leading to the appearance of various 
degradation substances and modified molecules. When hydroperoxide residues are 
produced in the bilayer core, hydrophobic interactions between adjacent phospholipids 
become unstable, allowing easier penetration of water molecules [220, 221]. Effects of 
ionizing radiation at doses below 10 Gy, as these doses are more compatible with cell 
survival, on biological membranes include alterations in membrane proteins, peroxidation 
of unsaturated lipids accompanied by perturbations of the lipid bilayer polarity. Finally, 
significant degradation of membrane function and structure may favor apoptosis [222, 
223]. Lipid peroxidation increased in the hours after radiation exposure, based on 
measurements of MDA and on the lipid peroxidation index after parinaric acid 
incorporation. (1) At 3 h after exposure to a dose of 2 or 4 Gy, the relative fluorescence 
of membrane-incorporated parinaric acid decreased significantly; (2) the MDA level also 
increased rapidly after exposure. Propagation of lipid peroxidation occurred in the hours 
after radiation exposure and returned to the basal level within 72 h. Radiation-induced 
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membrane damage may be a consequence not only of lipid peroxidation but also of 
protein oxidation [224]. Benderitter, et. al. showed that the carbonyl content of the 
membranes increased significantly in the hours after radiation exposure at doses as low as 
2 Gy. This study indicates that some alterations of membrane fluidity are observed after 
low irradiation doses and for some time thereafter. One consequence of the development 
of this oxidative stress is the reorganization of the fatty acid pattern, particularly of the 
PE. Specifically, Benderitter, et. al. also observed that the lipid compartment of the 
membrane became more fluid while the lipid–protein membrane interface became more 
rigid. After -radiation exposure, alterations occur in the plasma membrane that affects 
the state of the lipid–protein phase, the secondary structure of proteins, and the 
environment of aromatic amino acids [224]. Protein–lipid interactions that are known to 
occur in specific domains within the membrane may play an important role in mediating 
such radiation effects. The changes in membrane fluidity might reflect oxidative damage, 
thus confirming a radiation-induced fluidization of biological membranes. An imbalance 
between the radiation-mediated oxidative damages and the antioxidant capacity of the 
cells was observed in the hours after radiation exposure. This suggests that radiation 
exposure increases the oxidative damage to the cell membrane. These findings reinforce 
our understanding that the cell membrane is a significant biological target of radiation 
[224, 225]. 
 
2.4.1.3.2. Effects on DNA 
Damage to DNA occurs both directly, through the ionization of nucleotides, or 
indirectly, by the generation of ROS, or through the formation of DNA-protein 
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crosslinks. Radiolysis of water is thought to be the major potential cause of DNA damage 
in response to ionizing radiation. Ionizing radiation induces double strand breaks 
(DSB‘s), single strand breaks (SSB‘s), oxidized purines, oxidized pyrimidines, and abasic 
sites [226, 227]. In addition to inducing damage to isolated sites in the genome, ionizing 
radiation induces clustered lesions on DNA. Damage clusters have two or more lesions 
on opposing DNA strands within a few helical turns. These lesions are thought to be 
difficult to repair and may be a major source of IR induced cytotoxicity [228]. In human 
monocytes exposed to 1 Gy ionizing radiation, clustered DNA lesions represented 28% 
DSB‘s, 28% oxidized purines, 25% oxidized pyrimidines, and 20% abasic sites [229]. As 
cells attempt to repair DNA damage with glycosylases, double strand breaks can be 
induced [230]. Of the total damage to DNA caused by ionizing radiation, as much as 80% 
may result from radiation-induced water-derived free radicals and secondary carbon-
based radicals [211]. In addition to the generation of hydroxyl radicals, the hydrated 
electrons formed by ionizing radiation can reduce it to O2
-
. O2
-
 can dismutate to H2O2 
with the possibility of extra OH

 production by metal-catalyzed Fenton reaction [212]. 
 
2.4.1.3.3. Effects on Proteins 
Ionizing radiation is a very widely used treatment modality for cancer treatment. 
It is important to know how free radicals generated by IR during treatment of tissue 
interact with biological macromolecules like proteins and amino acids. After water, 
which is unreactive, proteins are the most abundant constituent of cells and extracellular 
fluids by weight. The probability of interaction between free radicals generated in 
biological systems by ionizing radiation and proteins is high [231, 232]. Proteins are 
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readily attacked by free radicals generated in vivo and in the process trap the energy of 
radicals acing as antioxidants. Many studies have shown that the antioxidant action of 
proteins in many cases leads to protein damage. In the presence of oxygen, serum 
albumins exposed to ROS suffer polypeptide chain scission. With -irradiation, all 
constituent amino acids of BSA are affected, but some show especially high damage, as 
much as 50-80% modification of proline, lysine etc [233].  Exception of cysteine, all 
amino acids of the type NH2CH(R) COOH undergo oxidative deamination in aqueous 
solution to yield ammonia, a-keto acid, and hydrogen peroxides. Although the aromatic 
and heterocyclic constituents and, in particular, the sulfur moieties appear to be the most 
susceptible to indirect action, the evidence is that the over-all reaction of protein involves 
a diversity of amino acid residues even at the lowest irradiation levels. Increased 
susceptibility to proteolysis is also a common consequence of protein oxidation [234].  
  
Figure 8. Peroxidation of amino acids by ionizing radiation. (A) Peroxidation of amino 
acids increase as the dose of ionizing radiation increases. (B) Peroxidation of proline 
increases as the concentration of proline increases [233]. 
Dilute aqueous solutions of BSA or lysozyme gave positive tests for 
hydroperoxides after exposure to ROS generated by -irradiation. Irradiation of dilute 
aqueous solutions containing oxygen leads to the production of both OH

 and O2
-
 and 
A. B. 
65 
 
 
free radicals in similar amounts. The oxygen free radicals effective in protein 
peroxidation were the hydroxyl and organic peroxyl, but not superoxide or its protonated 
form. Protein hydroperoxide yields corresponded to 1.2 –OOH groups per 100 eV of 
radiation absorbed for BSA and 0.8 for lysozyme. The peroxidation efficiency for BSA 
initiated by hydroxyl radicals was 40%. These protein hydroperoxides were relatively 
stable and decayed spontaneously with a half life of about 1.5 days. The rate of loss of 
hydroperoxides from the oxidized proteins shows that their lifetimes are long enough for 
reactions even at sites quiet remote from their point of formation [233]. 
Table 4. Peroxidation efficiency and peroxide yields of amino acids oxidized by free 
radicals produced by exposure of amino acid solutions to -irradiation [233]  
Amino Acid Peroxidation Efficiency G-Value 
Methionine 0 0 
Serine 0 0 
Threonine 0 0 
Cysteine 0.4 0.01 
Asparagine 2 0.06 
Tyrosine 3 0.08 
Phenylalanine 5 0.14 
Aspartic Acid 6 0.17 
Alanine 11 0.31 
Arginine 13 0.37 
Glutamine 16 0.44 
Tryptophan 18 0.51 
Glutamic Acid 28 0.77 
Glycine 28 0.07 
Histidine 34 0.12 
Lysine 34 0.96 
Isoleucine 43 1.21 
Leucine 44 1.22 
Proline 44 1.24 
Valine 49 1.37 
The amino acid composition of a protein is an important determinant of its 
susceptibility to peroxidation. Amino acids including Isoleucine, leucine, lysine, valine 
and proline were readily peroxidized by exposure to ionizing radiation and yields of 
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amino acid peroxides are dependent upon the concentration of amino acids and the dose 
of ionizing radiation (Figure 8). Exposure of common amino acids to hydroxyl radicals 
generated by ionizing radiation showed that six of them (glutamate, isoleucine, leucine, 
lysine, proline and valine) were peroxidized with similar efficiency to proteins, whereas 
the rest were inert or much less susceptible (Table 4). Further amino acid peroxidation 
was not linear with the duration of irradiation as seen in BSA and lysozyme and this 
might be attributed to progressive degradation of irradiated molecules [233]. 
Irradiation of organic biomolecules like protein and amino acids leads to free 
radical mediated peroxidation of these molecules [232]. The proteins and amino acids are 
not inert end-targets of free radical reactions and the formation of relatively stable 
hydroperoxides on molecules exposed to OH

 or ROO

 radicals in the presence of oxygen 
effectively traps some of their chemical energy, extending their lifetime and radius of 
operation. These amino acid and protein hydroperoxides may in turn act as second toxic 
messengers in cells and tissues leading to oxidation of GSH and ascorbate and depletion 
of primary antioxidants in vivo, which would eventually lead to oxidative cell and tissue 
damage.[231, 233] 
 
2.4.1.3.4. Cell Death 
Ionizing radiation (IR) at physiologically compatible doses of less than 10 Gy 
produces free radicals and ROS as the product of radiolysis of water. Radiation of tissue 
culture media generates electron paramagnetic resonance (EPR)-detectable hydroxyl and 
hydrogen radicals [235]. Recent evidence suggests a growing consensus that ROS such as 
hydroxyl radicals, superoxide anions, and organic hydroperoxides play an important role 
in cellular damage caused by ionizing radiation [212]. These ROS cause oxidative 
67 
 
 
damage to DNA, lipid peroxidation, and protein oxidation [213, 236, 237]. DNA is a 
particularly important target, suffering double and single strand breaks, deoxyribose 
damage, and base modification [74]. Cells may respond to such damage by growth arrest, 
cell senescence, and DNA repair or, if the damage is too severe to be repaired, undergo 
apoptosis [214, 238]. IR induced free radicals can also initiate a variety of cellular signal 
transduction pathways that may either aid the cell in coping with the excess oxidative 
stress resulting from radiation or set into motion pathways that lead to the destruction of 
cells damaged beyond the repair capabilities of the cell [239, 240]. Caspase-3 activation 
is generally associated with IR-induced apoptosis. Lipid metabolites have been 
implicated in IR-induced apoptosis. Deletion of the acid sphingomyelninase in transgenic 
mice rendered lymphocytes resistant to apoptosis induced by IR [241]. Ionizing radiation-
generated ROS (ROS) resulting in oxidative damage to the cell membrane and its 
consequent role in the mechanism of apoptotic cell death have been receiving growing 
attention in cellular radiobiology. In recent years, evidence has accumulated to suggest 
that it is the damage to the cell membrane that contributes to the radiation cell killing. It 
has been demonstrated that degradation of membrane-bound sphingomyelinase (SMase) 
after irradiation of bovine endothelial cell produces ceramide, which initiates an apoptotic 
cascade, suggesting membrane-triggered events in the mechanism of cellular apoptosis 
[242]. Ionizing radiation induces the production of ROS, which play an important 
causative role in apoptotic cell death. Therefore, there are several reports to suggest that 
antioxidant enzymes play a key role in the cellular defense against IR-induced oxidative 
damage by supplying NADPH in the mitochondria and for the regeneration of 
mitochondrial GSH or thioredoxin [243, 244]. Mitochondrial GSH becomes critically 
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important against ROS-mediated damage because it not only functions as a potent 
antioxidant but is also required for the activities of mitochondrial glutathione peroxidase 
and mitochondrial phospholipid hydroperoxide glutathione peroxidases. Mitochondria 
play central roles in cellular metabolism and apoptosis and are a major source of ROS. 
ROS play an important role in the radiation-induced apoptosis in multiple myeloma cells. 
It is well established that mitochondrial dysfunction is directly and indirectly involved in 
cell death including apoptosis and a variety of pathological states [245]. All the changes 
caused by ionizing radiation are compatible with mitochondrial failure, encompassing 
reduced production of ATP, generation of ROS, and accumulation of rhodamine 123 
which reflect mitochondrial swelling or changes in the mitochondrial inner membrane 
[246].  
Control of mitochondrial redox balance and the cellular defense against oxidative 
damage are some of the primary functions of mitochondrial NADP
+
- dependent isocitrate 
dehydrogenase (IDPm). Two distinct levels of ROS were generated following irradiation: 
a small increase observed early, and a pronounced late increase, associated with depletion 
of reduced glutathione (GSH) and collapse of mitochondrial membrane potential. Late 
ROS production is associated with IR-induced apoptosis in malignant cells. Upon 
exposure to low dose-irradiation, there was a distinct increase in of morphological 
evidence of apoptosis, DNA fragmentation, cellular redox status, oxidative damage to 
cells, mitochondrial function, and the modulation of apoptotic marker proteins in IDPm 
(an important mitochondrial antioxidant enzyme) knockdown cells as compared to 
control cells. IDPm knockdown cells showed increased apoptosis after exposure to low 
dose ionizing radiation while cells overexpressing antioxidant enzymes were resistant to 
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IR induced apoptosis. Elevation of mitochondrial NADPH and GSH by antioxidant 
enzymes like IDPm in turn suppressed the oxidative stress and concomitant IR induced 
ROS mediated cell death. Therefore, antioxidant enzymes may play a role in preventing 
apoptosis caused by ionizing radiation in cells. Studies also demonstrate that antioxidant 
enzymes abrogate the ionizing radiation-induced early production of ROS, leading to 
protection against apoptotic cell death. In conclusion IR leads to apoptotic cell death due 
to production of ROS leading to an increase in oxidative damage which cannot be 
repaired by the cells [246]. 
In conclusion, since IR primarily causes DNA damage, the mechanisms for 
apoptosis likely are more closely related to those observed for other DNA damaging 
agents such as UVC radiation, for example, than to direct exposure to H2O2 [241]. 
 
2.4.2. Hydrogen Peroxide 
Hydrogen peroxide is continually produced in many, if not all, tissues in vivo. 
Mitochondria may be significant contributors to cellular H2O2 generation, both by 
monoamine oxidases and by dismutation of O2
-
 from the electron transport chains 
Several enzymes generate H2O2, including xanthine, urate, glucose, monoamine and D-
amine acid oxidases as well as superoxide dismutase. Hydrogen peroxide mixes readily 
with water and can diffuse within and between cells in vivo. Although water does appear 
to diffuse across the lipid bilayer, much appears to pass through membrane water 
channels, the aquaporins. Hydrogen peroxide can also traverse these channels, but this 
may not be the only mechanism by which it crosses membranes [54]. 
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It is toxic to many cells at levels in the 10 to 100 uM, causing senescence or 
apoptosis, but at lower levels it can promote proliferation of certain cell types, and at 
higher levels it suppresses apoptosis and promotes necrotic cell death. Fortunately, given 
its widespread presence in vivo, H2O2 is only a weak oxidizing or reducing agent and is 
generally poorly reactive. This may allow it to play a role in signal transduction. No 
oxidation occurs when DNA, lipids or most proteins are incubated with H2O2, even at 
millimolar levels. Despite its poor reactivity, H2O2 can be cytotoxic and at high 
concentrations is often used as a disinfectant. Many animal cells in culture are injured or 
killed if H2O2 is added to the medium at concentrations at or above the 10 – 100 uM 
range [54].  
 
2.4.2.1. Biological Effects of Hydrogen Peroxide 
Hydrogen peroxide elicits a wide range of responses from proliferation to growth 
arrest, senescence and cell death (Figure 9). The proliferative response from low 
concentrations of peroxide (3 – 15 M) probably acts as a signaling agent for mitosis. 
Peroxide treatment of fibroblasts at concentrations of 100 – 150 M causes temporary 
growth arrest for 3 – 6 hours, during which time proliferating cells conserve energy 
through the reduced expression of non-essential genes, while the expression of genes 
involved in antioxidant defenses and damage removal or repair enzymes is increased. The 
transient growth arrest allows time for the cells to repair damaged DNA and build up an 
adaptive response to withstand further oxidant exposure. At concentrations of hydrogen 
peroxide between 200 - 400 M, fibroblasts lose the ability to replicate and undergo a 
permanent growth arrest resembling cell senescence. At even higher concentrations of 
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peroxide, cells undergo apoptosis or necrosis depending on the dose. The mechanism of 
apoptosis appears to involve loss of mitochondrial membrane potential. Necrosis occurs 
by a breakdown in cell membrane integrity. In addition, peroxide exposure induces the 
activation of antioxidant genes such as catalase, glutathione peroxidases, hemeoxygenase, 
and mitochondrial Mn-superoxide dismutase in different cell types [148]. 
 
Figure 9. Range of cellular oxidative stress responses to increasing levels of H2O2 [241] 
 
2.4.2.2. Cell Proliferation 
Proliferating mammalian cells exhibit a broad spectrum of responses to oxidative 
stress, depending on the stress level encountered. Exposure of dividing mammalian cells 
in culture to low concentrations of oxidants actually stimulates cell growth and division 
[247-249]. Very low levels of hydrogen peroxide, e.g., 3 to 15 M, or 0.1 to 0.5 mol/107 
cells; cause a significant mitogenic response, 25% to 45% growth stimulation. 
Presumably at such low concentrations H2O2 does not cause a true oxidative stress. In all 
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probability, H2O2 in this concentration range actually acts as a signaling agent for mitosis 
[148]. 
 
2.4.2.3. Cell Injury 
2.4.2.3.1. Effects on Lipids 
Hydrogen peroxide (H2O2) is an important mediator of acute oxidative injury to vascular 
endothelium. Because the plasma membrane is the initial site of interaction between 
endothelial cells and extracellular H2O2 produced by stimulated neutrophills or 
macrophages, we evaluated the effect of H2O2 on the physical state, i.e., fluidity, and 
function of porcine pulmonary artery endothelial cell plasma membranes. The precise 
mechanism responsible for H2O2-induced cellular injury and the specific cellular sites of 
H2O2 attack are not completely defined. However, recent evidence suggests that 
membrane fatty acids and phospholipids may be early and critical targets of moderate 
dose H2O2-related cytotoxicity. For example, 50 uM H2O2 has been reported to cause 
peroxidative cleavage of polyunsaturated fatty acids, to induce phospholipid hydrolysis 
by activation of phospholipases, and to stimulate the synthesis and/or release of 
membrane-derived lipid mediators, such as platelet-activating factor and prostacyclin, in 
endothelial cells. The earliest abnormality observed in the present study was rigidification 
of the glycerol backbone region of the endothelial cell plasma membrane bilayer. 
Compared with control cells, H2O2 caused significant increases in LDH release and in 5-
HT uptake 6 hr after exposure. These results indicate that H2O2 causes significant damage 
to the plasma membrane of pulmonary artery endothelial cells in vitro, leading to 
alterations in fluidity and leakiness of the membrane. First, H2O2 can react with iron via a 
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Fenton reaction to generate the highly reactive hydroxyl radicals (OH

). OH

 will react 
readily with the unsaturated bonds of plasma membrane fatty acids, resulting in the 
initiation of a lipid peroxidation cascade. A second possible mechanism responsible for 
H2O2 induced plasma membrane injury involves activation of pathways leading to 
hydrolysis of plasma membrane phospholipids. Thus H2O2 mediated injury is associated 
with reversible membrane lipid peroxidation, and can be prevented by pretreatment but 
not by post-treatment with lipophilic free radical scavengers like Vitamin E. A final 
possible mechanism to account for our observations in H2O2-treated endothelial cells is 
oxidation of plasma membrane protein sulfhydryl groups that leads, in turn, to altered 
plasma membrane protein lipid interaction, lipid packing, and membrane function [218, 
250]. 
 
2.4.2.3.2. Effects on DNA 
Although some cellular damage by H2O2 is direct, addition of H2O2 frequently 
leads to lipid, DNA and protein oxidation that cannot be mediated by H2O2. It may cross 
cell membranes and react with iron and probably copper ions to form more damaging 
species such as OH

. Indeed, OH

 accounts for most of all the damage done to DNA in 
H2O2 treated cells. H2O2 also interacts with haem proteins to cause oxidative damage. 
Sometimes, exposing cells to H2O2 can increase O2
-
 production, by activating NADPH 
oxidases [54]. 
 
2.4.2.3.3. Effects on Proteins 
In addition, H2O2 can oxidize protein sulfhydryl groups, leading to protein 
dysfunction and in erythrocytes, H2O2-induced oxidation of heme proteins has been 
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shown to alter membrane protein-lipid interaction and lipid packing. Soluble proteins 
from the human lens nucleus were incubated for 12 weeks with 0, 10, 100 and 1000 M 
H2O2. Progressive changes were observed in several of these parameters. Cysteine (up to 
100 %) and methionine (up to 45 %) were rapidly oxidized but no significant alterations 
were found in any other amino acids. The gradually increasing solvent accessibility of 
tryptophan residues indicated that the proteins were undergoing conformational 
alterations. This was accompanied by the insolubilization of protein (up to 75 %). No 
methionine sulphoxide was detected in the control and very low levels in the 10 M 
treatment. However, in the 1000 M and 100 M treatments, oxidation was rapid and 
appeared to reach a maximum at about 45 % of the total methionine content of the 
proteins. The control and 10 M treated proteins did not show any significant 
accumulation of insoluble proteins. However, in the 100 and 1000 M -treatments, the 
solubility of the proteins decreased until 65 and 75 % respectively was insoluble in water 
[251].  
 
2.4.2.4. Cell Senescence 
If dividing mammalian cells are exposed to greater concentrations of H2O2 than 
those that cause temporary growth arrest and transient adaptation, they can be forced into 
a permanently growth-arrested state. Thus, cells exposed to H2O2 concentrations of 250 
to 400 M, or 9 to 14 mol/107 cells, will never divide again [249]. Studies of both cell 
populations and individual cells have revealed that cultured mammalian cells (with a 
normal doubling time of 24±26 h) can survive for many weeks (at least) after exposure to 
100±200 M H2O2 without dividing again [249]. 
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2.4.2.5. Cell Death 
Although H2O2 is a relatively weak oxidant compared to other ROS such as •OH, 
it has emerged as an important signaling molecule based on its unique biochemical 
properties: H2O2 is ubiquitously present in the biological system with a relatively long 
half-life; and more importantly H2O2 is soluble in both lipid and aqueous media [131]. 
Thus it easily diffuses to its cellular targets. Recent research has suggested that the 
apoptosis signal can be transduced extracellularly by soluble factors. A population of 
cells stimulated with cytokines transmitted the apoptosis signal to neighboring cells 
through a soluble catalase-inhibitable factor, suggesting that H2O2 may act as a paracrine 
mediator of apoptosis [148, 241, 252]. 
A fraction of cells exposed to higher concentrations of H2O2, 0.5 to 1.0 mM, or 15 
to 30 mol/107 cells, will enter the apoptotic pathway. The mechanism of oxidative 
stress- induced apoptosis appears to involve loss of mitochondrial transmembrane 
potential [253]; release of cytochrome c to the cytoplasm [254]; loss of bcl-2 [255]; 
down-regulation and degradation of mitochondrially encoded mRNA, rRNA, and DNA 
[256-258]; and diminished transcription of the mitochondrial genome [259]. Current 
thinking about toxicant-induced apoptosis suggests that in multicellular organisms, the 
repair of severely damaged cells represent a major drain on available resources [148]. 
At even higher concentrations of hydrogen peroxide, e.g., 5.0 to 10.0 mM, or 150 
to 300 mol/107 cells, cells simply disintegrate or become necrotic. Membrane integrity 
breaks down at such high oxidant stress levels, and all is then lost (15, 59). Studies that 
purport to examine cellular responses to 10.0 mM H2O2 in mammalian fibroblasts are 
not really looking at the responses of cells but rather at the release of components those 
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cells originally contained. At a high enough level of oxidative stress (e.g., >10 mM 
H2O2), all mammalian cell cultures will turn into a necrotic mess (15). Oxidation-induced 
necrosis may play a significant role in ischemia-reperfusion injuries such as heart attacks, 
strokes, ischemic bowel disease, and macular degeneration. Unfortunately, necrotic cells 
cause inflammatory responses in surrounding tissues. Such secondary inflammation (also 
an oxidant stress) may be particularly important in many autoimmune diseases such as 
rheumatoid arthritis and lupus [148]. 
 
2.4.2.6. Role of Hydrogen Peroxide in Diseases 
Various studies have shown that the formation of extracellular or intracellular 
deposits of Amyloid beta (A)-like protein fibrils is a prominent pathological feature of 
many different neurodegenerative diseases, including Alzheimer‘s disease (AD) and 
Parkinson‘s disease (PD). There is abundant evidence for the involvement of free radicals 
and oxidative stress in the pathogenesis of nigral damage in PD. One of the fundamental 
molecular mechanisms underlying the pathogenesis of cell death in AD and PD, and 
possibly other neurodegenerative or amyloid diseases, could be the direct production of 
hydrogen peroxide during formation of the abnormal protein aggregates. The possibility 
that hydrogen peroxide and, subsequently, hydroxyl radicals, might be formed in the 
immediate vicinity of A could explain much of the oxidative damage observed when 
cells are exposed to this peptide. Studies have also shown that human A directly 
produces H2O2 by a mechanism that involves the reduction of metal ions, Fe (III) or Cu 
(II), setting up conditions for Fenton-type chemistry. The degeneration and loss of nerve 
cells in the brain in both AD and PD could be due to the direct production of hydrogen 
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peroxide during extracellular or intracellular protein aggregation, which would induce 
oxidative damage, particularly in the presence of metals where the hydrogen peroxide 
would be converted, via Fenton‘s reaction, into the highly reactive hydroxyl radical. Thus 
H2O2 plays an important role on the pathogenesis of neural cell death in both AD and PD 
[260-262]. 
 
2.4.3. Ultraviolet Radiation 
The sun emits ultraviolet (UV) radiation extending from the UVA band (315-400 
nm) through the UVB (280-315 nm) down to the high energy UVC band (190-280) and 
vacuum UV (below 190 nm). Ultraviolet radiation (UVR) includes UVA, UVB and UVC 
radiation. The majority of solar radiation reaching the earth (90%) is UVA radiation, with 
a wavelength of 320 – 400 nm. UVB radiation makes up a smaller fraction of solar 
radiation, however it is much more mutagenic [263]. The UV radiation is very (photo-) 
chemically active. Conjugated bonds in organic molecules absorb radiation of 
wavelengths around and below 200 nm, and in linear repeats or in ring structures the 
absorption bands of these bonds shift to higher wavelengths (250-300 nm and higher, 
e.g., the broad absorption up to 550 nm by/3-carotene with its extended linear repeats and 
terminal rings). After absorbing UV radiation, a molecule may become altered (damaged) 
and/or affect (damage) other molecules, e.g., by producing ROS (ROS) [264]. Thus, UV 
radiation, especially in the short wavelength range, forms a direct threat to the stability of 
unprotected organic molecules, which are essential to life on earth: foremost, DNA with 
aromatic rings in all of its bases (absorption maximum around 260 nm).  DNA is a 
chromophore of UVB, directly absorbing UVB‘s energy wavelength of 280 – 320 nm. As 
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a result of the energy absorption, chemical bonds may break in a process called 
photolysis. UVC radiation corresponds to a wavelength of 254 nm. This is close to the 
maximal absorption spectrum of DNA to initiate photochemical reactions and is used to 
study the effect of UV on DNA [265]. Both UVA and UVB generate ROS such as singlet 
oxygen, hydroxyl radicals and peroxynitrite radicals. The generation of singlet oxygen by 
the absorption of light energy is known as photosensitization. Further, UVR can cause 
photolysis of the chemical bonds of hydrogen peroxide forming hydroxyl radical [266]. 
 
2.4.3.1. Biological Effects of Ultraviolet Radiation 
As a result of UV-induced damage, the cell undergoes growth arrest and can 
engage programmed cell death pathways in response to high levels of damage [267]. In 
the next few sections we describe in detail the range of biological effects of UV. 
 
2.4.3.2. Cell Injury 
The ultraviolet A (UVA) radiation component of sunlight (320-380 nm) has been 
shown to be a factor in many of the consequences of exposure of animals to sunlight 
including carcinogenesis and aging [268-270]. Although the mechanisms by which UVA 
radiation is involved in these processes are largely unknown, redox active species have 
been implicated [271, 272]. Solar irradiation depletes antioxidant compounds in skin cells 
in situ [273], adds to the evidence that solar radiation is a source of oxidant stress to 
skin[274]. Indeed, UVA irradiation of cellular constituents in vitro leads to the generation 
of redox active species.  Hydrogen peroxide can be generated by the UVA irradiation of 
tryptophan [275],  and both hydrogen peroxide and superoxide can be generated from the 
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UVA irradiation of NADH and NADPH [276, 277]. Singlet oxygen can be generated as a 
result of absorption of UVA radiation by endogenous photosensitizers such as porphyrins 
[278]. The involvement of ferrous iron (Fe
2+
) in catalyzing redox reactions in vitro is well 
established. UVA radiation has been shown to reduce ferric iron (Fe
3+
) associated with 
ferritin in vitro and in the presence of hydrogen peroxide the ferrous ions can catalyze the 
formation of hydroxyl radicals. The role of hydroxyl radicals in the biological effects of 
UVA radiation has not been thoroughly investigated.  Ferrous ions are also good catalysts 
for the peroxidation of membrane lipids and give rise to membrane damage [279], but the 
role of iron in UVA radiation-dependent peroxidation of lipids is unknown. UVA 
radiation also enhances the ferrous ion catalyzed oxidation of protein sulphydryl groups 
in the presence of hydrogen peroxide [280-282]. 
Exposure of cultured human skin cells to UVA radiation immediately modifies 
cellular components and can eventually lead to cell death [283]. The peroxidation of 
lipids [284, 285] and the oxidation of glutathione [286] have been shown to be the 
immediate consequences of UVA irradiation of human skin cells and are typical of 
reactions of redox active species. Ferrous iron, singlet oxygen, and hydrogen peroxide 
have been identified as biologically important redox active species generated by UVA 
irradiation of human skin fibroblasts. These redox active species were shown to mediate a 
UVA radiation-dependent loss of protein sulphydryl groups in vitro and in human skin 
fibroblasts, and singlet oxygen and iron were shown to mediate UVA radiation-dependent 
peroxidation of phosphatidylcholine and fibroblast lipids. Because UVA radiation can 
reduce ferric iron associated with cellular molecules, it should be able to initiate 
biological redox reactions in which ferrous ions have been shown to have a catalytic role. 
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Such reactions include lipid peroxidation, sulphydryl oxidation, and the generation of 
subsequent redox active species such as the hydroxyl radical [287]. 
 
2.4.3.2.1. Effects on Lipids 
Thiobarbituric acid-reactive species were formed from phosphatidylcholine after 
UVA radiation in vitro. By using iron chelators, this process was shown to involve iron. 
Ferric iron associated with potential physiological chelators was reduced by UVA 
radiation, but iron within ferritin was not. By enhancing the half life-time with deuterium 
oxide or by using scavengers, singlet oxygen was also shown to be involved in the UVA 
radiation dependent peroxidation of phosphatidylcholine. UVA radiation-generated 
singlet oxygen reacted with phosphatidylcholine to form lipid hydroperoxides, and the 
breakdown of these hydroperoxides to thiobarbituric acid-reactive species was dependent 
on iron. Vile et. al. have shown that iron and singlet oxygen are also involved in the UVA 
radiation-dependent formation of thiobarbituric acid-reactive species in human skin 
fibroblasts, and proposed that a similar concerted effect of iron and singlet oxygen was 
involved in UVA radiation-dependent damage to fibroblast lipids [287].  
UVA radiation-dependent peroxidation of detergent dispersed 
phosphatidylcholine is dependent on iron in agreement with the general hypothesis that 
iron is an essential component in redox driven lipid peroxidation systems [279]. The role 
of iron in lipid peroxidation has been shown to be in the breakdown of lipid 
hydroperoxides (LOOH) according to reaction given in Equation (5). 
LOOH + Fe
2+
 ↔ LO + OH- + Fe3+                                                                                                                           (5) 
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An important feature of the biological effects of UVA radiation may be the ability of 
UVA radiation to interact with iron within lipid bilayers. Experiments  performed by Vile 
et. al. were consistent with the involvement of singlet oxygen in the UVA radiation-
dependent formation of thiobarbituric acid-reactive species from phosphatidylcholine. 
Further investigation also revealed that singlet oxygen (
1
O2) was involved at the level of 
the formation of phosphatidylcholine hydroperoxides [287]. This is probably via reaction 
described in Equation (6) 
1
O2 + LH ↔ LOOH                                                                                                           (6) 
Vile et. al. proposed that UVA radiation can break down phosphatidylcholine to 
thiobarbituric acid-reactive species via the concerted action of singlet oxygen and ferrous 
iron. The involvement of iron and singlet oxygen in the UVA radiation-dependent 
peroxidation of fibroblast lipids is consistent with the possibility that a mechanism, 
similar to that seen with phosphatidylcholine, is involved in fibroblasts. They could find 
any evidence for the involvement of superoxide or the hydroxyl radical in the UVA 
radiation-dependent peroxidation of phosphatidylcholine or cell lipids [287] 
 
2.4.3.2.2. Effects on DNA 
The major effect of UV radiation on DNA is the formation of pyrimidines 
dimmers between adjacent pyrimidines on the same strand of DNA. Pyrimidine 
dimmers, also called cyclobutane-type dipyrimidines (CPD‘s) are formed when adjacent 
pyrimidines become covalently linked through the formation of a four-membered ring 
structure resulting from the saturation of their respective 5,6 double bonds. Of all 
possible bipyrimidines, TT bipyrimidines are the most photoreactive. However, TT 
82 
 
 
CPD‘s are quickly repaired and not mutagenic. Another common adduct to DNA is the 
pyrimidines-pyrimidone 6, 4 photoproduct. While TC and CC CPD‘s are not very 
photoreactive, there are mutagenic, forming TC  TT and CC  TT transitions. These 
mutations are found in the p53 gene of UV-induced cancer cells [266, 267, 288, 289]. 
In addition to forming CPD‘s, both UVA and UVB generate ROS such as singlet 
oxygen, hydroxyl radicals and peroxynitrite radicals. The generation of singlet oxygen by 
the absorption of light energy is known as photosensitization. Further, UVR can cause 
photolysis of the chemical bonds of hydrogen peroxide, forming hydroxyl radical. As a 
result of increased presence of ROS on DNA, oxidatively modified bases, especially 8-
oxoguanine, can be detected following UV radiation [266].  
 
2.4.3.2.3. Effects on Proteins 
A concerted effect of iron and singlet oxygen was involved in UVA radiation-
dependent damage to fibroblast lipids. Vile et. al. also showed that a concerted effect of 
iron and singlet oxygen was also involved in the oxidization of sulphydryl groups of 
bovine serum albumin and human -globulin upon UVA irradiation in vitro. The use of 
scavengers and deuterium oxide showed that UVA radiation dependent sulphydryl 
oxidation was dependent on singlet oxygen. By adding or chelating iron, UVA radiation-
dependent oxidation of sulphydryl groups of bovine serum albumin and human -globulin 
was shown to be iron-dependent. The use of catalase and hydroxyl radical scavengers 
demonstrated that hydrogen peroxide, but not the hydroxyl radical, was involved. The 
oxidation of sulphydryl groups of proteins in human skin fibroblasts that occurs as a 
result of UVA irradiation was also shown to involve iron, singlet oxygen, and hydrogen 
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peroxide [287]. UVA irradiation of human skin fibroblasts at physiological doses has 
been shown to lead to a loss of intracellular glutathione, and Vile et. al. also show that 
similar doses of UVA radiation can lead to a loss of protein sulphydryl groups both in 
these cells and in vitro. The UVA radiation-induced protein sulphydryl loss was shown to 
involve iron and hydrogen peroxide, but not hydroxyl radicals. This is in agreement with 
other studies that have shown that the redox-dependent loss of sulphydryl groups requires 
iron and hydrogen peroxide, and that the hydroxyl radical is not involved [290, 291]. 
Hydrogen peroxide may mediate the oxidation of an iron-sulphydryl complex. Singlet 
oxygen readily reacts with protein sulphydryl groups, and we show that, in addition to the 
hydrogen peroxide/iron dependent mechanism, another pathway of UVA radiation-
dependent loss of protein sulphydryl groups occurs via singlet oxygen both in vitro and in 
human fibroblasts. Loss of protein sulphydryl groups can lead to inactivation of protein 
function such as Ca
2+
 transport by Ca
2+ 
- ATPase [281, 282]. Inactivation of sulphydryl 
containing proteins may be an important consequence of UVA irradiation. Indeed, UVA 
irradiation of skin cells in situ leads to inactivation of critical antioxidant enzymes.[287] 
 
2.4.3.3. Cell Death 
Ultraviolet radiation (UVR) has been divided into several functional wavelength 
ranges, the UVC (<280 nm) which is excluded by the earth‘s atmosphere; and the UVB 
(280–320 nm), the UVA (320–380 nm), and near visible (380–420 nm) components, 
which reach the earth‘s surface. UVA1 (340–400 nm) is a clinical definition of UVA for 
therapeutic applications [263]. The UVC and UVB regions overlap the DNA absorption 
spectra [292] and can cause direct DNA photodamage (i.e., cyclobutane pyrimidine 
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dimers), associated with mutagenesis and tumorigenesis [293]. In contrast, the UVA 
region of the solar spectra is not absorbed directly by DNA. UVA exposure generates 
cellular oxidative stress, such that it stimulates the intracellular production of ROS by  
 
Figure 10. UV radiation induced cell death. UVA can cause lipid peroxidation and 
membrane damage, depletion of intracellular glutathione, and oxidative DNA damage. 
UVC and UVB cause direct photochemical damage to DNA. DNA damage and 
subsequent cell cycle arrest may lead to the delayed apoptosis observed after exposure to 
these agents. 
photochemical reactions [263, 294]. The oxygen-dependence of UVA photokilling, and 
the specific involvement of 
1
O2 in UVA mediated gene regulation have been 
demonstrated, though the precise endogenous chromophores which mediate UVA-
induced ROS production remain poorly defined [263, 292, 294]. UVA cause cellular 
damage characteristic of oxidative stress, including membrane lipid peroxidation and 
oxidation of intracellular reduced glutathione (GSH). Furthermore, DNA damage can 
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occur after UVA exposure, including DNA strand breaks, and oxidative DNA damage 
such as 7, 8-dihydro-8- oxo-2-deoxyguanosine (8-OHdG) [285, 295-298]. 
The mechanisms of apoptosis following cellular exposure to UVR appear to be 
wavelength specific (Figure 10). To illustrate this, murine lymphoma cells were 
irradiated with UVA1, UVB, and UVC at isotoxic doses [299]. The UVA1 radiation 
(340–400 nm) induced both an immediate (<4 h) and a delayed (>20 h) apoptosis 
mechanism, while UVB or UVC radiation induced only the delayed apoptosis with no 
early component. The delayed apoptosis seen at all wavelengths was comparable to that 
observed with DNA damaging agents, whereas the early apoptosis associated with UVA1 
was inhibited by membrane antioxidants and inhibitors of the mitochondria transition 
pore [299-301]. Apoptosis after UVA radiation has been observed in a number of 
physiologically-relevant skin cell models, including human dermal fibroblasts [302], 
epidermal keratinocytes [303],[304], melanocytes [305]; as well as transformed cell lines 
([299, 306, 307]. Depending on the cell type, features of both extrinsic (Fas/caspase-8)-
dependent and intrinsic (mitochondria-dependent) apoptotic pathways have been reported 
following cellular irradiation with UVA or UVB, involving modulation of Bcl-2 family 
proteins and typically culminating in caspase-3 activation [263, 298, 308] 
 
 
2.4.3.4. Role of UV induced Oxidative Stress in Diseases 
Ultraviolet A radiation of wavelength 320 – 400 nm penetrates the epidermis 
resulting in damage to the dermis. This causes skin to age prematurely, with effects that 
include roughening, blotchiness, sagging and wrinkles[309]. UVA also contributes to the 
development of skin cancer. Ultraviolet B is radiation between 290 – 320 nm and causes 
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sunburn and skin cancer [310]. UVB radiation inhibits DNA, RNA and protein synthesis 
and induces erythemal responses. UVC radiation from 100 – 290 nm is filtered out by the 
ozone layer and does not reach the earth‘s surface [311]. 
 
2.4.3.4.1. Photoaging 
Premature aging of the skin is a well-documented consequence of exposure to 
Ultraviolet A (UVA) and Ultraviolet B (UVB) [309, 312]. Inflammation and the resulting 
accumulation of ROS play an important role in the photoaging of human skin in vivo. 
Environmental insults, primarily ultraviolet rays from the sun contribute to the generation 
of free radicals and ROS that stimulate the inflammatory process in the skin [313]. UV 
irradiation initiates and activates a complex cascade of biochemical reactions in the 
human skin. UV causes depletion of cellular antioxidants and antioxidant enzymes, 
initiates DNA damage leading to the formation of thymidine dimers, leads to 
immunosuppression and increased synthesis and release of pro-inflammatory mediators 
from a variety of skin cells. The net result of UV exposure of skin is inflammation and 
free radical generation. The inflammation and ROS lead to degradation of healthy skin 
and premature photoaging. In addition the inflammation and ROS cause oxidative 
damage to cellular proteins, lipids and carbohydrates which accumulate in the dermal and 
epidermal compartments, contributing to photoaging [311]. 
The acute effects of UV irradiation on human skin are well characterized. 
Immediately after UV exposure, keratinocytes release pro-inflammatory cytokines like 
TNF- [314]. UV photons have a direct effect on DNA to cause DNA strand breakage 
[315]. UV also leads to depletion of cellular antioxidants and generation of ROS 
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including hydrogen peroxide, hydroxyl radical, singlet oxygen and peroxyl radicals 
[316]. These ROS play an important role in the UV induced photoaging of human skin in 
vivo [317]. UV radiation also triggers cytokine production and effects cellular mitosis, 
apoptosis and necrosis [318, 319]. Finally free radical induced peroxidation of membrane 
lipids contributes to further inflammation and oxidative damage to the skin [320]. 
Chronic UV exposure is also associated with protein oxidation in the human skin, both in 
the living layers and the stratum corneum [321, 322]. UVB also modulates several signal 
transduction pathway(s) leading to generation of ROS [317, 323]. Superoxide, hydrogen 
peroxide and hydroxyl radicals are primarily produced by phagocytic cells and 
lymphocytes in response to inflammation induced by UV exposure of skin [324]. 
Lymphocytes produce large quantities of RIS by expressing high amounts of NADPH 
oxidase. Skin is uniquely vulnerable to the damage caused by ROS, being rich in 
unsaturated fatty acids and exposed to high oxygen tension and UV, both of which 
promote ROS generation. ROS, especially OH

 radicals, are capable of damaging 
biological macromolecules such as DNA, carbohydrates, lipids and proteins. ROS 
initiates the process of lipid peroxidation in cellular membranes, causing cellular 
membrane damage, leakage of cellular components and ultimately cell death. ROS are 
also responsible for inflammation, tissue remodeling, oncogenesis and apoptosis, 
processes that orchestrate many of the degenerative processes associated with photoaging 
[324, 325]. 
Another effect of UV on skin is to induce pigmentation. In order to protect skin 
from further damage by UV, UV radiation also stimulates melanocytes directly to 
produce more melanin. Melanogenesis protects skin from further UV damage by 
88 
 
 
preventing apoptotic cell death following UV injury[326]. UV damage to cellular DNA 
induces skin melanogenesis by activating cellular-signaling pathways and increased DNA 
repair after irradiation enhances UV induced melanogenesis. Excessive melanogenesis by 
increased DNA repair has its downside too. Incorrect DNA repair and excessive 
melanogenesis often leads to melanoma, a form of skin cancer [309, 315, 326] 
 
2.4.3.4.2. Skin Cancer 
Aerobic life, UV solar radiation, genetic susceptibility, and immune status 
contribute collectively to the development of human skin cancers. In addition to direct 
DNA damage, UV radiation promotes the generation of reactive oxygen intermediates 
that can cause oxidative damage and inflammation [288, 327], and ultimately lead to 
tumor formation. Besides enabling us to breath, the production of oxygen is a very 
fortunate evolutionary event: by absorbing the most energetic UV radiation (wavelengths 
below 240 nm) in the outer reaches of our atmosphere and by forming ozone in the 
process, oxygen protects the earth's surface from the most damaging solar UV radiation. 
The rare stratospheric ozone absorbs most of the radiation with wavelengths below 310 
nm. UV radiation below 290 nm is virtually undetectable at ground level. However, the 
fraction of UVB radiation that reaches us can still be absorbed by DNA and proteins and 
is enough to damage and kill unprotected cells (mainly through DNA damage). Hence, 
organisms on the earth's surface have to be well adapted, e.g., by forming UV-absorbing 
surface layers (skin and fur), by antioxidant defences to quench UV-generated ROS, by 
efficiently repairing damaged DNA, and by repairing or replacing damaged cells. Human 
skin--UV radiation does not penetrate any deeper--shows all of these adaptive features. 
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Nevertheless, the skin's defenses are not perfect and the continuous UV challenge leads 
to deterioration ("photoaging") in the long run and to an increasing likelihood of 
developing skin cancer [264, 310]. 
Ultraviolet B and A radiations (respective wavelength ranges 280-315 and 315-
400 nm) are present in sunlight at ground level. The ultraviolet radiation does not 
penetrate any deeper than the skin and has been associated with various types of human 
skin cancers. The carcinogenicity of UVB radiation is well established experimentally 
and, to a large extent, understood as a process of direct photochemical damage to DNA 
from which gene mutations arise. Although UVA is generally far less carcinogenic than 
UVB radiation, it is present more abundantly in sunlight than UVB radiation (>20 times 
radiant energy) and can, therefore, contribute appreciably to the carcinogenicity of 
sunlight. In contrast to UVB, UVA radiation is hardly absorbed by DNA. Hence, the 
absorption by other molecules (endogenous photosensitizers) becomes more important, 
thus radicals and, more specifically, ROS can be generated that can damage DNA, 
membranes, and other cellular constituents [328].  
Like UVB radiation, UVA radiation proved to be a complete carcinogen in 
experiments in which skin carcinomas developed in (hairless) mice under chronic 
exposure [269]. Unlike UVB radiation, UVA radiation initially induces mainly benign 
papillomas, which increase at a slow rate and are at a later stage outnumbered rapidly by 
carcinomas that increase at a much higher rate [329]. Chronic UVB exposure mainly 
induces a rapidly increasing number of squamous cell carcinomas (SCC) and actinic 
keratoses as precursors, with intermixed rare occurrences of benign papillomas, the 
chronic application of a (chemical) ―initiator‖ of tumor development (generally a 
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mutagenic agent) will lead to carcinomas, whereas the repeated application of a "tumor 
promoter" (after a single application of an 'initiator") will generate benign papillomas; the 
promoting action appears to be related to the release of ROS. In this perspective, UVB 
radiation appears to exert predominantly a "tumor initiating" effect, whereas "tumor 
promotion" is relatively more pronounced with UVA radiation. Like UVB radiation, 
albeit differently and less efficiently, UVA radiation is clearly a mutagenic and 
carcinogenic agent. In contrast to UVB radiation, the fundamental photochemistry and 
pre-mutagenic DNA lesions are still not well determined for UVA radiation. Ten to 20% 
of sunburn and carcinogenic UV doses from sunlight stems from the UVA band[330]. 
UVA radiation is therefore an important toxic factor in our natural environment [264, 
328].  
 
2.5. Summary 
Many modern treatment modalities including ionizing radiation, hydrogen 
peroxide, UV, photodynamic therapy, chemotherapy drugs, antibiotics, etc, operate via 
the induction of oxidative stress in cells and tissues by generating intracellular reactive 
oxygen species. The significance of the damage inflicted upon biological systems by 
ROS, produced exogenously or endogenously cannot be overestimated, as they have been 
implicated in numerous disease processes, including inflammation, degenerative diseases 
and tumor formation and involved in physiological phenomena, such as aging. It is 
imperative we harness the power of oxidative stress and we understand the mechanisms 
of interaction of oxidative stress with biological systems.  
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Chapter 3. Low Dose Non-Thermal Plasma Treatment 
 
As described in Chapter 2 oxidative stress has a broad spectrum of effects on 
proliferating cells ranging from cell proliferation, cellular adaptation, and cell senescence 
to cell death via apoptosis and eventually necrosis. Studies have shown that low levels of 
reactive oxygen species enhance cell proliferation in mammalian cells. 3 – 15 M of 
H2O2 induced a significant mitogenic response where 25 – 40% growth stimulation was 
observed [148]. Non-Thermal DBD plasma is known to produce a variety of ROS in 
liquid medium and the concentration of these ROS can be controlled by tuning the dose 
of plasma [17].  
We divide the dose of non-thermal plasma treatment in to two major regimes; low 
dose (Treatment time ranging from 2 s to 30s or a dose of 0.2 – 5 J/cm2) and high dose 
(treatment times greater than 30 s or a dose greater than 5 J/cm
2
). In this chapter we 
investigate the effects of low dose plasma treatment on endothelial cells and present 
results related to enhanced cell proliferation. We show that the dose of non-thermal 
plasma treatment can be tuned to enhance proliferation in mammalian via release of 
growth factors like FGF-2. 
 
3.1. Introduction 
Non-thermal plasma interaction with the vasculature must be understood prior to 
treating vascularized tissue. We hypothesize that plasma can grow or regress blood 
vessels in a dose-dependent manner. Endothelial cells control many aspects of the 
vasculature from vascular tone to coagulation to inflammation. Endothelial cells also play 
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a guiding role in angiogenesis [331]. Endothelial cells produce and secrete angiogenic 
growth factors such as fibroblast growth factor-2 (FGF2), which in conjunction with 
many other signals induces cells to invade the surrounding tissue, proliferate, and develop 
into new blood vessels [332]. Angiogenesis can be both helpful and harmful. In wound 
healing, angiogenesis is required at the wound site for healing, whereas in cancer, 
angiogenesis blockade may prevent tumor growth[333].  
Using an in vitro model, we investigated the effect of non-thermal DBD plasma 
on endothelial cells. Endothelial cell proliferation and death following plasma were 
measured. FGF2 release from endothelial cells and its effect on cell proliferation were 
quantified. Finally, mechanisms of non-thermal plasma effects were explored. We now 
show that while high dose non-thermal plasma induces endothelial cell death, lower 
doses induce endothelial cell proliferation. This proliferative effect is likely related to 
FGF2 release due to plasma-produced ROS. 
 
3.2. Materials and Methods 
Endothelial cell culture 
Porcine aortic endothelial cells (PAEC) were isolated from porcine aortae by the 
collagenase dispersion method and used between passages 4 and 9 [334]. PAEC were 
maintained in low glucose Dulbecco‘s Modified Eagle‘s Medium (DMEM) (Mediatech) 
with 5% fetal bovine serum (Hyclone), 1% L-glutamine, and 1% penicillin-streptomycin 
(Invitrogen). Medium was changed every two days. For plasma treatment, cells were 
washed with phosphate buffered saline, detached with 0.1% trypsin (Invitrogen), and 
seeded near confluence (4x10
5
 cells per well) on 18 mm uncoated glass cover slips 
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(VWR ) in 12-well plates (Corning). PAEC adhere well to bare glass, with close to 100% 
seeding efficiency. Cells were incubated for 24 hours prior to plasma treatment in 1.5 ml 
supplemented medium at 37°C and 5% CO2.  
Porcine tumor necrosis factor-α (TNF-α) was from R&D Systems. Recombinant 
human FGF2 was from Peprotech, and neutralizing FGF2 antibody was from Upstate 
Biotechnology. N-Acetyl-L-cysteine (NAC, Sigma), an intracellular ROS (ROS) 
scavenger and sodium pyruvate (Sigma), an extracellular ROS scavenger, were used to 
block plasma-produced ROS. 
Endothelial Cell Plasma Treatment 
Endothelial cells were treated with non-thermal plasma in vitro using the setup as 
illustrated schematically in Figure 3 and the operating parameters have been previously 
elaborated in section 1.2 on page 4. PAEC on glass cover slips were exposed to plasma 
for 5 to 120 seconds. Each cover slip was removed from the 12-well plate and placed on a 
microscope slide, which was positioned on the plasma device grounded base. 50 µl serum 
free medium was added to the sample to prevent drying. Following plasma, the cover slip 
was immediately placed in a new 12-well plate, 1.5 ml supplemented medium was added, 
and the samples were returned to the incubator. 
Three approaches were used for plasma-treatment of cells: direct, indirect and 
separated. In direct treatment, the sample was one of the electrodes creating the plasma as 
shown in Figure 2 and Figure 3. Plasma discharge occurred between the quartz and the 
sample, which exposed the sample directly to neutral reactive species and charged 
particles. For indirect treatment, a grounded mesh was placed between the high voltage 
electrode and the sample to eliminate charged particles. In separated plasma treatment, 
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medium was plasma treated separately from cells and then immediately applied to cells. 
In this case, cells were not in direct contact with any plasma component. 
Non-Thermal Plasma Induced Cell Death 
Non-thermal plasma endothelial cell cytotoxicity was measured via cell counts 
and Live/Dead assay. For cell counts, PAEC were plasma treated as described. 3 and 24 
hours following plasma treatment, attached (live) cells were trypsinized and counted 
using a Coulter counter (Beckman Coulter). These time points were selected to examine 
immediate and medium-term plasma toxicity effects. Since no change was detected 
between 3 and 24 hours, no longer time points were investigated. For the Live/Dead 
assay, 3 and 24 hours post treatment cells were labeled with 1 µM ethidium homodimer 
and 0.25 µM calcein (Invitrogen), incubated at room temperature for 45 minutes, and 
imaged by fluorescent microscopy (Olympus, USA) with a digital high performance 
CCD camera (Diagnostic Instruments). Live cells convert cell-permeant calcein to a 
FITC fluorescent form via intracellular esterases, whereas cell impermeant ethidium 
homodimer binds nucleic acids in membrane damaged dead cells to enhance TRITC 
fluorescence. Dead cells were manually counted in five distinct sample areas. 
Endothelial cell apoptosis was measured via annexin V-propidium iodide 
labeling. Annexin V binds phosphatidylserine translocated from the inner to the outer cell 
membrane. Cells in early apoptosis are identified as annexin V-positive and propidium 
iodide-negative. PAEC were prepared by combining floating and trypsin-released 
attached cells. Samples were centrifuged to pellet cells, washed thoroughly, resuspended 
in annexin binding buffer, and labeled with annexin V-fluorescein and propidium iodide 
95 
 
 
as per manufacturer instructions (BD Pharmingen). Samples were analyzed immediately 
by flow cytometry (BD FACScanto).  
Endothelial Cell Membrane Damage and FGF-2 Release 
Endothelial cell membrane damage following non-thermal plasma was quantified 
through lactase dehydrogenase (LDH) release. PAEC were plasma treated as described, 
however DMEM without sodium pyruvate was used since sodium pyruvate interferes 
with the LDH assay. TNF-α (10 ng/ml) was the positive control. 0.5 ml conditioned 
medium was collected 2, 4, 6, 8, 12 and 24 hours after plasma, and LDH was quantified 
using the Cyototox-ONE Homogeneous Membrane Integrity Assay (Promega) as per 
manufacturer instructions. FGF2 release from plasma treated cells was measured in 
collected medium 0.5 to 24 hours after plasma treatment. FGF2 levels were quantified via 
FGF ELISA (R&D Systems).  
Non-Thermal Plasma Induced Cell Proliferation 
Endothelial cell proliferation was measured through cell counts and BrdU 
incorporation on treated cells or using conditioned medium. For cell counts, 10,000 
PAEC were seeded on coverslips and plasma treated as described. Cell number was 
quantified on days 1, 3, 5 and 7 by counting trypsin-detached cells using a Coulter 
counter, with medium changes on days 2, 4 and 6. For directly treated cells, fold 
proliferation was determined by comparing cell number on day five to day one. For 
conditioned medium, confluent PAEC were plasma treated as described and incubated for 
3 hours in 1 ml serum-free DMEM. Conditioned medium was collected and centrifuged 
to remove dead cells. 0.5 ml conditioned medium, along with 1 ml supplemented 
medium, was added to sub-confluent PAEC (10,000 cells per well) on days 2, 4, and 6 
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and cell proliferation was assessed. Conditioned medium from untreated cells and serum-
free medium were controls. FGF2 effects were blocked by pre-incubating conditioned 
medium with FGF2 neutralizing antibody (1 µg/ml) for 30 min prior to adding it to cells. 
DNA synthesis induced by plasma-treated cell conditioned medium was 
determined by BrdU incorporation. Thymidine analogue 5-bromo-2-deoxyuridine (BrdU) 
is incorporated instead of thymidine into newly synthesized DNA. 10,000 cells per well 
were seeded in a 96-well plate in supplemented medium. Conditioned medium was 
collected from plasma-treated cells as described and added to each well in a 1:2 ratio with 
supplemented medium. After 18 hours, 20 µl BrdU labeling solution (Chemicon) was 
added to each well for 3 hours. Cells were fixed and incubated with anti-BrdU conjugated 
with peroxidase. The optical density (450/570), which was directly proportional to DNA 
synthesis level, was determined using a microplate reader (TECAN). 
Statistical Analysis 
Statistical analyses were performed with Prism software (Graphpad). Data were 
normally distributed and expressed as the mean ± S.D. Comparisons between two groups 
were analyzed by Student‘s t test, and comparisons between more than 2 groups were 
analyzed by ANOVA. A value of p ≤ 0.05 was considered statistically significant and is 
indicated with a pound sign (#). p ≤ 0.01 is indicated with an asterisk (*). 
 
3.3. Results  
3.3.1. Cell Proliferation in Response to Non-Thermal Plasma  
Endothelial cell proliferation is enhanced by low dose non-thermal plasma 
treatment. Five days after treatment, cells treated with plasma showed greater viable cell  
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number than control up to 30 seconds of plasma. PAEC exposed to 30 seconds of plasma 
demonstrated twice as many viable cells as untreated controls (Figure 11A). However,  
 
Figure 11. Plasma induces endothelial cell proliferation by direct treatment and through 
conditioned medium from treated cells. (A) PAEC were plasma treated on day 0, and 
counted on days 1 and 5, with medium changes on days 1 and 3. Data are presented as 
fold change, since plasma leads to some cell death on day 1. * p < 0.01 compared to 
untreated cells. (B) Conditioned medium was collected after three hours from untreated 
or plasma-treated cells and applied to untreated PAEC. Serum-free media, which does not 
contain soluble growth factors, was the negative control. Cell number was counted with a 
Coulter counter. * p < 0.01 compared to day 1; # p<0.01 comparing untreated cells with 
30 seconds plasma. 
plasma treatment beyond 30 seconds decreased cell number. A similar increase in cell 
number with 30 seconds of plasma treatment was observed for cells growth on collagen 
coated coverslips. To determine if increased cell number was related to a cell-secreted 
soluble factor, PAEC were incubated in conditioned medium from untreated or plasma 
treated cells (3.9 J/cm
2
, 30 s) (Figure 11B). Serum-free media, which does not contain 
soluble growth factors, was the negative control. Plasma dose was selected based on 
maximal observed effect. Viable cell number was twice as high in cells incubated with 
plasma-treated cell conditioned medium on days 3, 5 and 7 compared to cells incubated 
with untreated cell conditioned medium.  
 
 
A. B. 
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3.3.2. Cell Death in Response to Non-Thermal Plasma 
Decreased viable cell number was observed at high non-thermal plasma levels; 
therefore we investigated endothelial cell death in response to plasma. Plasma was 
relatively non-toxic to PAEC up to 60 seconds. While the number of live, attached cells 
decreased as plasma exposure increased, more than 75% of cells remained viable up to 60 
seconds plasma (Figure 12A). There was no significant difference in cell viability 3 & 24 
hours following plasma exposure, suggesting no long term plasma toxicity effects. A 
Live/Dead assay was used to confirm cell count results. Endothelial cells treated with 
plasma for short exposure times (up to 30 seconds) showed few dead cells (Figure 12B, 
quantified in Figure 12C), confirming that plasma is relatively non-toxic at short 
exposures. Dead cell number increased with increasing plasma exposure time (p < 0.01 
by ANOVA). While dead cell number increased slightly with 60 seconds plasma, at 120 
seconds a significant number of dead cells and few live cells were evident. This extensive 
cytotoxicity may be related to sample drying. Therefore, 120 seconds plasma was not 
used for subsequent assays.  
To determine the endothelial cell death mechanism induced by plasma, PAEC 
were analyzed 24 hours post-plasma for apoptosis (Figure 12D). Apoptosis increased 
with plasma treatment (p < 0.01 by ANOVA). At 30 and 60 seconds plasma, 20% of cells 
were apoptotic compared to 10% of untreated cells. At 120 seconds, nearly 60% of cells 
were apoptotic. These data confirm that shorter plasma exposures are non-toxic, and 
apoptosis is one mechanism of plasma-induced cell death.  
99 
 
 
 
Figure 12. Low dose plasma is relatively non-toxic to cells, but high dose induces 
apoptotic cell death. (A) Attached cells, confirmed as alive by Trypan blue, were counted 
3 and 24 hours after plasma (p < 0.01 by ANOVA). (B) Endothelial cell death was 
measured by Live/Dead assay. Live cells appear green, whereas dead cells appear red. 
Scale bar is 200 µm. (C) Quantified Live/Dead images (n=5). (D) Apoptosis was 
measured by Annexin V – propidium iodide 24 hours after plasma. 
 
3.3.3. FGF-2 Release Post Non-Thermal Plasma Treatment 
We next considered whether FGF2 was released from endothelial cells following 
plasma, and whether released FGF2 contributed to enhanced cell proliferation. FGF2 has 
no signal sequence for secretion, and therefore is primarily thought to be released during 
sub-lethal cell membrane damage. Cell-released FGF2 increased up to 3 hours after 
plasma treatment (3.9 J/cm
2
, 30 seconds) and then rapidly decreased up to 24 hours after 
plasma (Figure 13A). In contrast, FGF2 levels for cells treated with 10 ng ml
-1
 TNF-α as 
a positive control rose more slowly but continued to rise up to 24 hours. Endothelial cell 
A. 
C. D. 
B. 
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membrane damage was assessed by LDH release following plasma. Medium LDH 
increased significantly by 4 hours after plasma and continued to rise throughout the first 
24 hours (Figure 13B, p < 0.01 by ANOVA), comparable to TNF-α positive control.  
 
Figure 13. Endothelial cells release FGF2 after plasma, and cell-released FGF2 enhances 
proliferation. (A) FGF2 was quantified in cell medium after plasma by ELISA. Inset 
shows medium FGF2 up to 3 hours after treatment. (B) LDH release was measured in cell 
medium post-plasma. (C) FGF2 effects were blocked by incubating plasma-treated cell 
conditioned medium with FGF2 neutralizing antibody. (D) FGF-2 blockade reduced 
DNA synthesis in response to plasma-treated cell conditioned medium, measured by 
BrdU incorporation. Serum free media, which does not contain FGF2, was the negative 
control. 
The role of released FGF2 in plasma-enhanced endothelial cell proliferation was 
investigated by treating conditioned medium from plasma-treated cells with an FGF2 
neutralizing antibody to block FGF2 effects. Serum free media, which does not contain 
FGF2, was the negative control. The FGF2 neutralizing antibody significantly suppressed 
proliferation in PAEC exposed to plasma-treated cell conditioned medium (Figure 13C). 
C. D. 
A. B. 
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Viable cell number for samples with FGF2 blocked was similar to untreated cell 
conditioned medium. These data were confirmed with a BrdU assay (Figure 13D). BrdU 
incorporation was enhanced for cells incubated in plasma-treated cell conditioned 
medium, but the FGF2 neutralizing antibody abrogated the effect. These data suggest that 
plasma leads to FGF2 release, which contributes to enhanced endothelial cell 
proliferation following plasma. 
 
3.3.4. Mechanisms of Release of FGF-2 Following Plasma Exposure 
Plasma produces neutral short and long lived reactive species and charged 
particles like ions and electrons, yet which plasma component led to endothelial cell 
FGF2 release was unknown. To better understand FGF2 release mechanisms, PAEC were 
exposed to plasma directly, indirectly, or in a separated configuration. There was no 
statistically significant difference in FGF2 release between direct and indirect treatment 
(Figure 14A). Both direct and indirect cell plasma treatment induced significantly greater 
endothelial cell FGF2 release as compared to separated treatment, however separated 
treatment still produced significantly more FGF2 release than untreated control. 
Non-thermal plasma produces large amounts of ROS. These ROS may interact 
with endothelial cells, leading to FGF2 release. To determine the role of ROS in plasma-
induced cell FGF2 release, endothelial cells were pre-incubated in 4 mM NAC 
(intracellular ROS) and then plasma-treated in supplemented medium with or without 10 
mM sodium pyruvate (extracellular ROS). Both NAC and sodium pyruvate significantly 
suppressed FGF2 release from plasma treated cells (Figure 14B), suggesting that 
intracellular and extracellular ROS may contribute to plasma effects.  
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Figure 14. Endothelial cell FGF2 release is linked to neutral ROS. (A) PAEC were 
plasma treated directly, with a grounded mesh to remove charged particles (indirect), or 
medium was plasma treated and then applied to cells (separated). Medium FGF2 was 
measured by ELISA three hours after plasma. # p<0.05 compared to direct. (B) PAEC 
were pretreated with 4 mM (NAC, intracellular) or 10 mM sodium pyruvate (SP, 
extracellular), or both ROS scavengers (NSP). Samples were directly plasma treated, and 
cells pretreated with ROS scavengers were compared to cells directly treated with plasma 
alone (D). Medium FGF2 was quantified by FGF ELISA three hours after plasma. 
 
3.4. Discussion 
Non-thermal plasma interacts with the vasculature during tissue treatment, and 
plasma may be able to induce dose-dependent blood vessel growth and regression. We 
now show that high dose plasma induces endothelial cell death, whereas low dose 
enhances endothelial cell proliferation. The plasma proliferative effect is likely related to 
sub-lethal cell membrane damage by ROS, which leads to FGF2 release. FGF2, together 
with vascular endothelial growth factor and other critical signals, induces endothelial cell 
proliferation, migration, and tube formation [332]. Angiogenesis is a complicated 
process, and endothelial cell proliferation plays only a small initial role [331]. However, 
our data suggest that low-dose plasma could promote angiogenesis to accelerate wound 
healing, whereas high-dose plasma could inhibit angiogenesis to prevent cancer growth. 
A. B. 
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In cases where plasma cannot be used directly, fluid from plasma treated cells could also 
be used.  
While FGF2 alone will likely not complete the angiogenic process, additional 
subsequent plasma treatments could be tuned to induce other angiogenic signals. For 
example, ROS play an important role in vascular endothelial growth factor signaling, and 
thermal plasmas that produce nitric oxide could also promote angiogenesis. Thus 
repeated plasma treatments of different doses or with different plasma types could be 
timed to maximize the angiogenic response. During these repeated treatments, plasma 
effects on the surrounding tissue must also be considered. In our previous work, high 
plasma doses did not induce gross or histological skin damage in an animal model, and 
malignant epithelial cells were more sensitive to plasma-induced apoptosis [335, 336]. 
These data suggest that plasma may induce angiogenesis without harming the 
surrounding tissue, whereas plasma inhibition of angiogenesis may synergistically kill 
malignant cells. However, since each of these studies were performed under slightly 
different plasma and cell or tissue conditions, additional studies should be performed to 
directly compare plasma sensitivity of various cell types.  
Non-thermal plasma can induce endothelial cell death via the apoptotic pathway. 
In our previous work on ROS and endothelial cells, we showed that low ROS levels 
induce sub-lethal cell membrane damage, higher ROS levels induce apoptosis, and 
extremely high ROS levels induce non-specific cell death which is likely necrosis [337]. 
Our data suggest that plasma dose can similarly be used to modulate the cell death 
mechanism, which is an important consideration both in vivo and in vitro. Apoptosis is 
programmed cell death initiated by physiological or pathological signals. Apoptotic cells 
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are broken up into apoptotic bodies, which are engulfed by neighboring cells, leading to 
clean cell death without significant inflammatory response [338, 339]. On the contrary, 
necrosis is cell death accompanied by swelling, blebbing and increased membrane 
permeability leading to cytosolic content spillage. This typically leads to inflammation in 
surrounding tissue [338, 339]. By controlling plasma dose, we may be able to kill 
endothelial cells without significant necrosis and subsequent inflammation. 
Plasma induces endothelial cell FGF2 release. FGF2 is thought
 
to be released only 
at cell injury or death, since it has no signal sequence for secretion [332]. Since plasma 
effects occur shortly after treatment, plasma may induce sub-lethal endothelial cell 
membrane damage, rendering the cells leaky to intracellular contents like FGF2. Other 
stimuli which induce cell membrane damage lead to FGF2 release. Biochemical changes, 
such as high glucose, enhance FGF2 release also through ROS[337]. Transient plasma 
membrane disruption by mechanical forces leads to rapid cytosolic FGF2 release. This 
FGF2 release initiates growth required for tissue integrity maintenance and/or repair after 
injury [340]. Mechanical strain also stimulates a proliferative response in coronary 
vascular smooth muscle cells via FGF2 release, and strain can even enhance endothelial 
cell FGF2 mRNA expression [341, 342]. In vivo, FGF2 released into the coronary 
circulation after vascular injury promotes human vascular smooth muscle cell 
proliferation [343].  
Similar to mechanical damage, cell membrane injury from ionizing radiation 
induces FGF2 expression and release in endothelial and epithelial cells in vitro [344-346] 
and in vivo [347]. FGF2 enhances endothelial, epithelial, and hematopoetic cell survival 
after ionizing radiation[345, 348-350], and FGF2 release is critical to radiation damage 
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repair [345]. Pulsed electromagnetic fields can stimulate endothelial cell growth, 
angiogenesis, and wound healing through endogenous FGF2 release [351-353]. Non-
thermal plasma differs from irradiation and electromagnetic fields in that the latter are 
penetrating and injure surrounding tissue, or they need an expensive setup to be generated 
safely. Plasma provides a novel and safer means to induce FGF2 release and angiogenesis 
since it provides precise control of treatment area and depth. Non-thermal plasma devices 
are also small and relatively simple to produce. 
When endothelial cells are exposed to plasma, the conditioned medium FGF2 
level peaks three hours after treatment and then declines. In contrast, cells treated with 
TNF-α show a gradual increase in medium FGF2. Thus plasma FGF2 release kinetics is 
essentially different from TNF-α. One possible reason is that TNF-α remains in the 
medium continuously, whereas plasma treatment occurs over a short, finite time. An 
alternative is that while both plasma and TNF-α likely release FGF2 related to ROS, 
TNF-α takes longer to produce ROS. While TNF-α activates a variety of biochemical 
signaling pathways in endothelial cells, the most likely path for TNF-α FGF2 release is 
cell membrane damage, since FGF2 has no known signal sequence for secretion. TNF-α 
must bind the membrane-bound TNF receptor, which activates intracellular signaling 
cascades leading to ROS [354, 355]. Thus the indirect and extended FGF2 release from 
TNF-α induced cell damage differs greatly from the finite and direct nature of plasma-
induced rapid FGF2 release. The released FGF2 may then be bound by remaining viable 
cells, which explains the drop in medium FGF2 level after 3 hours and enhanced 
endothelial cell proliferation. This brief and defined FGF2 release may be critical to 
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angiogenesis, since timing and local biochemical environment play important roles in 
FGF2 signaling [356]. 
Both FGF2 and LDH are released from cells due to cell membrane damage, yet in 
our experiments, FGF2 and LDH release from plasma treated cells followed different 
trends. Whereas FGF2 release peaked three hours post-plasma and then declined, LDH 
release became significant only four hours after plasma treatment but then increased up to 
24 hours. This difference may be related to the relative LDH (134 kDa) and FGF2 (18 
kDa) sizes. FGF2 may be released after early sub-lethal plasma membrane damage, 
whereas LDH release occurs gradually after more extensive cell membrane damage. 
Additionally the gradual post-plasma LDH release may indicate that non-thermal plasma 
does not lead to immediate irreversible membrane integrity loss normally associated with 
severe trauma or cell death. Viable cells release low LDH amounts without hampering 
cell function [357]. LDH also has no extracellular function, whereas FGF2 binds to cell 
membrane receptors, thus cell-released LDH is not metabolized by other cells whereas 
FGF2 is. This correlates with FGF2 decrease up to 24 hours after plasma. Non-thermal 
plasma may lead to sub-lethal membrane damage which is gradually repaired as living 
cells uptake released FGF2 and remain viable. 
Plasma-induced FGF2 release is likely related to neutral ROS. Non-thermal 
plasmas produce long lived (O3, NO, HO2, H2O2) and short lived (OH, O, electronically 
excited O) neutral particles and charged particles (ions and electrons). Both charged and 
neutral particles can lead to ROS in treated fluid. When endothelial cells were treated 
directly or indirectly (excluding charged particles), endothelial cell FGF2 release was not 
significantly different. However, FGF2 release decreased in separated treatment, in which 
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medium was treated prior to applying it to cells. The time required to collect separately 
treated medium and apply it to untreated cells eliminated short lived neutral species and 
direct contact between plasma and cells. Direct plasma effects could include local heating 
by plasma streamers or UV radiation. Since separated treatment decreased FGF2 release 
by 50%, and FGF2 release remained significantly greater than in control cells, we believe 
that both short and long lived neutral species play a major role in plasma-induced FGF2 
release. While a wide variety of plasma-produced ROS could affect cells, both atomic 
and singlet oxygen are short lived and therefore highly likely to recombine before 
reaching the sample surface during treatment. The plasma-produced ROS most likely to 
contribute to endothelial cell FGF2 release are OH radicals, hydrogen peroxide, and HO2. 
Non-thermal plasma produces a large ROS concentration in extracellular medium during 
treatment. However, it is unclear if these ROS go inside cells. Both intracellular and 
extracellular ROS scavengers decreased FGF2 release following plasma. Combined 
scavengers reduced FGF2 release more than either scavenger alone. ROS produced by 
plasma extracellularly may move across the cell membrane through lipid peroxidation, 
opening transient cell membrane pores, or signaling pathways which modify ROS inside 
cells. Active species produced by plasma may also modify the cell medium, which in turn 
interacts with cells. Since many of active species have a short life span, they may 
immediately interact with medium components including amino acids and proteins, 
leading to production of long lived reactive organic hydroperoxides [358]. These 
hydroperoxides may then induce lipid peroxidation and cell membrane damage, or they 
may bind to cell membrane receptors and activate intracellular signaling pathways 
leading to FGF2 expression and release. 
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We believe that non-thermal plasma could be used in vitro and in vivo to stimulate 
angiogenesis. Potential plasma applications include vascularizing tissue engineering 
structures, enhancing transplanted tissue incorporation, and accelerating wound healing. 
Our two-dimensional treatment model – an endothelial cell monolayer on a glass 
substrate covered with a thin medium film (~100 µm) – is likely more severe than what 
would be experienced by cells either in vivo or in three-dimensional in vitro models. Both 
sample geometry and the amount of liquid covering the sample are crucial to plasma 
treatment efficacy. We previously showed that increasing media depth over malignant 
epithelial cells decreased plasma-induced cell death [336]. ROS are highly reactive and 
may be inactivated prior to reaching cells if the distance between the plasma and the cells 
is too great. In these situations, a higher plasma dose could be used to maintain plasma 
effects. In the future, we will examine plasma penetration depth variation with 
environmental conditions by treating endothelial cells within three-dimensional collagen 
gels. We observed similar plasma-induced proliferation results for cells seeded on 
uncoated and collagen-coated substrates in two dimensions, suggesting that plasma 
effects will be similar in a more tissue-like environment.  
 
3.5. Summary 
To summarize, mammalian cells were treated in vitro with a custom non-thermal 
plasma device. Low dose plasma treatment was relatively non-toxic to mammalian cells 
while treatment at high doses led to cell death. Endothelial cells treated with plasma at a 
dose of 4 J/cm2 demonstrated twice as much proliferation as untreated cells five days 
after plasma treatment. Release of fibroblast growth factor-2 (FGF2) peaked three hours 
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after plasma treatment. The plasma proliferative effect was abrogated by an FGF2 
neutralizing antibody, and FGF2 release was blocked by ROS scavengers. These data 
suggest that low dose non-thermal plasma enhances cell proliferation due to ROS 
mediated FGF2 release. Plasma may be a novel therapy for dose-dependent promotion 
or inhibition of endothelial cell mediated angiogenesis. 
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Chapter 4. High Dose Non-Thermal Plasma Treatment 
 
In Chapter 2, we saw that oxidative stress has a broad spectrum of effects on 
mammalian cells, ranging from cell proliferation to apoptosis. Studies have shown that 
high levels of oxidative stress leads to apoptosis in mammalian cells. 0.5 to 1 mM of 
H2O2 was shown to induce apoptosis in fibroblasts [148]. The dose of non-thermal 
plasma can be tuned to produce high concentrations of reactive oxygen species in 
medium [17]. As described in Chapter 3, plasma treatment exposures over 30 s of 
treatment or a dose of plasma greater than 5 J/cm
2
 were classified as high dose plasma 
treatment. In this chapter our aim was to investigate the effects of high dose plasma 
treatment on mammalian cells. Malignant cells have frequently acquired the ability to 
block apoptosis and proliferate indiscriminately and it is important that treatment 
modalities address this concern by inhibiting proliferation and at the same time limit 
inflammation by primarily inducing apoptosis over necrosis in malignant cells. Earlier 
studies had shown that non-thermal DBD plasma treatment demonstrates apoptosis like 
behavior in melanoma cells [42]. In Chapter 4 we rigorously tested this claim and present 
results related to induction of apoptosis in malignant cells by high dose of non-thermal 
DBD plasma treatment. 
 
4.1. Introduction 
The ability of a cell to self-regulate is a vital function in multicellular organisms 
allowing for appropriate growth, development, and death at the necessary times.  
Apoptosis, or programmed cell death, is a critical element of this self-regulation [201, 
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359]. The non-functioning of a tumor-suppressor gene that facilitates apoptosis, or the 
over expression of an anti-apoptotic protein are both important pathways in cancer 
development.  Many anti cancer therapies are aimed at modulating these factors with 
various bioactive agents in an attempt to target components of the apoptotic pathway 
[354, 360].  However, many of these approaches remain in preclinical development 
secondary to low efficacy and drug resistance [361, 362]. Our current research seeks to 
develop techniques to modulate apoptotic activity in cancer cells by evaluating an 
electro-physical approach to induce apoptosis. 
 In the present study, we sought to explore the effects of exposure of melanoma 
cells to non-thermal atmospheric pressure dielectric barrier discharge (DBD) plasma 
(non-thermal plasma) in cell culture.  To date there has been no investigation of the interaction 
between non-thermal atmospheric plasma discharges and the induction of apoptosis in living 
cells.  This information is critical if this is going to be a viable treatment strategy as a selective 
cytotoxic cancer therapy. We also present a few mechanisms underlying the induction of 
apoptosis by non-thermal plasma in melanoma cancer cells.  
 
4.2. Materials and Methods 
Cell Lines and Reagents 
The Melanoma cell line (ATCC A2058) was cultured in Dulbecco's modified 
Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 
4.5 g/L glucose (ATCC 30-2002), 10% fetal bovine serum (ATCC 30-2020) and 1% 
Penicillin/Streptomycin (Sigma-Aldrich, St Louis, MO).  The cells were propagated in 
100 mm plastic petri dishes (Greiner Bio One) in a 5% CO2 incubator at 37 ºC. Media 
was changed every 2 – 3 days. After 4 – 5 days of incubation, the cells were trypsinized 
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(0.25% (w/v) Trypsin - 0.53 mM EDTA) harvested and transferred to 44 mm diameter 
aluminum Petri dishes (Fisher Scientific, Pittsburgh, PA). To improve the cell adhesion 
on aluminum petri dishes, the dishes were pre-treated with poly L-lysine for 1h. 
Experiments were begun 2 days after plating cells in aluminum dishes. The number of 
cells in each Petri dish at the beginning of each experiment was about 1 x 10
6
 with 3-9% 
Trypan blue positive.  
Actinomycin D (Biovision Inc., Mountain View, CA), a potent inducer of 
apoptosis, was used as a positive control. N-Acetyl-L-cysteine (2 mM, Sigma-Aldrich, St 
Louis, MO), an intracellular ROS (ROS) scavenger was used to block the ROS produced 
by non-thermal plasma treatment. 
Non-Thermal Plasma Treatment of Melanoma Cells 
  Early experiments revealed that plastic Petri dishes prevented application of 
uniform plasma discharge to the cells.  As an alternative, aluminum Petri dishes (Fisher 
Scientific) were used to plate and treat cells in-vitro.  The only drawback was the 
inability to observe the cells directly on the plates.  For this reason, additional controls 
were prepared in parallel with standard Petri dishes of the same size. At the start of each 
experiment all the media from each experimental or control Petri dish was aspirated and 
200 µl of fresh media was added to keep the cells moist. The cells were exposed to non-
thermal plasma and immediately after treatment; 2 ml of fresh media was added for 
further incubation until the time of analysis. Negative control dishes were treated as 
above without plasma exposure. 
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Trypan Blue Exclusion Test 
  Trypan blue exclusion was used in the initial dose response and time-course 
experiments using the following protocol.  Cells were trypsinzed and scraped and 
collected in 15ml tubes, centrifuged at 1000 rpm for 10min in 4
0
C. Fluid was aspirated 
and the cell pellet was re-suspended in 5 ml of 1x PBS. Then 10µl of suspension was 
mixed with 10µl of Trypan Blue dye (Cambrex) and transferred to a hemocytometer 
slide. The total number of cells and relative percentages of viable and dead cells were 
counted and calculated. The same procedure was performed for untreated (control) cells. 
Trypan Blue exclusion was used for cells treated with different doses of Plasma (5, 10, 
15, 20, and 30 J/cm
2
) and at different periods of time after treatment (immediately, 1 hr, 3 
hr and 24 h later).  
Colony Survival Assay 
1 x 10
6
 Melanoma cells were seeded in aluminum petri dishes two days before 
plasma treatment. Cells were plasma treated as described at various doses of plasma and 
then incubated for one day after plasma treatment. 300 cells were seeded onto 60-mm 
dishes after exposure to non-thermal plasma or H2O2 (positive control). Colonies, which 
formed 11 days after plating MCF10A cells, were fixed and stained with a crystal violet 
solution (0.5% in 20% ethanol) and then counted. Assays were done in triplicate. 
Annexin-V/PI Assay 
Cell propagation and Plasma treatment were done as above. In order to confirm 
apoptotic activity, cells were cultured as above and then exposed to non-thermal plasma 
at a dose of either 5 J/cm
2
 or 15 J/cm
2
. A negative control of untreated cells and a 
positive control of Actinomycin D treated cells were run in parallel.  The cells were 
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harvested at 0, 24, 48, and 72 hours after treatment and stained using the Guava Nexin 
apoptosis kit (Guava Technologies, Hayward CA).  Analysis was performed using the 
Guava® Personal Cell Analysis (PCA) 96 System.  Annexin V is a calcium-dependent 
phospholipid binding protein with high affinity for phosphatidylserine (PS), a membrane 
component normally localized to the internal face of the cell membrane. Early in the 
apoptotic pathway, molecules of PS are translocated to the outer surface of the cell 
membrane where Annexin V can readily bind them. This assay incorporates this PS-
Annexin V binding as an indicator of early stage apoptotic cells. The Guava Nexin™ 
assay kit utilizes Annexin V-PE to detect PS on the external membrane of apoptotic cells. 
The cell impermeable dye, 7-AAD, was used as an indicator of membrane structural 
integrity. 7-AAD is excluded from live, healthy cells and early apoptotic cells, but 
permeates late stage apoptotic and dead cells. These populations of cells can then be 
distinguished in this assay.    Numerous samples of each group were run consecutively at 
each time point to establish statistical validity. 
Caspase-3 Cleavage 
Protein expression and modification were analyzed by immunoblot. Total cell 
lysates were prepared by direct lysis of floating and attached cells in 2X SDS sample 
buffer containing β-mercaptoethanol. Samples were electrophoresed on a 1.5 mm 15% 
polyacrylamide gel at 150 V in Tris-glycine SDS running buffer [25 mmol/L Tris, 192 
mmol/L glycine, 0.1% SDS (pH 8.3)]. Following electrophoresis, proteins were 
transferred on to PVDF (Millipore, MA, USA) membrane for three hours at 65V in Tris-
glycine transfer buffer [10% SDS, Deionized Water, Tris-Glycine and Methanol (VWR, 
PA USA)]. Immunoblotting was done by blocking membranes in 5% bovine serum 
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albumin (BSA, Fraction V, Fisher Scientific) in PBST for 30 min followed by incubation 
with primary antibody in 5% BSA in PBST for cleaved caspase-3 overnight for 10 to 12 
h at 4ºC with rocking. Primary antibodies used for immunoblot included rabbit polyclonal 
antibodies specific for cleaved caspase-3 [Millipore, MA, USA]. The primary antibody 
was detected with fluorescently tagged goat anti-rabbit Alexa and Fluor 488 (Santa Cruz 
Biotechnology). Immunoblot was developed using Odyssey Infrared Gel Imaging system 
(LI-COR Biosciences, NE, USA). 
TUNEL ® Assay 
One of the hallmarks of late-stage apoptosis, or programmed cell death, is the 
fragmentation of nuclear chromatin. This generates DNA strands with exposed 3'-
hydroxyl ends, which are enzymatically labeled in the TUNEL assay. Cells were 
harvested as above at 24, 48 and 72 hours after treatment in triplicate and were stained 
using the DeadEnd
tm Fluorometric TUNEL assay (Promega Co.). The DeadEnd™ 
Fluorometric TUNEL System is a classic TUNEL Assay designed for the specific 
detection and quantitation of apoptotic cells within a cell population. The DeadEnd™ 
Fluorometric TUNEL System measures nuclear DNA fragmentation, an important 
biochemical hallmark of apoptosis in many cell types. The DeadEnd™ Fluorometric 
TUNEL System measures the fragmented DNA of apoptotic cells by catalytically 
incorporating fluorescein-12-dUTP
(a)
 at 3´-OH DNA ends using the enzyme Terminal 
Deoxynucleotidyl Transferase (TdT), which forms a polymeric tail using the principle of 
the TUNEL (TdT-mediated dUTP Nick-End Labeling) assay. The fluorescein-12-dUTP-
labeled DNA can then be visualized directly by fluorescence microscopy or quantitated 
by flow cytometry. 
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For fluorescence microscopy, cells were fixed on Lab-Tek slides for the TUNEL 
assay. Samples were analyzed in a fluorescence microscope using a standard fluorescence 
filter set to view the green fluorescence of Fluorescein at 520 ± 20 nm. Both control and 
treated cells were cultured in aluminum dishes to analyze the possibility of apoptosis 
developing from contact with aluminum. 
For flow cytometry analysis, cell suspensions were treated with the DeadEndTM 
Fluorometric TUNEL System (Promega US Co), following the manufacturer‘s 
instructions. Counterstaining was done by incubating cells for 20 min at room 
temperature in the dark in phosphate-buffered saline containing 6 ng/mL RNAse (Roche 
Applies Sciences, Indianapolis, IN) and 5 ng/mL propidium iodide (Invitrogen, Carlsbad, 
CA) in PBS. Suspensions were washed once in PBS and resuspended in PBS for analysis. 
Flow cytometry was performed using a FACSORT flow cytometer (BD Biosciences, San 
Diego, CA). Data acquisition was done using Lysis II software (version 2.0, BD 
Biosciences). Fluorescence spill-over was removed by compensation. At least ten 
thousand events were acquired per sample. Data analysis was performed using WinMDI 
software (Joseph Trotter, The Scripps Research Institute, La Jolla, CA, available online 
from http://www.facs.scripps.edu). Apoptotic and necrotic cells were differentiated by 
plotting PI fluorescence over fluorescein in a bivariate plot. Quadrants were set to define 
TUNEL-negative cells with normal DNA content; TUNEL-positive cells were counted as 
apoptotic, TUNEL-negative cells with lower DNA content as necrotic. 
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4.3. Results and Discussion 
4.3.1. Cell Viability 
4.3.1.1. Trypan Blue 
The first set of experiments sought to determine the short-term sub-lethal dose of 
non-thermal Plasma in our melanoma cell line.  When control cells were compared to 5, 
10, 20 and 30 J/cm
2
 of Plasma exposure one hour after treatment as shown in Figure 15A, 
we found that doses greater than 10 J/cm
2
 of exposure decreased the total number of cells 
in culture significantly (2.5 x10
6
 vs. <1.1x x10
6
; p<0.05). In addition, a dose 10 J/cm
2 
reduced the percent of viable cells from 92% to 23% (p<0.05).    
 
4.3.1.2. Colony Assay 
Cell number and trypan blue exclusion gives an indication of cell growth; 
however, it does not indicate true long term survival which is better assessed by colony 
survival assays.  In order to determine whether the decrease in cell number was due to 
induction of cell death and whether the remaining cells were viable, colony survival assay 
was performed at various time points after plasma treatment.  Melanoma cell survival 11 
days after plasma treatment was significantly decreased as the dose of plasma increased 
as shown in Figure 15B. Twenty eight percent of the cells treated at 5 J/cm
2
 were viable 
11 days after treatment (p < 0.001) and15% and 8% survival were observed at 10 J/cm
2
 
and 15 J/cm
2
, respectively, (p < 0.001) as compared to untreated cells. Non-thermal 
plasma decreases long term viability and survival of melanoma cells. This indicates that 
non-thermal plasma is not only able to kill melanoma cells but many of the cells that 
appear to survive are not really viable, i.e. they cannot form a colony 
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Figure 15. Dose dependent response of melanoma cells. (A) Data from triplicate samples 
(± S.E.M.) are expressed relative to total number of cells in untreated control. Trypan 
blue testing revealed that plasma treatment up to 10 seconds decreased the total number 
of cells 1 h, 3 h and 24 h after plasma treatment (p < 0.001). Also total number cells 
decreases linearly as the dose of plasma exposure increases from 5 J/cm
2
 to 30 J/cm
2
 (p < 
0.01). # p < 0.05 as compared to untreated control * p < 0.001 as compared to untreated 
control
 
(B) Cells were treated with the indicated dose of non-thermal plasma; one day 
after treatment, 300 cells were plated in a 6 cm dish and colonies were counted after 11 
days. Data from triplicate samples (±S.E.M.) are expressed relative to the # of colonies in 
the untreated control. Survival of melanoma cells post plasma treatment decreases 
significantly as the dose of plasma exposure increases (p < 0.001). * p < 0.001 as 
compared to untreated control 
 
4.3.2. Apoptosis 
4.3.2.1. Annexin – V/PI 
 To confirm that non-thermal plasma was inducing apoptosis in melanoma cells, 
Annexin-V/PI staining was utilized.  The cells were treated with non-thermal plasma at 
two different doses; viz, 5 J/cm
2
 and 15 J/cm
2
.  Untreated cells were used as a negative 
control. Cells were treated with 4 mm Actinomycin D as a positive control.  The cells 
were analyzed 3 h, 24 h, 48 h, and 72 h after treatment. As shown in Figure 16, Annexin-
V/PI staining confirmed no significant increase in apoptosis early time points (3 h) after 
non-thermal plasma treatment, but a significant increase in apoptosis was observed in 
plasma-treated cells 24, 48, and 72 hours post-treatment (p < 0.001). As shown in Figure 
A. B. 
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16, 3 h after plasma treatment  the number of total apoptotic cells in untreated cells was 
8%, as compared with 12% and 10% after treatment with 5 J/cm
2
 and 15 J/cm
2
, 
respectively.  
 
Figure 16. Annexin-V/Propidium Iodide Staining (A) Annexin staining confirmed no 
significant increase in apoptosis immediately after plasma treatment, but a significant 
increase in apoptosis in plasma-treated cells compared to untreated control cells 24, 48, 
and 72 hours post-treatment * p < 0.001. Cells treated at 15 J/cm
2
 showed significantly 
more apoptosis as compared to cells treated at 5 J/cm
2
 of plasma exposure at 48 and 72 h 
after plasma treatment # p < 0.05  
Twenty four hours after treatment with 5 J/cm
2
 and 15 J/cm
2
, the amount of 
Annexin-V/PI positive cells increased to 22% and 27%, respectively, (p < 0.001) as 
compared to untreated cells, which had only 8% apoptotic cells. 48 h after plasma 
treatment total apoptotic cells in 5 J/cm
2
 and 15 J/cm
2 
increased to 40% and 57%, 
respectively (p < 0.001) as compared to untreated control which had only 10% apoptotic 
cells. Seventy two hours after plasma treatment, the total apoptotic cells were 42% and 
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50% respectively (p < 0.001) in cells treated with 5 J/cm
2
 and 15 J/cm
2 
as compared to 
15% in untreated control. Thus, immediately following treatment with non-thermal 
plasma there was no significant increase in apoptotic cells.  However, at later time points 
after treatment, non-thermal plasma induced significant apoptosis at both 5 J/cm
2
 and 15 
J/cm
2
. 
 
 
Figure 17. Caspase-3 cleavage assay. Cells were treated with non-thermal plasma at two 
different doses, 5 J/cm
2
 and 15 J/cm
2
. Caspase-3 cleavage was analyzed by immunoblot. 
Total cell lysates at 8 h, 12 h, 24 h, 36 h and 48 h after plasma treatment were prepared 
by direct lysis of floating and attached cells in 2X SDS sample buffer containing β-
mercaptoethanol. Samples were electrophoresed at on 1.5 mm 15% polyacrylamide gels 
at 150 V in Tris-glycine SDS running buffer. Following electrophoresis, proteins were 
transferred to PVDF membrane for three hours in Tris-glycine transfer buffer. (A) No 
significant cleavage of caspase-3 was observed until 48 h after plasma treatment at a dose 
of 5 J/cm
2
 while (B) we observed caspase-3 cleavage at 36 h after plasma treatment at a 
dose of 15 J/cm
2 
and significant cleaved caspase at 48 hours. 
 
4.3.2.2. Caspase – 3 Cleavage 
To test whether non-thermal plasma treatment of mammalian cells indeed led to 
induction of apoptosis by initiating the caspase-3 mediated apoptosis, we determined 
A. 
B. 
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cleavage of caspase-3 post non-thermal plasma treatment by carrying out a western blot 
analysis of the cell lysates collected at various time points after plasma treatment. As 
shown in Figure 17A, no significant cleavage of caspase-3 is observed up to 48 h after 
plasma treatment at a dose of 5 J/cm
2
 while as shown in Figure 17B, we see significant 
cleavage of caspase-3 48 h after plasma treatment at a dose of 15 J/cm
2
. Thus non-
thermal plasma induces cleavage of caspase-3 in melanoma cancer cells which may be 
related to the formation of intracellular ROS post non-thermal plasma treatment. 
 
4.3.2.3. TUNEL® Assay 
To determine whether the decreased cell viability at a dose of 5 J/cm
2
 as assessed 
by trypan blue staining (Figure 15A) and colony survival (Figure 15B) was the result of 
apoptosis, terminal deoxyribonucleotide transferase–mediated nick-end labeling 
(TUNEL) assays were done in plasma treated melanoma cells. Cells treated for 5 s were 
then incubated and stained for DNA fractionation 24 h later. Following the TUNEL assay 
procedure it was observed that a significant percentage of these cells exhibit apoptotic 
behavior post non-thermal plasma treatment as is evident in Figure 18A while Figure 18B 
shows untreated cells. The number of TUNEL-positive cells (indicative of fragmented 
DNA) after treatment was significantly increased in cells treated with non-thermal 
plasma at a dose of 5 J/cm
2
. The results of the flow cytometry tests performed 24, 48, and 
72 h following treatment is presented as a representative in Figure 18C. As shown in 
Figure 18D, apoptosis develops 24 hours following treatment, where 25.5% of cells are 
present in the treated group, compared with 2.2% in the control group (p < 0.001). As 
time progresses, even more cells undergo apoptosis, further reaching 72.8% of apoptotic  
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Figure 18. TUNEL
®
 assay. Images of untreated (A) and treated (B) melanoma cells 
following TUNEL assay. All cells are stained blue (darker circles) and apoptotic cells are 
also stained green (bright spots). Assay performed 24 h following treatment with 5 J/cm
2
. 
(C) TUNEL
®
 analysis of cells treated at a dose of 5 J/cm
2
 demonstrated a significant 
increase in apoptotic activity at 72 hours post plasma treatment. (D) Data from triplicate 
samples (± S.E.M.) analyzed via flow cytometry 24, 48 and 72 h after plasma treatment 
at a dose of 15 J/cm
2 
show a significant increase in TUNEL positive cells as compared to 
untreated cells. (* p < 0.001) confirming late stage apoptotic behavior of melanoma cells. 
 
A. B. 
C. 
D. 
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cells in the treatment group vs. 3.2% in the control group 72 h following treatment (p < 
0.001). This indicates that non-thermal plasma treatment induces apoptosis 24 h after 
plasma treatment and cells continue to die long after plasma treatment. TUNEL positive 
cells result from fragmentation of the nuclear chromatin, a hallmark of cells in the late 
stages of apoptosis. 
 
4.3.3. Mechanisms of Induction of Apoptosis 
4.3.3.1. Role of pH 
 It is known that non-thermal plasma treatment of cell culture medium leads to 
significant reduction of pH and this may be a cause for the observed cell death. As shown 
in Figure 19A, plasma treatment of cell culture medium at lead to drop in pH from 8.5 to 
5.5 with increasing dose of plasma from 5 J/cm
2
 to 30 J/cm
2
. To test the role of change in 
pH post plasma treatment as a mediator of plasma induced cell death, plasma treatment of 
cells at a dose of 30 J/cm
2 
was compared to incubation of melanoma cells in acidified 
medium (pH 5.4) for one minute. As shown in Figure 19B, the number of dead cells in 
plasma treated (30 J/cm
2
) samples is significantly higher (p < 0.001) than those in 
untreated control or cells placed in acidified medium (pH 5.4) for 1 minute or untreated 
control. Change of pH of the medium after plasma treatment does not play a significant 
role in plasma induced apoptosis. 
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Figure 19. Mechanisms of non-thermal plasma induced apoptosis. (A) pH of the 
medium covering the cells during treatment drops from 8.5 to 5.5 as the dose of plasma 
exposure increases from 5 J/cm
2
 to 30 J/cm
2 
(B) Number of dead cells in plasma treated 
(30 J/cm
2
) samples is significantly higher (p < 0.001) than those in untreated control or 
cells placed in acidified medium (pH 5.4) for 1 minute. Change of pH of the medium 
after plasma treatment does not play a significant role in plasma induced apoptosis. (C) 
Pretreatment with 2.25 mM N-acetylcysteine (NAC), a free radical scavenger, 
significantly decreased apoptosis in plasma-treated cells as analyzed by Annexin-V/PI 
staining 24 h after plasma treatment at 5 J/cm2 (p < 0.001) as compared to untreated or 
cells treated with N-acetyl cysteine alone. 
 
4.3.3.2. Role of ROS 
Non-thermal plasma is known to produce various active neutral short and long 
living ROS like (OH, O, electronically excited oxygen O (1D), O2 (1Δg)) and (O3, HO2, 
H2O2) in cell culture medium [363, 364]. To test the role of these ROS in non-thermal 
plasma induced apoptosis, we pre-incubated melanoma cells for 30 min in 2.25 mM N-
A. B. 
C. 
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Acetyl cysteine (NAC), an intracellular scavenger of ROS, followed by treatment at a 
dose of 5 J/cm
2
. Untreated cells and untreated cells with NAC alone were used as 
negative controls and cells treated at the same dose in the absence of NAC were used as 
positive control. As shown in Figure 19C, pre-treatment with 2.25 mM N-acetylcysteine 
(NAC), a free radical scavenger, significantly decreased the level of apoptosis induced in 
response to plasma-treatment by 50% as analyzed by Annexin-V/PI staining 24 h after 
plasma treatment (p < 0.001); plasma treatment incuced apoptosis in 28% of the cells, 
which was reduced to 12 % by pre-treatment with NAC, while NAC alone had no effect 
on the melanoma cells.  These results indicate that ROS generated by non-thermal plasma 
are likely mediating non-thermal plasma induced apoptosis.  
 
4.3.4. Discussion 
The melanoma cell line (ATCC 2058) was chosen as our model because they are 
very rapidly proliferating and adherent. We did not aim to find a de novo treatment for 
skin melanoma, but rather investigate the influence of the non-thermal plasma on human 
cells. Initial experiments began by identifying the characteristics of a sub-lethal dose. 
This is the dose where we observed the ability of DBD plasma to induce apoptosis but 
not significant necrosis.  We went on to follow the effects of this exposure on cell death 
over time. The cells were evaluated using standard approaches to measure apoptosis.   
Non-thermal plasma was shown to induce apoptosis in melanoma cells at a dose 
of 5 and 15 J/cm
2
 or higher. During apoptosis, cells undergo a series of complex 
biochemical changes leading to cell death without causing significant inflammation. That 
treated cells do not initially die but stop growth and die en masse 12–24 h following 
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treatment, while untreated cells continue to grow and proliferate, suggested that plasma 
treatment might induce apoptosis. Early apoptotic behavior was confirmed with Annexin-
V/PI and Caspase-3 cleavage assays while late apoptotic behavior was confirmed through 
TUNEL staining with subsequent flow cytometry.  
Previously we [12] and other groups [14, 23, 34, 50, 51, 365-369] have shown 
that plasma is able to destroy cells; however, it was also observed that plasma might be 
able to initiate or catalyze some biochemical processes in biological systems [12, 13, 38, 
363, 370, 371]. Cell death after treatment of melanoma cells with non-thermal plasma 
occurs via the apoptotic pathway. The cell death mechanism post plasma treatment in 
vivo or in vitro is an important consideration. Apoptosis is a mode of programmed cell 
death initiated by physiological or pathological signals. Apoptotic cells are broken up 
into apoptotic bodies, which are engulfed by neighboring cells leading to a clean cell 
death without significant inflammatory response [201, 359, 360]. On the contrary, 
necrosis is a form of accidental cell death accompanied by cellular swelling, blebbing and 
increased membrane permeability leading to spilling of cytosolic content. This typically 
leads to inflammation in the surrounding tissue [201, 359, 360]. There is significant 
therapeutic advantage in cancer treatment to kill cells by apoptosis and avoid necrosis 
and the associated inflammation. By controlling plasma dose, it should be possible use 
plasma to induce apoptosis rather than necrosis. Although these results are promising, 
quite a few unanswered questions remain 
By acidifying the media it was shown that the plasma treatment initiates this 
behavior in cells not through a pH change in the growth media or through interaction 
with the aluminum dishes, but through direct interaction with the cells. Pre-incubation of 
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melanoma cells with 4 mM N-acetyl cysteine significantly reduced the amount of 
apoptosis as compared to untreated control or cells without NAC. This indicates that 
intracellular ROS produced after plasma treatment are likely involved in plasma induced 
apoptosis. Plasma-induced apoptosis in melanoma cancer cells is likely related to neutral 
ROS. Here we have presented results indicating that adding N acetyl-cysteine reduces the 
apoptotic effect of plasma in our model. The source of the ROS is still unknown in this 
model, although interactions of the charged particles produced by plasma with 
atmospheric oxygen, water, lipid peroxides, carbohydrates and even amino acids are all 
possible sources in this system. Non-thermal plasmas produce long lived (O3, NO, HO2, 
H2O2) and short lived (OH, O, electronically excited O (1D), O2 (1Δg)) neutral particles 
and charged particles (ions and electrons). Both charged and neutral particles can lead to 
additional ROS production in the treated fluid [363, 364]. Direct effects of non-thermal 
plasma treatment could include local heating caused by plasma streamers or UV 
radiation. Non-thermal atmospheric pressure DBD plasma is able to produce a large 
concentration of ROS in the extracellular media during treatment [17]. However, it was 
unclear if these ROS go inside cells. Interestingly, the intracellular ROS scavenger NAC 
decreased induction of apoptosis in melanoma cells after plasma treatment. ROS 
produced by plasma extracellularly may move across the cell membrane through lipid 
peroxidation, active transport across the bilayer, transient opening of pores in the 
membrane, or activation of signaling pathways that modify ROS concentration inside 
cells.  
Active species produced by non-thermal plasma may also modify the cell media, 
which in turn interacts with cells. Since many of these active species have a very short 
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life span, they may immediately interact with media components including amino acids 
and proteins, leading to production of long lived reactive organic hydroperoxides [233]. 
These long-lived hydroperoxides may induce lipid peroxidation and cell membrane 
damage, or they may bind to cell membrane receptors and activate intracellular signaling 
pathways leading to apoptosis. Various studies have shown that intracellular ROS can 
induce apoptosis in a caspase-3 dependent manner [372-375]. 
Ionizing radiation [376-378] and chemotherapy [379-381] are the most commonly 
used treatments for various types of malignancies, including melanoma, but both of the 
treatments have severe side effects since they not only kill the tumor but also damage 
healthy tissue surrounding the malignant tissue. Melanoma is the most aggressive form of 
skin cancer and is notoriously resistant to radiation and chemotherapy. Combination 
treatments utilizing immunotherapy and hyperthermia with radiation [382-386] or 
chemotherapy [387-391] have been somewhat more successful. Recently, pulsed electric 
fields have also been shown to be able to initiate apoptosis in melanoma cancer cell but 
pulsed electric fields need expensive equipment and skilled manpower [392]. Recently, 
photodynamic therapy (PDT), which combines a photosensitizing drug with a specific 
wavelength of light generated by lasers, is now being developed for treatment of 
melanoma and other skin cancers and has been shown to be somewhat successful [393, 
394]. Non-thermal plasma differs from photodynamic therapy, ionizing radiation, 
chemotherapy and electromagnetic fields; chemotherapy has systemic side effects and 
electromagnetic fields are penetrating and therefore injure surrounding tissue.  Ionizing 
radiation requires extensive and expensive equipment for administration. Various studies 
also suggest that melanoma cells frequently acquire radiation resistance [395] and 
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chemoresistance [396] by exploiting their intrinsic resistance to apoptosis and by 
reprogramming their proliferation and survival pathways during melanoma progression. 
Photodynamic therapy needs photosensitizers, which sensitize patients to light and the 
treatment itself can cause burns, swelling, pain, and scarring in nearby healthy tissue 
[394]. Non-thermal plasma on the other hand provides a novel and safer means to induce 
apoptosis since it is non-penetrating and therefore provides precise control of treatment 
area and depth and since it is cold, it causes no thermal damage to healthy tissue. Non-
thermal plasma devices are also relatively inexpensive, small and simple to manufacture 
and operate. on-thermal plasma has the benefit that it can be applied directly to specific 
areas of interest potentially avoiding systemic side effects. Since this non-thermal plasma 
can be attached to the end of a probe it has the added benefit of potentially being able to 
target areas of the body that are technically difficult to reach such as the lungs.   
Future work will endeavor to better delineate the pathways that are triggered by 
exposure to sub-lethal amounts of DBD plasma.  Evaluation of key signaling components 
of the apoptotic pathway will be performed.  The intrinsic and extrinsic pathway will be 
analyzed in order to determine how the non-thermal plasma induced effects lead to cell 
apoptosis.  Molecular arrays and real time PCR can identify target pathways and proteins 
respectively that are intimately involved in the cellular response to Plasma exposure.  A 
second avenue of research will focus on the actions of the various components of a 
Plasma discharge.  Future investigations are warranted in order to better understand the 
interaction of biological tissues with non-thermal plasma exposure, with the ultimate goal 
of creating a non-thermal plasma discharge that would be selective for in vivo cancer cell 
killing while sparing the surrounding normal tissue.  
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From the results presented here, it is clear that plasma dose can be regulated and 
can be administered at doses that appear to induce apoptosis in cells to an equal or 
greater degree than a known apoptosis inducer.   
 
4.4. Summary 
To summarize, initiation of apoptosis is an important issue in cancer treatment as 
cancer cells frequently have acquired the ability to block apoptosis and thus are more 
resistant to chemotherapeutic drugs. Targeted and selective destruction of cancer cells is 
desirable for many reasons, ranging from the enhancement of or aid to current medical 
methods to problems currently lacking a solution, e.g., lung cancer. We demonstrated in 
this section the induction of apoptosis in a human melanoma cell line in vitro by exposure 
to non-thermal atmospheric pressure plasma. Non-thermal Plasma may provide a novel 
approach to treat malignancies via induction of apoptosis. The purpose of this study was 
to evaluate the apoptotic effects of non-thermal plasma on melanoma cells. Melanoma 
cells in-vitro were exposed to non-thermal plasma and evaluated by Trypan blue 
exclusion test, TUNEL
®
 analysis, Annexin-PI staining and caspase-3 cleavage to 
determine viability and apoptotic activity. Trypan blue staining revealed that non-thermal 
plasma treatment significantly decreased the number of viable cells in a dose dependent 
manner.  Annexin-V/PI staining revealed a significant increase in apoptosis at 24, 48, and 
72 hours post-treatment. Caspase-3 cleavage was observed at 48 hours post plasma 
treatment at a dose of 15 J/cm
2
. TUNEL
®
 analysis of cells treated at 15 J/cm
2
 
demonstrated an increase in apoptosis at 48 and 72 hours post-treatment. Pre-treatment 
with N-acetyl cysteine (NAC), an intracellular free radical scavenger, significantly 
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decreased apoptosis in plasma-treated cells. Plasma treatment induces apoptosis in 
melanoma cells through a pathway that appears to be dependent on production of ROS 
(ROS) during treatment. ROS likely induce DNA damage resulting in the induction of 
apoptosis.  
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Chapter 5. Non-Thermal Plasma Treatment of Living Tissue – In Vivo Studies 
 
In Chapter 3 we saw that low dose non-thermal plasma treatment of cells enhanced 
cell proliferation which would make plasma very attractive for applications related to 
wound healing and tissue regeneration. Further, in Chapter 4 we saw that higher doses of 
non-thermal plasma induce apoptosis in malignant melanoma cells in vitro without 
significant necrosis which would make plasma an interesting alternative to IR or it could 
be used in conjunction with other cancer treatment modalities. Before we start applying 
plasma directly on tissues and wounds we need to evaluate the toxicity of low dose non-
thermal plasma treatment of intact skin and wounds in vivo and investigate the effects of 
plasma on and try to understand the mechanisms of interaction of plasma with cells in 
their native environment.  
Non-thermal atmospheric pressure dielectric barrier discharge plasma applied 
directly to living tissues is now being widely considered for various clinical applications.  
One of the key questions that arise in this type of topical treatment is if the skin or tissue 
remains undamaged after non-thermal plasma treatment. The results from the previous 
rodent model provided strong evidence for the ability of non-thermal plasma to sterilize 
the surface of the tissue without any thermal damage to the tissue. It is well established 
that porcine (pig) skin closely resembles human skin; hence we evaluated the potential 
toxic effects of non-thermal plasma treatment on underlying skin cells and tissue on 
porcine skin. In a Yorkshire pig model, intact skin and wounded tissue treatment was 
carried out at varying doses of non-thermal plasma to determine a dosage regime where 
we observe damage to the skin or tissue and the resulting skin or tissue damage was 
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analyzed. In this dissertation we study the possible short term and long term toxic effects 
of the non-thermal plasma treatment on intact and wounded living tissue while 
identifying the boundaries of skin or wound toxicity after non-thermal electrical plasma 
treatment.  
Moreover, in recent studies on plasma initiated blood coagulation [12, 13], skin 
sterilization [12, 28] and tissue toxicity after plasma treatment [40, 41], non-thermal 
plasma did not demonstrate gross toxicity in the surrounding living tissue. To test this 
claim vigorously we carried out non-survival and survival in vivo animal studies and in 
Chapter 5 we present results related to the in vivo studies aimed at investigating the 
toxicity of non-thermal plasma treatment of intact porcine skin and wounded porcine 
tissue. 
 
5.1. Introduction 
Over the past few years non-thermal atmospheric pressure plasma has emerged as 
a new promising tool in medicine. Non-thermal plasma has been widely used for 
sterilization of inert substrates [23-27] and is now being developed for treatment of inert 
substrates with the purpose of modulating cell attachment [397, 398]. Only recently has it 
been demonstrated that non-thermal atmospheric pressure plasma can be applied directly 
to living cells and tissues [29, 33, 34], killing bacteria without any gross histological 
changes in tissue [12] and inducing blood coagulation without any heating [12, 13]. It has 
also been shown that non-thermal plasma treatment  can promote apoptosis in malignant 
cells [42] enhance cell transfection [30-32], enhance cell proliferation[36], sterilize root 
canals [399, 400],  and possibly prove useful in wound healing [37-39].  Non-thermal 
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atmospheric pressure plasma is generated through direct contact with living tissue. 
Compared to the effects of the more conventional thermal plasma [5], non-thermal 
plasma can be selective in its treatment because of the ability to avoid burning healthy 
tissue [12]. In order for non-thermal plasma to be widely accepted by clinicians and 
doctors for various pathologies we have to prove that the dose of non-thermal plasma can 
be tuned to be able to operate it in a non-damaging regime while achieving beneficial 
effects. Hence, our goal in this section was to identify the boundaries of skin and wound 
toxicity after treatment of intact and wounded skin with non-thermal electrical plasma.  
 
5.2. Materials and Methods 
Non-Thermal Plasma Treatment 
Non-thermal atmospheric pressure dielectric barrier discharge plasma was 
produced using an experimental setup similar to one previously described [12, 13] and 
the operating parameters have been previously elaborated in section 1.2 on page 4. 
 
Figure 20. Non-Thermal Plasma Treatment of intact porcine skin and wounded porcine 
tissue. (A) Non-Thermal dielectric barrier discharge plasma treatment electrode held in a 
jacket which maintained the gap between the electrode and the surface of the intact skin. 
Setup shows the method used to treat intact skin. (B) Modified non-thermal dielectric 
barrier discharge plasma treatment planar electrode for treatment of wounded tissue. 
Setup shows the technique used to treat wounded skin.  (C) The dorsum of the pig was 
separated into treatment areas for both intact and wounded skin. 
A. B. C. 
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The discharge gap between the bottom of the quartz and the treated skin or wound 
surface was fixed at 3 mm using a special electrode holder (Figure 20A) or a modified 
planar electrode (Figure 20B) respectively. Discharge power density was measured to be 
0.13 W/cm
2 
(at 500Hz) and 0.31 W/cm
2
 (at 1.5 kHz) using both electrical 
characterization and a specially designed calorimetric system [18].  
Study Design 
We evaluated the potential toxic effects of the DBD plasma on both intact and 
wounded porcine skin in 7 Yorkshire pigs. Standard operative procedure included the 
following: The pig was anesthetized and the dorsum of the pig was marked and divided 
for treatment areas (Figure 20C). When intact skin was studied, the plasma electrode was 
placed 3 mm ± 1 mm above the skin by adjusting the holder, varying the power and time 
of treatment. When wounded skin was studied, a dermatome was used to create a skin 
abrasion, removing 1 square inch of the epidermis and dermis (approximately 1.5 mm ± 
0.5 mm deep), followed by plasma treatment. In this case the planar plasma electrode was 
again placed 1.5 mm ± 1 mm above the skin by using spacers of the required height, 
varying the power and time of treatment. Pigs were then sacrificed immediately or 24 
hours after surgical procedure. Tissue specimens from each treatment area were harvested 
and sent for histological analysis. 
For the intact skin model (3 pigs), we had a total of 42 treatment areas on the 
three pigs that were harvested 24 hours after surgery. One area of intact skin (n=1) was 
treated with an electrocautery burn (positive control, Figure 21A, 17B and 17C), and one 
area of intact skin (n=1) was untreated (negative control). The remaining 40 areas were 
treated with 1 of 4 power settings: Highest power 0.31 Watt/cm
2
 (12 specimens), 0.17 
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Watt/cm
2 
(12 specimens), 0.15 Watt/cm
2
 (12 specimens), and lowest power 0.13 
Watt/cm
2
 (4 specimens). For 0.31 Watt/cm
2
 and 0.17 Watt/cm
2
, there were 3 samples 
(n=3) treated with plasma for each of the following time points: 30 seconds, 1 minute, 2 
minutes, and 3 minutes. For 0.15 Watt/cm
2
, there were 3 samples (n=3) treated with 
plasma for each of the following time points: 1 minute, 2 minutes, 5 minutes, and 15 
minutes. For 0.13 Watt/cm
2
, there was 1 sample (n=1) treated with plasma for each of the 
following time points: 1 minute, 2 minutes, 5 minutes, and 15 minutes. 
 
Figure 21. High frequency ‗Bovie‘ electrocautery knife was used as a positive control. 
(A) doted circle indicates area of treatment. A half inch long burn was achieved with the 
‗Bovie‘ knife in the centre of the dotted circle. (B) Gross visual observation of the burn 
due to the ‗Bovie‘ knife. (C) Microscopic histological observation of burnt tissue after 
treatment with the ‗Bovie‘ knife. The arrow indicated disruption in the epidermis and we 
can observe collagen condensation indicative of severe burn. 
For the wounded skin model (4 pigs), we had a total of 42 treatment areas on 2 
pigs harvested immediately after surgery and 42 treatment areas on 2 pigs harvested 24 
hours after surgery. In the non-survival pigs there were 21 specimens treated with low 
power (0.13 Watt/cm
2
) and 21 specimens treated with high power (0.31 Watt/cm
2
). In the 
24 hour survival pigs, there were also 21 specimens treated with low power (0.13 
Watt/cm
2
) and 21 specimens treated with high power (0.31 Watt/cm
2
). Each group of 21 
specimens had a breakdown of 3 samples (n=3) treated for the following time points: no 
A. B. C. 
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treatment (negative control), electrocautery bovie (positive control), 30 seconds, 1 
minute, 3 minutes, 5 minutes, and 15 minutes. 
Histological Staining 
In addition to recording all gross observations of the specimens, all specimens 
were analyzed with microscopic histological analysis. Specimens were longitudinally 
sectioned and fixed for 24 hours in formalin. Sections for histology were processed in a 
standard fashion and stained with hematoxylin-eosin. Our pathologists were blinded to all 
specimens and categorized each specimen into a burn grading system for the intact and 
wounded skin data analysis. For intact skin, as shown in Figure 22, the specimens were 
either classified as normal, minimal change, epidermal damage, or full burn through the 
dermis. For wounded skin, as shown in Figure 27, the specimens were either classified as 
normal, presence of a clot or scab, and full burn through the dermis. 
Immunohistochemistry 
Slides prepared in triplicates were used for immunohistochemical staining to 
analyze basement membrane integrity (laminin for immunostaining), and the 
demonstration of the DNA damage using γ-H2AX as a marker in our intact skin samples. 
Anti-laminin mouse monoclonal (Sigma Chemical Co, St. Louise, MI) or anti-γ-H2AX 
mouse monoclonal antibodies (Abcam, Cambridge, MA) were used. In brief, the slides 
were first warmed at 60
o
C to melt the paraffin wax and then hydrated through a graded 
ethanol series. Heat-induced target retrieval was performed by heating the slides to 95
o
C 
in a modified citrate buffer (Dako North America, Inc, Carpentaria, CA) to improve 
antibody binding. To block nonspecific binding sites, the tissue sections were incubated 
with heat-inactivated goat serum for 1 hour at room temperature. Slides were then 
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incubated with the primary antibody overnight at 4
o
C. The next day, the slides were 
washed three times with PBS to remove excess primary antibodies and then incubated 
with a rhodamine-conjugated anti-mouse secondary antibody (Santa Cruz Biotechnology, 
Inc. Santa Cruz, CA) for 2 hours at room temperature and protected from light. Three 
more washes with PBS were performed to remove excess secondary antibody, and then 
the slides were incubated for 3 minutes with a nuclear stain, Hoechst 33258 (0.05%) 
(Sigma). The slides were washed another 3 times with PBS and then mounted with 
Citifluor antifading mounting medium (Electron Microscopy Sciences, Fort Washington, 
PA) and examined for fluorescence microscopy using Leica DMRX fluorescence 
microscope with attached Leica DG300FX digital camera system, using appropriate 
band-pass filter (for corresponding blue and red dyes). The images were captured from 5 
randomly selected areas for three different sets of experiments, saved as TIFF file and 
edited using Adobe Photoshop CS3.    
 
5.3. Results 
5.3.1. Intact Skin 
The plasma device was tested on 3 pigs with intact skin at 4 different power settings, all 
harvested 24 hours after the procedure. Untreated skin appeared normal up on gross and 
histological observation. With minimal change, there was a small area of erythema on the 
skin. With epidermal damage, there was mild erythema that resolved itself usually within 
20 minutes. With full burn through the dermis, there was diffuse erythema that remained 
until time of harvest (Figure 22 and Figure 23).  
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Figure 22. Gross and histological analysis of plasma treated intact skin. 3 and 24 h after 
plasma treatment, samples from treated and untreated skin were harvested and preserved 
in formalin until further analysis. H&E staining was used to evaluate the treated and 
untreated intact skin samples histologically.  Representative histological classification of 
intact skin and associated gross (left column) and microscopic findings (right column). 
(A) Normal undamaged intact skin. (B) Minimal change and collagen condensation 
observed after low dose plasma treatment at 0.15 W/cm
2
 up to 15 min. (C) Epidermal 
damage seen after moderate dose plasma treatment at 0.17 W/cm
2
 up to 3 min and (D) 
Second degree burn observed after high dose plasma treatment at 0.31 W/cm
2
 for 3 min. 
A. 
B. 
C. 
D. 
Visual Histological 
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At low power 0.13 Watt/cm
2
 (4 specimens), 1 specimen treated with plasma for 1 
minute was classified as normal skin. The remaining 3 specimens treated with plasma at 
2, 5, and 15 minutes all showed epidermal damage on histology and mild erythema on 
gross examination (Table 5A). 
At the next higher level of power 0.15 Watt/cm
2
 (12 specimens), 3 specimens 
treated with plasma for 1 minute were classified as normal skin. In the samples treated for 
both 2 and 5 minutes, 2 samples showed epidermal damage and 1 with normal skin. In  
the 15 minute plasma treatment group, 1 sample showed epidermal damage and 2 with 
normal skin (Table 5B).                     
At power setting 0.17 Watt/cm
2 
(12 specimens), 3 specimens treated with plasma 
for 30 seconds and 3 treated for 1 minute were classified as normal skin. In the samples 
treated for 2 minutes, 2 samples showed minimal change and 1 with normal skin. In the 3 
minute plasma treatment group, 2 samples showed epidermal damage and 1 sample 
showed minimal change (Table 5C). 
At high power 0.31 Watt/cm
2
 (12 specimens), 3 specimens treated with plasma 
for 30 seconds were classified as normal skin. In the samples treated for 1 minute, 1 
sample showed minimal change, 1 with epidermal damage and 1 with normal skin. In the 
2 and 3 minute plasma treatment groups, 2 samples showed full thickness burn and 1 with 
epidermal damage each (see Table 5D). 
For our controls, one specimen (n=1) served as our positive control, that of an 
electrocautery burn which yielded a full thickness burn. Another specimen (n=1) was 
intact skin without any plasma treatment, serving as our negative control. 
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Figure 23. Summary of observations after plasma treatment of intact skin specimens (A) 
Intact skin before plasma treatment (B) Intact skin after plasma treatment at a dose of 
0.13 W/cm
2
 for 5 min (C) histological analysis of intact skin after plasma treatment at 
0.15 W/cm
2
 for 5 min (inset: gross observation of treated skin shows mild erythema 
which disappears after 20 min) and (D) histological analysis after plasma treatment at a 
dose of 0.31 W/cm
2
 for 3 min (inset: gross observation of skin after plasma treatment 
shows a full thickness burn) 
 
 
 
 
 
 
 
A. 
C. D. 
B. 
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Table 5. Classification of results after non-thermal plasma treatment of intact skin at four 
different power settings. 
(A) Low Power: 0.13 W/cm2 
Time (min) Normal Minimal Change Epidermal Damage Full Burn Total (n) 
1 1    1 
2   1  1 
5   1  1 
15   1  1 
 4 
(B) 0.15 W/cm2 
Time (min) Normal Minimal Change Epidermal Damage Full Burn Total (n) 
1 3    3 
2 1  2  3 
5 1  2  3 
15 2  1  3 
     12 
(C) 0.17 W/cm2 
Time (min) Normal Minimal Change Epidermal Damage Full Burn Total (n) 
0.5 3    3 
1 3    3 
2 1 2   3 
3  1 2  3 
     12 
(D) High Power: 0.31 W/cm2 
Time (min) Normal Minimal Change Epidermal Damage Full Burn Total (n) 
0.5 3    3 
1 1 1 1  3 
2   1 2 3 
3   1 2 3 
     12 
 
143 
 
 
 
Figure 24. Schematic showing safe regimes of non-thermal plasma treatment of intact 
tissue. Plasma treatment at normal operating parameters does not cause tissue damage: 
Plasma doses up to 10 times longer than required for complete sterilization are safe. 
(Inset: We see a burn formation only after 10 min of continuous application of high 
power (> 0.31 W/cm
2
) plasma dose). 
 
In order to complement our gross and histological findings, we had performed 
immunohistochemical studies to looks at the architecture of laminin layers and nuclear 
damage in the form of DNA double strand breaks (DSB). This was performed for our 
intact skin samples. Integrity of laminin is essential for healthy state of skin tissues, and 
any breach or dissociation of the laminin layer indicates damage to skin epidermis and             
underlying structures. Figure 25 demonstrates laminin changes associated with non-
thermal plasma treatment of intact skin. Normal skin showed integrity of the laminin 
layer (Figure 25A) whereas application of ‗bovie‘ high frequency electrocautery caused 
burns, demonstrating classical disintegration of the laminin layer (Figure 25D), thus 
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serving as our controls. Upon comparison with controls, it is observed that non-thermal 
DBD plasma is safe to apply for duration of up to 5 minutes at low power (0.13 W/cm
2
), 
after which slight laminin damage is observed (Figure 25B and 24C). These findings are 
consistent with H&E histological analysis done earlier.  
To look at the change at the sub-cellular level, we carried out dual staining for 
nucleus using  fluorescent dye Hoechst and antibody tagged with a fluorophore directed 
against -H2AX, a commonly used marker for determining DNA damage. During DNA 
damage, H2AX gets phosphorylated (at all 4 serine residues, and remarkably at serine 
139) giving rise to -H2AX, which is considered as a marker for DNA damage, and is 
essential in DNA repair, acting as one of the signals for DNA repair initiation[401-403]. 
After plasma treatments, we analyzed the immunostained skin tissue sections for 
accumulation of -H2AX foci. Figure 26 shows the representative micrographs showing 
untreated control (Figure 26A) and positive control (Figure 26D) for DNA damage along 
with two plasma exposure time points. -H2AX foci formation was observed after 5 
minutes of exposure to non-thermal plasma at low power (0.13 W/cm
2
) (Figure 26C) and 
onwards. We did not see any DNA damage in lower plasma exposure-time points (Figure 
26B) 
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Figure 25. Laminin studies on intact skin samples. Untreated and plasma treated tissue 
samples were harvested 3 h and 24 h after surgery and snap frozen in liquid nitrogen and 
preserved until further analysis. Frozen samples were analyzed for presence of laminin 
using the procedure described in the methods section. (A) Normal skin showing integrity 
of laminin layer. (B) Laminin layer appears to be intact 2 min after exposure to non-
thermal plasma at low dose (0.13 W/cm
2
) (yellow arrows). (C) Damage to the laminin 
layer appears after 5 minutes of plasma treatment at low power (white arrows). (D) 
Classical disintegration of the laminin layer is observed due to burning of tissue after 
application of high frequency electrocautery device. 
 
 
 
 
 
 
A. 
C. 
D. 
B. 
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Figure 26. -H2AX studies on intact skin. Untreated and plasma treated intact skin 
samples were harvested 3 h and 24 h after surgery and snap frozen in liquid nitrogen and 
preserved until further analysis. Frozen samples were analyzed for -H2AX foci, which 
are commonly used markers for DNA damage, using the procedure described in the 
methods section. (A) Normal skin showing no DNA damage seen from the absence of red 
staining (-H2AX). (B) DNA appears to be intact 2 min after exposure to non-thermal 
plasma at low dose (0.13 W/cm
2
) as seen by the absence of -H2AX staining. (C) -
H2AX staining appears after 5 minutes of plasma treatment at low power indicating 
plasma induced DNA damage (white arrows). (D) uniform -H2AX staining indicating 
large scale DNA damage due to burning of tissue after application of high frequency 
electrocautery device. 
 
A. 
C. 
D. 
B. 
 
Nuclear Stain Merge 
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5.3.2. Wounded Tissue 
The plasma device was tested on 4 pigs with wounded skin with either low (0.15 
Watt/cm
2
) or high (0.31 Watt/cm
2
) power settings. Two pigs were harvested immediately 
after the procedure, and two pigs were harvested 24 hours after the procedure. With 
normal histologic skin samples, the skin appeared normal grossly. With the presence of a  
 
 
 
Figure 27. Gross and histological analysis of plasma treated wounds. 3 and 24 h after 
plasma treatment, samples from treated and untreated wound were taken and preserved in 
formalin until further analysis H&E staining was used to evaluate the treated and 
untreated wound samples histologically. Representative histological classification of 
wounded skin and associated gross (left column) and microscopic findings (right 
column). (A) Normal untreated wound. (B) Scab or Clot formation observed after low 
dose plasma treatment at 0.13 W/cm
2
 up to 15 min and (C) Burns observed after high 
dose plasma treatment at 0.31 W/cm
2 
up to 15 min. 
clot seen on histology, the clot was visible on gross examination in pigs harvested after 
surgery. In pigs harvested at 24 hours, a scab was seen on gross examination instead of a 
A. 
C. 
B. 
 
Visual Histological 
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clot. With full burn through the dermis seen on histology, there was burned tissue seen 
grossly (see Figure 27 and Figure 28).  
For the pig treated with low power 0.13 Watt/cm
2
 (21 specimens) harvested 
immediately, 3 samples of our untreated wounds (negative control) and 3 samples of 
wounds with an electrocautery burn (positive control) showed normal tissue and full 
thickness burn respectively. 3 samples with 30 seconds treatment showed a clot on 
histology. With 1, 3, and 5 minute treatment groups, 2 showed a clot and 1 was normal in 
each group. With 15 minute treatment, all 3 samples showed a clot (see Table 6A).   
             
Figure 28. Summary of observations after plasma treatment of wounded tissue specimens  
(A) Wounded tissue  after plasma treatment at a dose of 0.13 W/cm
2
 for 1 min. (B) 
wounded tissue after plasma treatment at a dose of 0.31 W/cm
2
 for 15 min. (C) 
histological analysis of wounded tissue  after plasma treatment at 0.13 W/cm
2
 for 1 min 
(inset: gross observation of wounded tissue shows normal wound without burn) and (D) 
histological analysis after plasma treatment at a dose of 0.31 W/cm
2
 for 15 min (inset: 
gross observation of wounded tissue after  plasma treatment shows scab formation due to 
blood coagulation). 
For the pig treated with high power 0.31 Watt/cm
2
 (21 specimens) harvested 
immediately, 3 samples of our untreated wounds (negative control) and 3 samples of 
A. 
C. D. 
B. 
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wounds with an electrocautery burn (positive control) showed normal tissue and full 
thickness burn respectively. With 30 seconds, 1 and 3 minute treatment groups, all three 
specimens showed a clot. With 5 and 15 minutes of plasma treatment, 2 showed a clot 
and 1 was normal in each group (see Table 6B). 
Table 6. Classification of results of non-thermal plasma treatment of wounded skin at 
low and high power settings and harvested either immediately or 24 hours after plasma 
treatment. 
(A) Low Power: 0.13 W/cm2 (non-survival) 
Time (min) Normal Clot Full Burn Total 
0.5  3  3 
1 1 2  3 
3 1 2  3 
5 1 2  3 
15  3  3 
 15 
(B) High Power: 0.31 W/cm2 (non-survival) 
Time (min) Normal Clot Full Burn Total 
0.5  3  3 
1  3  3 
3  3  3 
5 1 2  3 
15 1 2  3 
 15 
(C) Low Power: 0.13 W/cm2 (24 h survival) 
Time (min) Normal Scab Full Burn Total 
0.5 1 2  3 
1  3  3 
3  3  3 
5  3  3 
15 1 2  3 
 15 
(D) High Power: 0.31 W/cm2 (24 h survival) 
Time (min) Normal Scab Full Burn Total 
0.5 1 2  3 
1 2  1 3 
3 2  1 3 
5   3 3 
15  1 2 3 
 15 
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For the pig treated with low power 0.13 Watt/cm
2
 (21 specimens) harvested 24 
hours after, 3 samples of our untreated wounds (negative control) and 3 samples of 
wounds with an electrocautery burn (positive control) showed normal tissue and full 
thickness burn respectively. With 30 seconds of treatment, 2 samples showed a burned 
scab and 1 with normal tissue. With 1, 3, and 5 minutes of treatment, all 3 samples in 
each group showed a burned scab. With 15 minutes of treatment, 2 showed a burned scab 
and 1 was normal (see Table 6C). 
 
Figure 29. Schematic showing safe regimes of plasma treatment of wounded tissue. 
Plasma treatment at normal operating parameters does not cause tissue damage in 
wounds. Non-thermal Plasma starts coagulating an open wound after 3 min which 
protects the underlying wound from further damage by the plasma. (Inset: We see 
coagulated wounds at higher doses of 0.31 W/cm
2
 or longer treatment times beyond 5 
min). 
For the pig treated with high power 0.31 Watt/cm
2
 (21 specimens harvested 24 
hours after, 3 samples of our untreated wounds (negative control) and 3 samples of 
wounds with an electrocautery burn (positive control) showed normal tissue and full 
thickness burn respectively. With 30 seconds of treatment, 2 samples showed a burned 
scab and 1 with normal tissue. With 1 and 3 minutes of treatment, 1 sample in each group 
151 
 
 
showed a burned scab and 2 with normal tissue. With 5 minutes of treatment all 3 
samples showed a burned scab. With 15 minutes of treatment 2 samples showed a full 
thickness burn and 1 with a burned scab (see Table 6D). 
 
5.4. Discussion 
This animal study was the first in vivo study to assess the boundaries of non-
thermal plasma toxicity on living tissue. From data of plasma treatment of intact skin, we 
can conclude that 2 minutes is the observed threshold  for any signs of histological tissue 
damage created from non-thermal plasma treatment at all power settings except for high 
power (0.17 W/cm
2
) treatment. When high power plasma was used, signs of minimal 
change, epidermal damage and full thickness burn were all seen beginning as early as 1 
minute. The pathologists defined ―minimal change‖ as the presence of epidermal and 
dermal cellular changes in both size of the cell and nucleus. Although almost appearing 
similar to normal skin, it was determined that due to the presence of some microscopic 
changes that an additional grading of ―minimal change‖ be provided. With epidermal 
damage, there was notable increased vascular congestion and cellular disorganization. 
We determined a safe operating regimen for plasma treatment of intact skin. As shown in 
Figure 24, plasma treatment at normal operating parameters does not cause tissue 
damage. Plasma doses up to ten times longer than required for complete sterilization do 
not induce burn formation and is safe for application to intact skin. 
From data of plasma treatment of wounded skin, we can conclude that the 
presence of a wound induced clot formation on all wounds which was protective to the 
underlying skin from plasma treatment damage. In non-survival pigs, a clot was seen on 
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the wounded skin, and in 24 hour survival pigs, a scab was seen on the wounded skin. All 
time points (30 seconds, 1, 3, 5, and 15 minutes) showed some type of clot or scab 
formation without disruption and/or damage to the underlying skin except for only one 
subgroup: high power treatment of wounded skin for 15 minutes (2 specimens showed 
full thickness burn). It has been reported in the literature that plasma treatment of tissue 
may sterilize tissue with as little as 30 seconds of treatment [12, 28]. Since tissue 
coagulation is a property of non-thermal plasma [12, 13], we can see that the ability to 
sterilize wounded tissue while stopping bleeding and inducing the formation of a 
protective clot may be of a clinical benefit in the field of medicine. We also determined a 
safe operating regime for plasma treatment of wounded tissue. As shown in Figure 29, 
plasma treatment at normal operating parameters does not cause tissue damage in 
wounds. Non-thermal Plasma starts coagulating an open wound after 3 min which 
protects the underlying wound from further damage by the plasma. 
Continuous plasma application for five minutes at low power causes changes in 
skin tissue such as the dissociation of the laminin layer and changes in nuclear DNA 
(double stranded breaks) in our intact skin specimens. In harvesting skin tissue 24 hrs 
after plasma treatments, it is unlikely that tissues would have an adequate opportunity to 
undergo complete normal cellular repair. Under normal physiological conditions, injuries 
to cells and tissues occur every day in the body, but the body‘s repair and defense 
mechanisms takes time to heal completely. Our findings indicate that plasma exposure 
time of less than 5 minutes at low power in intact skin is safe, and does not cause any 
acute toxicity in skin tissues and no significant loss of architecture noted at lower time 
points. We have looked at both laminin and -H2AX in intact skin and studies looking at 
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the relationship between gamma-H2AX and laminin with wounded tissue are being 
currently being conducted. 
 
5.5. Summary 
Non-thermal plasma has only recently been applied within the field of medicine. 
It has been shown to induce apoptosis in malignant tissue and provide a means for tissue 
coagulation and sterilization while limiting damage to healthy tissue both grossly and 
microscopically. From our pig studies, we have shown that non-thermal plasma treatment 
of tissue can safely be applied to intact skin for up to two minutes at a dose of 0.31 
W/cm
2
 without inducing any gross or microscopic tissue damage. When applied to 
wounded skin, its coagulative properties helps induce a clot which acts as a protective 
layer preventing any underlying tissue damage for at least five minutes at a dose of 0.31 
W/cm
2
 and possibly as high as fifteen minutes at a dose of 0.13 W/cm
2
. Once application 
of non-thermal plasma can be safely shown to prevent and/or limit toxicity in the animal 
model, its use may be studied and applied in humans for the sterilization of skin, 
treatment of various diseases including treatment of skin cancer and for wound healing. 
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Chapter 6. Mechanisms of Interaction of Non-Thermal Plasma with Living Cells 
 
In this dissertation we have shown using mammalian cells in culture that non-
thermal DBD plasma has dose-dependent effects that range from increasing cell 
proliferation at low doses as shown in Chapter 3 to inducing apoptosis at high doses as 
described in Chapter 4. In Chapter 5, we showed that non-thermal plasma is relatively 
non-toxic to intact skin at low doses and to wounded tissue at both low and high doses. In 
order to develop non-thermal plasma as a clinical tool it is important that we understand 
the mechanisms of interaction of non-thermal plasma with living cells and tissues. In 
Chapter 6 we try to investigate the mechanisms of interaction of non-thermal plasma with 
living cells.   
 
6.1. Introduction 
Devices, such as argon plasma coagulators, which are used clinically to cauterize 
living tissues, typically generate plasmas at temperature far exceeding room temperature. 
The effects of such hot plasmas on tissues are non-selective and difficult to control 
because they occur primarily through transfer of intense heat [5]. In contrast, in non-
thermal plasmas gas can be maintained close to room temperature. Although electrical 
discharges that generate non-thermal plasma have been known for a long time, their 
clinical potential has been largely ignored, and applications have been confined to inert 
surfaces [12, 14, 20, 23-26, 50-52] for sterilization or to modulate cell attachment [29, 
33]. Only recently has it been demonstrated that non-thermal atmospheric pressure 
plasma can be applied directly to living cells and tissues [29, 33], killing bacteria and 
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inducing blood coagulation without significant heating [12, 13]. It has also been shown 
that non-thermal plasma treatment can enhance cell transfection [404, 405], sterilize root 
canals [49, 399, 400] and possibly increase wound healing [406]. The simplicity and 
flexibility of devices required to generate non-thermal plasma and apply it to tissues is 
particularly appealing. However, there is still a substantial lack of understanding of 
mechanisms by which non-thermal plasma may interact with living cells and tissues, 
required to fully develop its clinical applications. 
Prior studies related to mechanisms of interactions focused mainly on killing of 
bacteria [28]. It has also been shown that bactericidal effects require the presence of 
oxygen in plasma [26, 407], suggesting that oxidative stress may be mediating the 
interaction between non-thermal plasma and living organisms. Although it has been 
suggested that non-thermal plasma influences living systems through oxidative stress 
(among other factors) [14, 33, 52], to date there are no data to support this hypothesis. It 
was believed that, since non-thermal plasma does not produce sufficiently energetic 
particles or photons, cellular genetic material would not be affected.  
Non-thermal DBD plasma produces various ROS in gas phase. A typical list of 
such ROS and their relative concentrations are provided in supplemental data (Table 2) 
[21, 22, 408]. The dependence of ROS concentration on plasma power density can be 
rather complex. Description of DBD plasma characterization employed in this work has 
been presented elsewhere [12, 18]. Measurement of ozone concentration at typical 
operating conditions and power level of 0.1 W/cm
2
 yielded several hundred ppm, while 
nitric oxide (NO) concentration was measured to be below 1ppm (see methods section). 
Such measurements are entirely consistent with other published reports [14, 52, 409]. 
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Several different methods of non-thermal plasma generation at atmospheric 
pressure are known [22]. The type of non-thermal plasma discharge employed in this 
study is called Dielectric Barrier Discharge (DBD), which was invented by Siemens in 
1859 [15]. DBD occurs at atmospheric pressure in air or other gases when high voltage 
of sinusoidal waveform of  microsecond or nanosecond duration pulses are applied 
between two electrodes, with at least one electrode being insulated [16]. The insulator 
prevents current build-up between the electrodes, creating electrically safe plasma 
without substantial gas heating. This approach allows direct treatment of biological 
specimens without the thermal damage observed in more conventional thermal plasma 
[5]. The human body, with its high capacity for charge storage as a result of its high 
water content and a relatively high dielectric constant can function as the second 
electrode [410, 411].  
It is demonstrated here that non-thermal plasma induces a variety of effects on 
mammalian cells ranging from increased cell proliferation to apoptosis. Moreover, it can 
cause DNA damage. The DNA damage cascade activated by non-thermal plasma 
treatment is shown to result from oxidative stress and is different from that associated 
with IR or H2O2 [37]. 
 
6.2. Materials and Methods 
Cell Culture 
Mammalian Breast Epithelial Cells (MCF10A) were maintained in high glucose 
Dulbecco‘s Modified Eagle‘s Medium/Ham‘s F12 50:50 mixture (Cellgro, Mediatech, 
VA, USA) supplemented with 5% horse serum (Sigma Aldrich, St. Louis, MO, USA), 
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Epidermal Growth Factor (EGF, 100 µg/ml, Sigma Aldrich, St. Louis, MO, USA), 
Hydrocortisone (1 mg/ml, Sigma Aldrich, St. Louis, MO, USA ), Cholera Toxin (1 
mg/ml, Sigma Aldrich, St. Louis, MO, USA ), Insulin (10 mg/ml, Sigma Aldrich, St. 
Louis, MO, USA ) and Penicillin/Streptomycin (500 l, 10000 U/ml penicillin and 10 
mg/ml streptomycin, Sigma Aldrich, St. Louis, MO, USA). For plasma treatment, cells 
were washed with phosphate buffered saline (PBS), detached with 0.25% Trypsin 
(GIBCO, Invitrogen, CA, USA), and seeded near confluence (4 x 10
5
 cells/well) on 22 x 
22 mm square glass cover slips (VWR, PA, USA ) in 6-well plates (Greiner Bio One, 
NC,  USA). Cells were cultured for 24 hours prior to plasma treatment in 2.0 ml 
supplemented media in a 37°C, 5% CO2 incubator to allow full attachment and spreading.  
Amino acids; serine, methionine, cysteine, arginine, leucine, lysine, isoleucine, 
valine, proline, glutamic acid and glutamine, (100 M, Sigma-Aldrich, St Louis, MO) 
were used to treat cells directly and separately to determine their role in inducing DNA 
damage after plasma treatment. 
N-Acetyl-L-cysteine (NAC, 4 mM, Sigma-Aldrich, St Louis, MO), an 
intracellular ROS (ROS) scavenger was used as a scavenger for the ROS produced by 
non-thermal plasma treatment. 
Non-Thermal Plasma Treatment 
MCF10A cells on glass cover slips were exposed to non-thermal plasma at 
various doses (0.13 - 7.8 J/cm
2
). Briefly, each cover slip was removed from the 6-well 
plate, drained, and placed on a microscope slide, which was then positioned on the 
grounded base of the plasma device. 100 µl of complete media was added to the glass 
cover slip before plasma treatment to prevent sample drying. Following plasma 
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treatment, the cells were held in the treated medium for one minute and then the cover 
slip was placed in a new 6-well plate containing 2 ml of supplemented media was added 
to the well, and the samples were returned to the incubator for one hour before analysis 
by immunofluorescence or western blot.  
The plasma treatment dose in J/cm
2
 was calculated by multiplying the plasma 
discharge power density by the plasma treatment duration. For example, plasma 
treatment of cells at a power density of 0.13 W/cm
2
 for 15 s would correspond to a dose 
of 1.95 J/cm
2
. The non-thermal DBD plasma has a g-factor (number of ROS generated 
per electron volt or eV) of between 0.3 and 0.5 [19]. For a plasma dose of 3.9 Joules/cm
2
, 
3.66x10
16 – 6.1 x1016 ROS are generated. Concentration of ozone produced by DBD 
plasma in the gas phase was measured using a calibrated optical ozone meter MedOzon-
245/5 (MedOzone, Russia) and the concentration of NO was measured using an NO/NOx 
chemiluminescent analyzer Model 600 CLD (California Analytical Instruments, USA). 
Immunofluorescence 
MCF10A cells were plated onto glass cover slips 24 h before treatment. One hour 
after plasma treatment, cells were subjected to in situ cell fractionation as described 
[412], by incubation in pre-extraction buffer (1X PBS + 0.2% Triton-X + 1:50 PMSF) for 
5 min at 4C, followed by one wash with PBS and incubation in fixation solution (3% 
paraformaldehyde + 2% Sucrose in PBS) for 10 min at room temperature. Cells were 
then washed in PBS, and incubated in permeabilization buffer (1X PBS + 0.5% Triton-X) 
for 5 min a 4C. Cells were washed twice with NaN3 + PBST at room temperature and 
incubated overnight at 4C in primary antibody (mouse monoclonal -H2AX (serine 139, 
Upstate Biotechnology, 1:1000). After three washes in NaN3 + PBS, cells were incubated 
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for 1 h in the dark in secondary antibody (AlexaFlour594 donkey anti-mouse antibody, 
diluted 1:1,000). The secondary antibody solution was removed followed by incubation 
of slides in 1 l DAPI + PBST + NaN3 , three washes in NaN3 + PBST and mounting 
using DAPI-free mounting media (Vector Labs)  on glass microscope slides overnight. 
The slides were then frozen at -20 C for one day prior to imaging them on an upright 
fluorescence enabled microscope. 
Western Blot 
Protein expression and modification were analyzed by immunoblot. Total cell 
lysates were prepared by direct lysis of washed cells in 2X SDS sample buffer containing 
-mercaptoethanol. Samples were electrophoresed at 150 V in Tris-glycine SDS running 
buffer (25 mmol/L Tris, 192 mmol/L glycine, 0.1% SDS (pH 8.3)). Following 
electrophoresis, proteins were transferred to PVDF (Millipore, MA, USA) membrane for 
two hours in Tris-glycine transfer buffer (10% SDS, Deionized Water, Tris-Glycine and 
Methanol (VWR, PA USA)). Immunoblotting was done by blocking membranes in 1% 
nonfat dried milk (Carnation) in PBS with 0.1% Tween 20 (PBST) for -tubulin or 5% 
bovine serum albumin (BSA, Fraction V, Fisher Scientific) in PBST for -H2AX 
followed by incubation with primary antibodies overnight for 10 to 12 h at 4ºC with 
rocking. Primary antibodies used for immunoblot included mouse monoclonal antibodies 
specific for -H2AX [phospho-histone H2AX (serine 139), clone JBW301; Upstate] and 
-tubulin (Santa Cruz Biotechnology). The primary antibodies were detected with 
fluorescently tagged goat anti-mouse Alexa and Fluor 488 (Santa Cruz Biotechnology). 
Immunoblot was developed using Odyssey Infrared Gel Imaging system (LI-COR 
Biosciences, NE, USA). 
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Detection of Intracellular ROS 
 The intracellular generation of reactive oxygen species after plasma treatment was 
detected using the commonly used fluorescent probe 5-(and-6)-chlroromethyl-2‘, 7‘-
dichlorodihydrofluorescein diacetate (CM-H2DCFDA, Molecular Probes). Untreated 
cells, cells treated with 100 M H2O2 and plasma treated cells were analyzed for changes 
in fluorescence. MCF10A cells (4 x 10
6
) were plated on glass cover slips one day before 
plasma treatment. On the day of the experiment the cells were washed 2X with PBS, and 
then preincubated with 10 M CM-H2DCFDA at 37°C for 30 min in the dark. After 30 
min, the excess dye was washed off with PBS and cells were allowed recovery time of 30 
min in full growth medium at 37°C in the dark. During the recovery time, the acetate 
groups on CM-H2DCFDA were removed by intracellular esterases, trapping the probe 
inside the cells. Production of ROS was measured by changes in the fluorescence of 
dichlorofluorescein (DCF) 5 min, 30 min and 1 h after plasma treatment using an upright 
fluorescence enabled microscope. 
Cell Growth Assay 
MCF10A cell proliferation was measured through cell counts on directly treated 
cells. 10,000 MCF10A cells were seeded on 22 x 22 mm square cover slips in 6-well 
plates one day before plasma treatment. Cells were plasma treated as described at various 
doses of plasma and incubated for an additional 3 days with a media change on day 2. 
Cell number was quantified on days 1 and 3 by counting Trypsin-detached cells using a 
Cell Viability Assay (Guava EasyCyte Plus, Millipore, MA, USA). Fold growth was 
determined by taking the ratio of the number of attached cells on day three to day one.  
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Colony Survival Assay 
4 x 10
5
 MCF10A cells were seeded on 22 x 22 mm square cover slips in 6-well 
plates one day before plasma treatment. One day after treatment with DBD plasma or 
H2O2 (positive control), 300 cells were seeded onto 60-mm dishes.  Eleven days after 
plating, cells were fixed and stained with a crystal violet solution (0.5% in 20% ethanol) 
and colonies were counted. Assays were done in triplicate. 
Apoptosis 
Apoptosis was measured via Annexin V-propidium iodide labeling. Annexin V 
binds phosphatidylserine translocated from the inner to the outer cell membrane. Cells in 
early apoptosis are identified as Annexin V-positive and negative for the vital dye 
propidium iodide.  Floating and trypsin-released cells were collected and centrifuged, 
washed thoroughly, resuspended in Annexin binding buffer, and labeled with Annexin V-
fluorescein and propidium iodide as per manufacturer instructions (BD Pharmingen, San 
Jose, CA). Samples were analyzed immediately by flow cytometry (Guava EasyCyte 
Plus, Millipore, MA, USA).  
Lentivirus Production and Cell Transduction 
Lentivirus was prepared from MISSION shRNA (Sigma Aldrich, St Louis, MO, 
USA) following the manufacturer‘s instructions for targeting ATM (NM_000051.2-9380; 
NM_000051.2-2990) and ATR (NM_001184.2-231) and pLKO-Non-targeting (shC002), 
pLKO-GFP (shC104) were used as controls. The shRNA plasmids were then transfected 
into 293T cells with VSVG, RRE and RSV-Rev packaging vectors to generate 
corresponding pseudoviruses. Virus was collected 48 h post transfection. For stable 
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knockdown, 72 h after transduction, MCF10A cells were selected in 1 g/ml puromycin 
for 48 h. 
pH and Ca
2+
 Measurement 
Changes in pH and Ca
2+
 concentration were determined immediately after plasma 
treatment.  pH of the sample was measured using a pH meter (Lazar Research Labs 
6230n pH/mV/Temp meter) and pH micro-electrode (Lazar Labs PHR146XS).  Ca
2+
 
concentration was measured after the treatment using the above meter with a micro-ion 
selective electrode (Lazar Research Labs LIS-146CACM) and micro reference electrode 
(Lazar Research Labs LIS 146DJM). The mV values obtained were converted to molar 
values using software (Arrow Lab Systems
TM
). 
SEM Analysis of Blood Samples 
Morphological evaluation of the clot layer, formed on the surface of blood post e-
plasma treatment was conducted at the Drexel Material Characterization Facility. The 
blood sample was treated for 30 s by e-plasma using the setup illustrated in Fig. 1. After 
the treatment, the clot layer was gently transferred onto a silicon wafer and immediately 
fixed overnight in 2.5 % glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4 [413, 414]. 
The clot layer was then washed four times in distilled water and dehydrated in a graded 
series of increasing ethanol concentration (30-100%) over two hours. The specimens 
were mounted, sputter coated with platinum palladium in a SEM coating unit for 15 s, 
and examined in a Philips XL30 Field Emission Environmental Scanning Electron 
Microscope. 
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Dynamic Light Scattering 
Dynamic Light Scattering (DLS) was used to detect aggregation of protein 
solutions (fibrinogen and albumin) due to non-thermal plasma treatment. DLS measured 
particle size distributions in fibrinogen and albumin solutions before and after e-plasma 
treatment were obtained using Malvern Instruments, Zetasizer NanoZS. The Zetasizer 
uses a 633 nm He-Ne laser to measure intensity of the light scattered due to the proteins 
and protein aggregates present in the solution.  
Lipid Peroxidation 
Bromotrichloromethane (BrCCl3, Sigma-Aldrich, St. Louis, MO, USA) was used 
as a known inducer of lipid peroxidation. N-acetyl-cysteine (Sigma-Aldrich, St. Louis, 
MO, USA), was used as an intracellular scavenger of reactive oxygen species and 
Diphenyl-phenyl-enediamine (DPPD, Sigma-Aldrich, St. Louis, MO, USA), a lipophilic 
synthetic alternative to Vitamin E was used as a lipid peroxidation inhibitor.  
Malondialdehyde-thiobarbituric acid (MDA-TBA) levels were used as a measure 
of lipid peroxidation after non-thermal plasma treatment of mammalian cells. Cells were 
treated either directly or separately for 15 s at a dose of 1.95 J/cm2. Cells were held after 
plasma treatment for either 1 min or 10 min before adding butylated hydroxtoluene 
(BHT). The cells were scrapped with a rubber policeman and homogenized at 4°C. 
Whole lysates were used to measure the level of MDA following the manufacturer‘s 
protocol (OxiSelect
TM
 TBARS Assay kit, Cell BioLabs, San Diego, CA, USA). The TBA 
test was carried out under acidic (pH 3.5) conditions with a colorimetric 96-well 
microplate assay and the level of TBARS was expressed relative to the response of the 
assay to malondialdehyde (MDA) using a plate reader at 532nm.  
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Statistical Analysis 
All experimental data points were from triplicate samples and are expressed and 
or plotted as the mean ± S.E.M.  Data were analyzed by Student t test to establish 
significance between data points. 
 
6.3. Results  
 
Figure 30. Dose-dependent effects of non-thermal atmospheric pressure dielectric barrier 
discharge (DBD) plasma on MCF10A cells. (A) Schematic of the apparatus for 
administration of DBD plasma. (B) 10
4
 MCF10A cells plated on glass cover slips were 
treated with the indicated dose of DBD plasma as described.  Cells were counted 24 and 
72 hours after treatment.  (C) Cells were treated with the indicated dose of DBD plasma; 
and colony survival assays were performed as described. Data are expressed relative to 
the # of colonies in the untreated control. (D)  3 days after treatment with the indicated 
dose of DBD plasma, cells were harvested and stained with Annexin V/ propidium iodide 
(PI) and analyzed by Guava.   
A. B. 
D. C. 
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In order to test the effects of plasma treatment on mammalian cells, DBD plasma 
was applied to human breast epithelial cells (MCF10A).  Cells were grown on glass cover 
slips and exposed to non-thermal plasma as illustrated (Figure 30A). Cells were treated in 
100 l of media and incubated for 1 minute prior to placement in 2 ml of media.  The 
initial experiment involved establishing the dose-dependent effects of plasma treatment 
on cell proliferation and survival by direct cell count and colony formation.  At low 
doses, cell number increased, whereas at higher doses, cell number and survival 
decreased (Figure 30B, C).  Annexin V/propidium iodide staining of cells treated with 
DBD plasma at doses ranging from 0.65 to 3.9 J/cm
2
 revealed that apoptosis was induced 
at higher doses (Figure 30D).  
 
6.3.1. Effects on DNA 
One possible mechanism underlying these dose-dependent effects is generation of 
ROS, which at low levels is known to increase cell proliferation and at high levels 
induces cell death through DNA damage [413]. DNA damage induced by IR has been 
shown to result from formation of ROS [414, 415]. To determine whether DBD plasma 
treatment of cells could induce DNA damage, we looked at phosphorylation of H2AX, a 
histone variant that is phosphorylated in response to DNA damage [53]. Western blot 
with an antibody that detects H2AX phosphorylated at Ser139 (-H2AX) revealed that 
treatment of cells with DBD plasma induces a dose-dependent increase in -H2AX 
(Figure 31A).  Indirect immunoflorescence also revealed foci of -H2AX (Figure 31B) 
which increased in number at higher doses. These data demonstrate that DBD plasma 
treatment of cells induces a dose-dependent increase in DNA damage.   
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Figure 31. Reactive oxygen species mediate induction of DNA damage by DBD plasma. 
(A) MCF10A cells were treated with the indicated dose of DBD plasma as described. 
After one hour incubation, lysates were prepared and resolved by SDS-PAGE and 
representative immunoblots with antibody to -H2AX or -tubulin are shown. (B) 
Indirect immunofluorescence of MCF10A cells was performed as described one hour 
after treatment with 1.55 J/cm
2
 DBD plasma. (C) MCF10A cells were incubated for 2 
hours with 4 mM N-acetyl cysteine (NAC) (+) or cell culture medium (-), followed by 
treatment with the indicated dose of DBD plasma. -H2AX (upper panel) or -tubulin 
(lower panel) was detected by immunoblot of cell lysates prepared one hour after plasma 
treatment. 
 
6.3.2. Role of ROS 
We next sought to directly test whether the damage induced by DBD plasma is due to 
ROS (e.g. H2O2, OH
•
, 
1
O2, atomic oxygen, O2
-
, etc.) generated in the media and/or cells 
by plasma treatment. Pre-treatment of cells with the ROS scavenger, N-acetyl cysteine 
(NAC), blocked induction of -H2AX even at high doses of DBD plasma treatment 
(Figure 31C), suggesting that the induction of DNA damage as measured by -H2AX is 
mediated by ROS.  
 
B. C. 
A. 
HOECHST DCF MERGE 
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Figure 32. Non-Thermal plasma treatment of cells leads to intracellular generation of 
reactive oxygen species. Detection of intracellular ROS was performed as described 1 h 
after plasma treatment. Representative images are shown for (A) untreated control. (B) 
200 M H2O2. (C) Plasma treatment at a dose of 1.55 J/cm
2
 and (D) Plasma treatment at 
a dose of 4.65 J/cm
2
. 
In order confirm the results of ROS scavenging and to evaluate whether plasma 
induces oxidative stress only in the extracellular environment or the effects of plasma are 
able to penetrate the cells and induce generation of intracellular ROS, we directly tested 
for intracellular ROS in MCF10A cells post non-thermal plasma treatment using a 
commonly used ROS detection dye CM-H2DCFDA. Untreated cells were used as 
controls to evaluate baseline oxidative stress in cells (Figure 32A) while 200 M 
H2O2was used as a positive control (Figure 32B). As shown in Figure 32C, 1 h after 
A. 
B. 
C. 
D. 
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treatment, non-thermal plasma induces generation of significant levels of intracellular 
ROS in MCF10A cells at a dose of 1.55 J/cm
2 
as measured by fluorescence microscopy. 
The level of intracellular oxidative stress induced is higher as the dose of plasma is 
increased to 4.65 J/cm
2
 as shown in Figure 32D. These results indicate that non-thermal 
plasma treatment of cells induces generation of significant levels of 
 
Figure 33. (A) ROS accumulate in media and effects on cells are dependent on their 
concentration.  Cells on cover slips overlaid with 100 µl cell culture media were treated 
with 1.55 J/cm
2
 DBD plasma, followed by dilution in 2 ml of media at the indicated 
holding time after treatment.  Cell lysates were subjected to immunoblot after 1 hour of 
incubation. (B) Cells were treated in 100 µl cell culture media and immediately after 
treatment, it was diluted with media as indicated; all samples were incubated at the 
indicated dilution for one minute followed by incubation for 1 hour in 2 ml of medium. 
(C) The results of (B) are quantified. 
A. 
B. 
C. 
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intracellular ROS and the resultant oxidative stress may lead to observed DNA damage. 
Consistent with this finding, longer incubation in the 100 l in which cells were treated 
before dilution into 2 ml of media resulted in higher levels of -H2AX (Figure 33A).  
Additionally, when the treated media was diluted immediately after treatment, the 
amount of damage was directly related to the dilution, i.e. damage was greater at the 
lowest dilution (Figure 33B, C)   These data suggest that generation of intracellular ROS 
and induction of DNA damage is the result of interaction of plasma with extracellular 
media, the effect of which depends upon the concentration and the length of exposure. 
Moreover, these findings suggest that active species in the media are responsible for the 
effects of DBD plasma on cells. 
 
6.3.3. Biochemical Interaction of Plasma 
  As seen in previous sections direct non-thermal plasma treatment has various dose 
dependent effects ranging from enhancing cell proliferation to inducing apoptosis. It was 
also apparent that reactive oxygen species produced by DBD plasma play a prominent 
role in mediating the biological effects of non-thermal plasma. Though, it was still 
unclear how the ROS produced by plasma would interact with cells. As plasma is 
primarily a surface phenomenon, ROS produced by plasma would very likely encounter 
the cell membrane before intracellular components of the cells. Further, as most of these 
ROS are short lived it seems unlikely that they could travel through the organic medium 
covering the cells during treatment to reach the surface of the cells and directly attack the 
cell membrane. We hypothesized that ROS produced by non-thermal plasma interact with 
organic content to produced long living organic species which eventually mediate the 
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Figure 34. Coagulation of non-thermal plasma treated non anti-coagulated whole blood 
and citrated whole blood. (A) Non anti-coagulated donor blood treated with non-thermal 
plasma for 15 s exhibits immediate clot layer formation. (B) Citrated whole blood treated 
with non-thermal plasma for 15 s exhibits immediate clot layer formation. 
interaction of plasma with cells. In order to test this hypothesis we decided to test the 
effects of non- thermal plasma on the most natural organic product of the human body, 
blood. We investigate mechanisms of blood coagulation by non-thermal atmospheric 
pressure plasma using an experimental setup similar to one previously described in [13] 
and schematically illustrated in Figure 3. For this study, de-identified whole blood 
samples with three different types of anticoagulants were obtained from  Drexel 
University College of Medicine (DUCOM) Chemistry lab. 500 µl of the three different 
types of anti-coagulated whole blood, viz; heparinized whole blood; citrated whole blood 
and Ethylene Diamine Tetraacetic Acid (EDTA) whole blood were used. Each blood 
A. 
B. 
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sample was treated for 5 s, 15 s, 30 s and 60 s to study the effect of non-thermal plasma 
treatment on blood. 
 
Figure 35. SEM observation of Non-Thermal plasma initiated blood coagulation. (A) 
Citrated whole blood (control) showing single activated platelet (white arrow) on a red 
blood cell (black arrow). (B) Citrated whole blood (control) showing many non-activated 
platelets (black arrows) and intact red blood cells (white arrows). (C) Citrated whole 
blood (treated) showing extensive platelet activation (pseudopodia formation) and 
platelet aggregation (white arrows). (D) Citrated whole blood (treated) showing platelet 
aggregation and fibrin formation (white arrows) 
  Evaluated visually, a drop of blood, with a volume of 500µl, drawn from a 
healthy donor and left on a stainless steel surface coagulates on its own in about 15 
minutes, while a similar drop treated for 15 s by non-thermal plasma coagulates in under 
1 minute as shown in Figure 34A. Similarly, 0.5 ml of citrated whole blood left in a well 
does not coagulate on its own even when left in the open air for well over 15 minutes, 
A. 
C. D. 
B. 
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while the same sample treated with DBD-plasma for 15 s exhibits immediate clot layer 
formation on the surface exposed to plasma discharge as shown in Figure 34B.  
 To gain further insight into the structure of the clot layer of the anti-coagulated 
blood samples, morphological examination of the clot layer was performed by Scanning 
Electron Microscopy. Figure 35A shows a single platelet [416] over a red blood cell in 
untreated (control) citrated whole blood. Figure 35B shows some activated, but many 
non-activated platelets and red blood cells in the untreated anti-coagulated whole blood. 
No platelet aggregation or fibrin strands are observed in these samples. On the other 
hand, extensive platelet activation (pseudopodia formation) and platelet aggregation was 
observed in the non-thermal plasma treated (30 s) whole blood as evident from Figure 
35C. Figure 35D shows platelet activation, platelet aggregation and fibrin formation 
(white arrows) in the e-plasma treated anti-coagulated whole blood. 
Natural blood coagulation is a complex process that has been studied extensively 
[417] and various non-thermal plasma products can affect this process. It was 
hypothesized previously that direct exposure to non-thermal plasma initiates coagulation 
of blood through increase in concentration of Ca
2+
[12], an important factor in the 
coagulation cascade [418, 419]. Calcium circulates in blood in several forms. 45%-50% 
is free ionized, 40-45% is bound to proteins, mostly albumin, and rest is bound to anions 
such as bicarbonate, citrate, phosphate and lactate [420]. Bound calcium is in equilibrium 
with free calcium. pH has a significant effect on calcium ion binding to protein, with each 
unit decrease or increase in pH causing ionized calcium to change inversely by about 
0.36 mmol/L [421]. It was proposed that non-thermal plasma is effective in increase of 
Ca
2+
 concentration through a redox (reduction/oxidation) mechanism. We tested the 
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validity of this hypothesis experimentally by measuring Ca
2+ 
concentration
 
in the non-
thermal plasma treated anti-coagulated whole blood using a calcium selective micro-
electrode. Calcium concentration was measured immediately after non-thermal plasma       
     
Figure 36. Coagulation of blood by non-thermal plasma treatment does not occur due to 
changes in pH or Ca
2+
 concentration. (A) Calcium concentration in different anti-
coagulated whole blood treated with non-thermal plasma. There is no significant change 
in calcium ion concentration during the time non-thermal plasma treated blood 
coagulates. (Note: average error is less than 0.01 mM). (B) pH of whole blood after non-
thermal plasma treatment for different durations. pH does not change significantly in the 
duration in which plasma treated blood coagulates. 
treatment for 5 s, 15 s, 30 s, 60 s and 120 s. Figure 36A demonstrates that calcium 
concentration remains almost constant for up to 30 s of treatment and then increases very 
slightly for prolonged treatment times of 60 s and 120 s. Thus, although, non-thermal 
plasma is capable of coagulating anti-coagulated blood within 15 s, no significant change 
occurs in calcium ion concentration during this time in discharge treated blood. 
Therefore, we conclude that release of Ca
2+
 may not be the mechanism for non-thermal 
plasma triggered coagulation.  
Changes in blood pH could also trigger blood coagulation through increase in 
calcium ion concentration due to redox mechanism [12]. In-vivo, the pH of blood is 
maintained in a very narrow range of 7.35-7.45 by various physiological processes [422]. 
Non-thermal plasma has been confirmed to generate a significant amount of hydrogen 
A. B. 
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ions which changes pH of water and phosphate buffered saline significantly within 30 s 
of treatment [12]. We tested the hypothesis that the non-thermal plasma treatment 
triggers coagulation through changes in the pH of blood. This was tested by measuring 
pH of each blood sample immediately after non-thermal plasma treatment as described in 
the methods section. Figure 36B shows that no significant change in pH occurs in the 
anti-coagulated blood samples during the time needed for non-thermal plasma treated 
blood to coagulate. 
It was previously demonstrated that significant changes occur in blood plasma 
protein concentrations after treatment by non-thermal plasma of samples from non anti-
coagulated and blood with various anti-coagulants [12]. Direct activation of intermediate 
protein factors by non-thermal plasma may be one of the mechanisms of coagulation of 
blood. Conversion of fibrinogen into cross-linked fibrin fibers is the final step in 
coagulation of blood [423]. Therefore, we postulated that one of the pathways by which 
non-thermal plasma treatment coagulates blood may be through direct effect on 
fibrinogen. To test this hypothesis we investigated the effect of the non-thermal plasma 
treatment (30 sec) on buffered fibrinogen solution (TRIS buffered saline solution, 20 
mM) at physiological pH of 7.4 using the set up used for blood treatment. As compared 
to the untreated fibrinogen solution shown in Figure 37A, the opacity of the treated 
fibrinogen solution changes as shown in Figure 37B indicating that non-thermal plasma 
initiates changes in the fibrinogen solution. Dynamic Light Scattering (DLS) 
measurements on the treated and untreated fibrinogen solutions were carried out to test 
the possibility that the observed changes in opacity are due to conversion of fibrinogen 
into larger molecular structures. 
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Figure 37. Treatment of buffered solution of fibrinogen (A) control, (B) 30 sec plasma 
treatment and buffered solution of albumin (C) control, (D) 30 sec plasma treatment. (B) 
shows change in opacity of fibrinogen solution after treatment whereas in (D) we see no 
change in opacity of albumin solution. 
Figure 38A compares untreated (control) and treated fibrinogen solution. The 
diameter of a fibrinogen molecule is around 9 nm [423], which is demonstrated in Figure 
38B. Treated fibrinogen exhibits a multimodal distribution of sizes with the largest 
increase in size by about two orders of magnitude as compared to the control. The largest 
fibrinogen aggregates have an average size of 2 µm. Thus coagulation of blood by non-
thermal plasma treatment does not occur due to changes in pH or Ca
2+
 concentration. 
Non-thermal plasma appears to promote rapid blood coagulation by enhancing the natural 
coagulation processes. The results presented in this section indicate that direct conversion 
of fibrinogen into fibrin may be one of the mechanisms by which non-thermal plasma  
A. B. 
C. D. 
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Figure 38. Dynamic light scattering measurements (A) Comparison of control and 
treated solution of fibrinogen. (B) Comparison of control and treated solution of albumin. 
Treated and untreated albumin show the same size distribution with average size of about 
6nm, which corresponds well to the published albumin size of around 8 nm [424]. 
initiates coagulation. This indicates that non-thermal plasma not only has direct effects 
attributed to charges but also indirect biochemical effects which may be initiated by 
interactions of reactive oxygen species with organic content including proteins and amino 
acids. 
 
6.3.4. Role of Plasma Generated Charged Species vs Neutral Active Species 
Non-thermal plasma is known to produce many charged species (electrons and 
ions) and long living and short living neutral species in gas phase as well as in liquid 
phase [17]. To determine which of these species are responsible for inducing generation 
of intracellular ROS and the induction of DNA damage, DBD plasma was applied in 
different modes. Experiments shown in Figure 30, Figure 31 and Figure 32 utilized direct 
treatment, in which all the species produced by plasma come in contact with the surface 
of the medium covering the cells during treatment. Indirect treatment involves placement 
of a grounded mesh between the high voltage electrode and the medium, which blocks 
charged species and allows only neutral species to come in contact with the surface of the 
medium. Phosphorylation of H2AX was not significantly different in indirect treatment  
 
A. B. 
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Figure 39. Effects of DBD Plasma are mediated by neutral species generated in the 
media. (A) Cells were subjected to DBD as described earlier (direct, D) or a grounded 
mesh was placed between the electrode and the medium (indirect, I). (B) Cells were 
subjected to direct treatment with DBD plasma (D) or media (100 l) was exposed to 
DBD plasma and then transferred to the cells (separate, S).  (A, B) Representative 
immunoblots with -H2AX or -tubulin are shown.  The graphs below the immunoblots 
show quantification using Odyssey. (C) Media (100 l separated treatment) was 
subjected to DBD and was transferred to cells after holding for 1 to 60 min.  After 1 
minute incubation with cells, cover slips with treated media and cells were transferred to 
a dish with 2 ml of media. 
as compared to direct treatment (Figure 39A), indicating that active neutral species 
produced by DBD plasma are responsible for the generation of ROS leading to induction 
of DNA damage.     
 
6.3.5. Direct vs Separated Plasma Treatment 
To determine whether the effects of DBD plasma are due to modification of the 
cell medium by the plasma treatment as opposed to a direct effect on the cells, the media 
A. B. 
C. 
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was treated separately and added to cells, 100 l of medium on a coverslip (without cells) 
was treated with DBD plasma and then transferred to a coverslip with cells, which we 
have termed ‗separated treatment‘.   The effect of media separately treated with DBD 
plasma and added to cells was not significantly different from the effect of direct 
treatment of cells overlaid with media (Figure 39B).  To begin to address what 
component of the medium is affected by the treatment, we initially addressed the stability 
of the separately treated medium. The medium was separately treated as described above 
and then held for increasing times before being added to cells.  Induction of DNA 
damage by the treated medium was not reduced by holding the medium up to one hour 
prior to adding it to cells (Figure 39C), suggesting that stable component(s) such as 
organic peroxides [233] may be formed in the cell medium ,  
 
6.3.6. Presence of Organic Content and Role of Amino Acid Peroxidation 
To identify the active components, we compared the effect of separated treatment 
of complete medium vs. inorganic phosphate buffered saline (PBS). We observed no 
DNA damage in cells exposed to separately treated PBS (Figure 40A), whereas 
separately treated medium induced DNA damage as anticipated.  This suggests that the 
presence of organic components in the medium is essential for the observed effects.  
Cell culture medium used in the experiments described above is composed of 
amino acids, glucose, vitamins, growth factors and inorganic salts, as well as serum.  
Gebicki et al. have shown that -radiation (IR) induces formation of amino acid and 
protein hydroperoxides in aqueous solutions containing BSA or individual amino acids 
[233]. Equivalent levels of H2AX phosphorylation were induced in cells subjected to  
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Figure 40. The amount of DNA damage induced is proportional to the peroxidation 
efficiency of the amino acid. (A) Cells overlaid with 100 l of PBS were treated directly 
with DBD plasma (direct, D) or separately (S). (B) DNA damage is induced in cells 
subjected to DBD plasma treated serum-free media or PBS with BSA, but not PBS alone. 
100 l of PBS, media without serum, or PBS with 100 g/ml BSA were treated with 1.55 
J/cm
2 
DBD plasma and immediately added to cells on a coverslip (S).  Cells overlayed 
with 100 l of the indicated solution were treated with 1.55 J/cm2 DBD plasma (D). (C) 
Peroxidation efficiency of various amino acid components of cell culture medium when 
treated with IR [233]. (D) Solutions containing the indicated amino acid (100 M) were 
separately treated with DBD plasma and then added to MCF10A cells. (A, B, D) After 1 
minute incubation, cells on cover slips were diluted in 2 ml media, followed by lysis and 
Western blot for -H2AX or -tubulin. 
DBD plasma treated serum-containing media, serum-free media or PBS with BSA, but 
not PBS alone (Figure 40B), suggesting that amino acid peroxidation may be involved.  
Peroxidation efficiency  is widely variable among different amino acids [233]. To 
determine whether the observed results were related to the peroxidation efficiency of 
organic components in cell culture medium, 11 different amino acids with a range of 
peroxidation efficiencies were dissolved individually in PBS and separately treated with 
DBD plasma and then added to cells. As shown in Figure 40, phosphorylation of H2AX 
(Figure 40D), there is a direct correlation between peroxidation efficiency and the 
amount of DNA damage, with valine producing the most significant level of damage and 
B. 
C. 
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serine and methionine producing no detectable DNA damage (Figure 40C),. These data 
provide strong support for the hypothesis that organic peroxides are produced in the 
medium by plasma treatment and are responsible for the observed effects on DNA, 
although further confirmation is required.   
 
 
6.3.7. Role of Ozone 
DNA damage is induced in cells treated directly in PBS (Figure 40 a), albeit less 
than that induced by direct treatment in media. Since separately treated PBS has no effect 
on cells and organic components are not present in PBS, it seems likely that the DNA 
damage induced by direct treatment of PBS must result from short-lived active species 
generated in PBS, like OH radicals or ozone. As shown in Figure 40, as interaction of 
plasma produced neutral active species with amino acids leads to DNA damage it is 
possible that ozone may play a role in mediating the interaction of non-thermal plasma 
with mammalian cells by modifying amino acids, producing long living organic 
hydroperoxides. [425] have shown that ozone is capable of reacting with various amino 
acids including methionine and cysteine with high rates of reaction at physiological 
values of pH. Although typically requiring much higher treatment time than the typical 
times reported here, ozonation is, in fact, widely employed to kill micro-organisms in 
water [426] and ozone therapy is now being widely studied as a novel treatment for 
various pathologies [427-430].  Since DBD plasma produces significant amounts of  
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Figure 41. Ozone treatment is qualitatively different from Plasma treatment. Solutions 
containing the indicated amino acid (100 M) or medium or PBS were ozonated for 15 s 
and then added to MCF10A cells. After 1 minute incubation, cells on cover slips were 
diluted in 2 ml media, followed by lysis and Western blot for -H2AX or -tubulin. Cells 
exposed to separately plasma treated valine were used as control. 
ozone [431, 432], it is possible that the DNA damaging effects of plasma may be 
mediated by ozone to some extent. To test the possibility, ozone plays a major role in 
mediating the DNA damage induced by plasma, we exposed cells to 100 l  of PBS 
containing cysteine, methionine, proline and valine dissolved in PBS, serum-containing 
medium or PBS alone that were separately treated with ozone. As shown in Figure 41, 
PBS containing amino acids cysteine, valine or proline, cell medium or PBS, separately 
treated with ozone resulted in no detectable DNA damage in MCF10A cells as measured 
by phosphorylation of H2AX, while we observed DNA damage in cells exposed to 
methionine separately treated by ozone. We, therefore, conclude that ozone treatment is 
qualitatively different from non-thermal DBD plasma and does not play a major role in 
these studies since it affects mostly methionine and cysteine, while not affecting valine 
and leucine [425] , which are most strongly affected in DBD treatment as shown in 
Figure 40B. Further investigation is necessary to determine which of the neutral species 
plays a major role in observed interactions of non-thermal plasma with mammalian cells 
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6.3.8. Lipid Peroxidation 
Non-thermal plasma produces a large ROS concentration in the extracellular 
medium during treatment. However, it is unclear how these ROS go inside cells. N-
acetylcysteine, an intracellular ROS scavenger completely blocked phosphorylation of 
H2AX after non-thermal plasma treatment of MCF10A cells, which indicates that, ROS 
produced by plasma extracellularly may move across the cell membrane through lipid 
peroxidation, opening transient cell membrane pores, or signaling pathways which 
modify the concentration of ROS intracellularly.. In this section we attempt to investigate 
whether non-thermal plasma induced lipid peroxidation is responsible for the observed 
DNA damage. 
 
6.3.8.1. Mammalian Cells 
Since many of active species produced by plasma including OH

, O2
-
, RO

, 
ROO

, 
1
O2, have a short life span, they may immediately interact with medium 
components including amino acids and proteins, leading to production of long lived 
reactive organic hydroperoxides [233]. These hydroperoxides may then induce lipid 
peroxidation and the by-products of lipid peroxidation, like MDA [433] may lead to 
DNA damage [434], or they may bind to cell membrane receptors and activate 
intracellular signaling pathways leading to subsequent DNA damage. 
It is well known that ROS like OH radicals, superoxide radicals, atomic oxygen, 
singlet oxygen, organic protein and amino hydroperoxides, etc. react with 
polyunsaturated fatty acid residues in membrane phospholipids to initiate lipid 
peroxidation which results in the production of a plethora of by-products, many of them 
183 
 
 
reactive toward protein and DNA[435]. One of the most abundant carbonyl products of 
lipid peroxidation induced by endogenous and exogenous ROS-inducing chemicals is 
malondialdehyde (MDA)[436]. It reacts with DNA to form adducts to deoxyguanosine 
and deoxyadenosine. The major adduct to DNA is a pyrimidopurinone called M1G. Site-
specific mutagenesis experiments indicate that M1G is mutagenic in bacteria and is 
repaired by the nucleotide excision repair pathway [433, 435, 437, 438]. 
As described earlier, DNA damage induced by non-thermal plasma was mediated 
by ROS. ROS are known to induce lipid peroxidation in mammalian cells. Plasma 
produces ROS in the medium covering the cells during treatment. These ROS are likely 
to first encounter the cell membrane before DNA and it is possible that they either 
directly or by modifying organic content in the medium induce lipid peroxidation. To  
 
Figure 42. Non-Thermal plasma treatment leads to release of malondialdehyde (MDA), a 
commonly used marker for measuring lipid peroxidation in mammalian cells. Plot shows 
MDA equivalent for untreated cells and cells treated at indicated dose Data from 
triplicate samples (± S.D.) are plotted.  
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Figure 43. MCF10A cells were incubated for 1 hour with 10 M N-diphenyl-phenyl-
enediamine (DPPD) (+DPPD) or cell culture medium (-DPPD), followed by treatment at 
the indicated dose of DBD plasma or with 1 mM bromotrichloromethane (BrCCl3). Lipid 
peroxidation was measured via release of malondialdehyde (MDA). Plot shows MDA 
equivalent for untreated cells (control) and cells treated at indicated plasma dose or with 
1 mM BrCCl3. Data from triplicate samples (± S.D.) are plotted. 
determine whether DBD plasma treatment induced lipid peroxidation in cells, we looked 
at formation of malondialdehyde (MDA), a by-product of lipid peroxidation, which is 
commonly used as an index for measuring lipid peroxidation [439]. As shown in Figure 
42, we see that plasma indeed induces lipid peroxidation in cells immediately after 
treatment, when treated under medium either directly or separately. In contrast, non-
thermal plasma does not induce lipid peroxidation in mammalian cells treated under PBS, 
either directly or separately. This suggests that long living organic hydroperoxides, 
produced as a result of interaction of neutral active species produced by non-thermal 
plasma in medium with organic components of the medium like proteins and amino, may 
induce lipid peroxidation. These data are consistent with the fact that DNA damage is 
induced by organic peroxides formed as a result of ROS produced by neutral active 
species. 
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Figure 44. Non-Thermal plasma induced lipid peroxidation does not lead to the observed 
DNA damage. MCF10A cells were incubated for 1 hour with 10 M N-diphenyl-phenyl-
enediamine (DPPD) (+DPPD) or cell culture medium (-DPPD), followed by treatment at 
the indicated dose of DBD plasma or with 1 mM bromotrichloromethane (BrCCl3). (A) 
Representative Immunoblot with -H2AX or -tubulin are shown. (B) The graph below 
the immunoblot show quantification of triplicate data samples from three separate 
experiments.  
We next sought to test whether plasma induced lipid peroxidation led to the 
observed DNA damage. In order to block lipid peroxidation in MCF10A cells after 
plasma treatment, we used N-Diphenyl-phenyl-enediamine (DPPD), a synthetic lipophilic 
antioxidant and bromotrichloromethane (BrCCl3) a known inducer of lipid peroxidation 
as a pro- oxidant. DPPD is frequently used in cell culture and in in-vivo studies to inhibit 
lipid peroxidation by various chemical agents [440-443]. MCF10A cells were pre-
incubated with DPPD for 15 min at 37°C before plasma treatment or addition of 1 mM 
BrCCl3. As shown in Figure 43, DPPD significantly inhibits lipid peroxidation in 
MCF10A cells, both after plasma treatment and after incubation of cells with BrCCl3 for 
B. 
A. 
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2 hours. Thus, DPPD is a potent inhibitor of non-thermal plasma induced lipid 
peroxidation. DPPD proving to be a potent blocker of lipid peroxidation, we next sought 
to investigate the role of non-thermal plasma induced lipid peroxidation in the observed 
DNA damage. As earlier, MCF10A cells were preincubated with 10 mM DPPD for 15 
min before exposing the cells to non-thermal plasma at a dose of 1.95 J/cm
2
 (15 s at low 
frequency) or to 1 mM BrCCl3 for 2 h. After plasma treatment cells were incubated for 
1h at 37°C prior to lysing for analyzing DNA damage. DNA damage was analyzed as 
earlier by western blot technique for measuring -H2AX. As shown in Figure 44, DNA 
damage after plasma treatment of MCF10A cells with or without pre-incubation of DPPD 
was same while DNA damage induced by BrCCl3 was significantly reduced by DPPD. 
Non-thermal plasma induced lipid peroxidation does not lead to non-thermal plasma 
induced DNA damage. Non-thermal plasma produces a lot of ROS in the medium 
covering the cells during treatment which may lead to lipid peroxidation and DNA 
damage simultaneously, but DNA damage is not induced as a result of lipid peroxidation 
Further investigations are necessary to determine other pathways of non-thermal plasma 
induced DNA damage in mammalian cells, which may include ROS mediated cellular 
signaling or uptake of long lived ROS via active transport. 
 
6.3.8.2. Fungi 
As shown in the previous section, DNA damage in mammalian cells induced by 
non-thermal plasma is not mediated via non-thermal plasma induced lipid peroxidation. 
Lipid membranes in mammalian cells transiently allow transport of nutrients, water and 
other metabolites and small molecules across for proper functioning of the organism. 
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Reactive oxygen species produced by plasma may also be up taken by active transport 
mechanisms and thereby the effects of plasma could be transported across the cell 
membrane. To confirm that the effects of non-thermal plasma are not mediated via lipid 
peroxidation and physical membrane damage we chose to test the effects of non-thermal 
plasma on fungi which have multiple layers of membranes and cell walls as opposed to 
single bilayer in mammalian cells. We investigated the efficacy of plasma killing of fungi 
and visually studied morphological changes in the fungal membrane post non-thermal 
plasma treatment. 100 l of fungal suspension of Alternaria Brassicicola is placed on a 
glass microscope slide and allowed to dry for about an hour. After drying the fungi are 
treated with non-thermal plasma and immediately after treatment the fungi are swabbed 
from the glass slide and spread on to an agar plate and incubated at room temperature for 
3-5 days. Two approaches were used for plasma-treatment of fungi (Alternaria B.): direct 
and separated. In direct treatment, the sample was one of the electrodes creating the 
plasma. Plasma discharge occurred between the quartz glass dielectric and the sample, 
which exposed the sample directly to neutral reactive species and charged particles. In 
separated plasma treatment, DI water or other fluids like phosphate buffered saline (PBS) 
was plasma treated separately from the fungi and then immediately applied to fungi. In 
this case, the fungi were not in direct contact with any species produced by non-thermal 
plasma. 100 l of fungal suspension is placed on a microscope slide and allowed to dry 
completely for about an hour. After drying the fungi are treated with plasma and 
immediately after treatment the fungi are swabbed from the glass slide and spread on to a 
sterile agar plate, the plate was sealed with parafilm and incubated at room temperature 
for five days. As shown in Figure 45A, Figure 45B, Figure 45C and Figure 45D we see 
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no colony formation after only 30 s of plasma treatment. Direct plasma treatment for 30 s 
completely inhibits growth of alternaria brassicicola. We see similar results after direct 
treatment for 60 s and 120 s. Figure 45E shows inactivation curves for directly treated 
fungi. 
 
Figure 45. Direct plasma treatment of dried Alternaria Brassicicola. 100 l of the fungal 
suspension was placed in a hanging drop microscope slide and allowed to sit for 1 h. 
After 1 h the dry fungi were directly treated with non-thermal plasma at increasing doses. 
(A) We see growth of untreated fungi 3 days after plating on an agar dish. (B), (C) and 
(D) Non-thermal plasma treatment for 30, 60 and 120 s significantly inhibits growth of 
fungus and we see no growth of fungi five days after plasma treatment. (E) Inactivation 
of growth of alternaria brassicicola after direct non-thermal plasma treatment 
In the separated mode of plasma treatment, 100 l of fungal suspension was 
placed on a microscope slide and allowed to dry for an hour. On a separate hanging drop 
slide 100 l of DI water was treated at different doses of plasma and after treatment the 
separately treated water was poured on to the untreated dry fungi and allowed to sit for 
the same time as the duration of plasma treatment. The suspension was then pipetted on 
to a sterile agar plate. Any remaining fungi were swabbed with a sterile polystyrene 
applicator and transferred on to the same agar plate. The suspension was evenly spread 
E. A. B. 
D. C. 
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over the agar plate using a sterile spreader. The agar plate was sealed with parafilm and 
then incubated at room temperature for five days. 
 
Figure 46. Separated plasma treatment of dried Alternaria Brassicicola on a hanging drop 
glass slide. 100 l of the fungal suspension was placed on a microscope slide and allowed 
to sit for 1 h. After 1 h, DI water was separately treated for varying doses and 
immediately poured on the dried fungi. The fungi were then plated on agar dishes. (A) 
We see normal growth of untreated fungi 3 days after plating on an agar dish. (B) Fungi 
exposed to DI water separately treated with plasma for 30 s seem to grow normally, (C) 
As we increase the time of exposure to 60 s we start seeing significant inhibition in the 
growth of fungi after treatment and (D) after 120 s of separated treatment we see an 
almost complete inhibition of the growth of fungi. (E) Inactivation of growth of alternaria 
brassicicola after separated non-thermal plasma treatment. 
As shown in Figure 46A, Figure 46B, Figure 46C and Figure 46D, the number of 
fungal colonies formed three days after plasma treatment decreases as the duration of 
plasma exposure increases from 30 s to 120 s. As shown in Figure 46E, where the 
number of colonies are quantified as a function of plasma exposure time, we see dose 
dependent inhibition of fungal growth after separated plasma treatment and we see 
complete inhibition of fungal growth after 120 s of separated treatment. 
As shown in Figure 45 and Figure 46 above non-thermal plasma treatment can 
inactivate fungi after direct or separated treatment for 120 s. We wanted to test whether 
the fungal killing effects of plasma are mediated via membrane damage or not. Fungi 
E. A. B. 
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were treated as discussed in the above sections. Treated fungi were imaged immediately, 
5 min, 30 min and 1 h after treatment with non-thermal plasma for 120 s and 300 s. As 
shown in Figure 47B and Figure 47C, 1 h after plasma treatment fungi look intact and the 
membranes do not seem to be ruptured even after treatment for as long as 300 s. 120 s of  
 
Figure 47. Plasma treatment of Alternaria Brassicicola. (A) Untreated fungi. Fungi were 
plasma treated on a glass cover slip for (B) 120 s and (C) 300 s, and imaged immediately, 
after 5 min, 30 min and 1 h. Representative images are shown for samples imaged 1 h 
after plasma treatment. 
plasma treatment was sufficient to kill the fungi. This again confirms the fact that the 
effects of non-thermal plasma on living cells are not primarily due to physical membrane 
damage which may be induced by charged particles or lipid peroxidation known to be 
induced by reactive oxygen species produced by non-thermal plasma. We hypothesize 
that receptor mediated signaling (or Redox signaling) or active transport mechanisms 
may play a major role in the interaction of non-thermal plasma with living cells. 
 
6.3.9. Type of DNA Damage 
To more precisely identify DNA damage pathways, we next sought to identify the 
kinase that phosphorylates H2AX in response to non-thermal plasma. H2AX is phospho- 
A. C. B. 
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Figure 48. ATR dependence of Non-thermal plasma induced phosphorylation of H2AX. 
(A) Immunoblot of -H2AX (top), and -tubulin (bottom) from MCF10As exposed to 
non-thermal plasma at a dose of 1.95 J/cm
2
 or 200 M H2O2 in the presence (+) or 
absence (-) of 100 mol/L Wortmannin (Wort.) or 10 mol/L KU55933 (KU). (B) 
MCF10As were depleted of endogenous ATM by shRNA (bottom, immunoblot of ATM 
from cells 72 h post transfection with ATM shRNA or nontargeting (NT) shRNA). 
Seventy-two hours after shRNA transfection, cells were trypsinized and plated on glass 
cover slips for 24 h. After 24 h, cells were exposed to DBD plasma at a dose of 1.95 
J/cm
2
 or 200 M H2O2. After one hour incubation, lysates were prepared representative 
immunoblots with antibody to -H2AX or -tubulin are shown. (C) MCF10As were 
depleted of endogenous ATR by shRNA (bottom, immunoblot of ATR from cells 72 h 
post transfection with ATR shRNA or nontargeting (NT) shRNA. Seventy-two hours 
after shRNA transfection, cells were trypsinized and plated on glass cover slips for 24 h 
followed by exposure to non-thermal plasma at a dose of 1.95 J/cm
2
 or 200 M H2O2. 
After one hour incubation, lysates were prepared and representative immunoblots with 
antibody to -H2AX or -tubulin are shown.   
A. 
C. 
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rylated on Ser139 by the phosphatidyl inositol kinase-related kinases (PIKK), ataxia 
telangiectasia mutated (ATM), ATM and Rad - 3-related kinase (ATR) and -DNA protein 
kinase (DNA-PK). Initially, the effect of addition of KU55933, an ATM specific 
inhibitor [444] and Wortmannin, which inhibits ATM, ATR,  and DNA-PK[445], was 
assessed. Pretreatment of MCF10A cells with 10 M KU55933 for 1h did not 
significantly reduce the phosphorylation of H2AX in response to plasma treatment, 
whereas it significantly reduced it in response to H2O2 (Figure 48A). Phosphorylation of 
H2AX in response to non-thermal plasma (as well as H2O2) was markedly reduced in 
cells pretreated with 100 M Wortmannin (Figure 48A). These findings indicate that 
ATR and/or DNA-PK is required for the phosphorylation of H2AX at Ser139 in response 
to non-thermal plasma, although they do not rule out that other kinases may involved. To 
more directly assess the role of ATM and/or ATR, shRNAs were utilized.  ATM shRNA 
effectively reduced levels of ATM, but did not significantly affect the phosphorylation of 
H2AX induced by non-thermal plasma treatment (1.95 J/cm
2
) as compared to non-
targeting shRNA, whereas phosphorylation of H2AX was not detected in ATM 
knockdown cells treated with hydrogen peroxide (Figure 48B). These findings indicate 
that the ATM is not the primary mediator of H2AX phosphorylation in response to non-
thermal plasma treatment.  Depletion of ATR, [403], by shRNA reduced phosphorylation 
of H2AX by 92% relative to non-targeting shRNA; H2AX phosphorylation in response to 
hydrogen peroxide was reduced 40% by ATR shRNA (Figure 48C). Taken together, our 
findings demonstrate that non-thermal plasma treatment activates ATR. 
 
 
193 
 
 
6.3.10. Selectivity of Non-Thermal Plasma Treatment 
Since effects of non-thermal plasma on mammalian cells seem to be mediated by 
ROS similar to ionizing radiation or photodynamic therapy, we wanted to compare the 
effects of non-thermal plasma on normal cells compared to malignant cells. Ionizing 
radiation and photodynamic therapy are effective anti-cancer treatment therapies because 
they exploit the susceptibility of malignant cells over healthy cells to oxidative stress by 
inducing formation of ROS primarily intracellularly which ultimately lead to significant 
DNA damage that cannot be repaired by malignant cells. 
 
Figure 49. Selectivity of Non-Thermal plasma treatment in inducing apoptosis in 
malignant cells over healthy cells. (A) 48 h after treatment with the indicated dose of 
DBD plasma, MCF10A cells were harvested and stained with Annexin V/ propidium 
iodide (PI) and analyzed by Guava. (B) 48 h after treatment with the indicated dose of 
DBD plasma, MCF10A - NEUT cells were harvested and stained with Annexin V/ 
propidium iodide (PI) and analyzed by Guava.  Data from triplicate samples (± S.D.) are 
plotted. 
Non-thermal plasma on the other hand produces ROS primarily extracellularly. 
To see if ROS produced extracellularly by non-thermal plasma induces apoptosis in 
mammalian cells and to investigate whether malignant cells (MCF10A – NEUT) were 
more susceptible than healthy cells, normal mammary epithelial cells (MCF10A) and 
A. B. 
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transformed malignant cells (MCF10A-NUET) were exposed to increasing doses of DBD 
plasma and level of apoptosis was measured by Annexin-V/PI assay.  
After DBD plasma treatment at doses ranging from 0.65 to 7.8 J/cm
2
; a dose 
dependent increase in Annexin-V +ve, PI –ve cells was observed (Figure 49). Further, at 
low doses up to 1.95 J/cm
2
 the level of apoptosis as seen by the Annexin-V +ve cells, in 
both cells lines (Figure 49) was similar, but at higher doses (> 1.95 J/cm
2
) malignant 
MCF10A-NUET cells (Figure 49B) were more vulnerable to plasma treatment as seen by 
almost twice the number of apoptotic cells compared to that in normal cells (Figure 49A). 
These data suggest that malignant cells are more vulnerable to plasma than normal cells. 
By controlling plasma dose, we may be able to selectively kill malignant cells without 
inducing significant necrosis and subsequent inflammation in surrounding tissue. 
 
6.4. Discussion 
Based on its ability to produce dose-dependent effects from increased 
proliferation to apoptosis, non-thermal plasma offers the potential for therapeutic 
applications.  In order to exploit the potential therapeutic applications, it is essential to 
understand the mechanism by which it can exert effects.  The present study demonstrates 
that the dose- dependent effects of non-thermal plasma on mammalian cells are related to 
production of intracellular ROS, which induce a variety of effects, ranging from 
increased cell proliferation to apoptosis depending on concentration [413]. While the 
effects of IR and hydrogen peroxide are also primarily due to generation of ROS, these 
agents induce several different types of DNA damage directly, including DNA double 
strand breaks.  A significant limitation of IR is the requirement for specialized equipment 
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and skilled personnel.  Non-thermal plasma can be generated with a reasonably portable, 
compact and inexpensive device.   
Cell death in response to non-thermal plasma treatment in the dose range 
examined is primarily though induction of apoptosis, which is an important therapeutic 
consideration. Apoptotic cells are broken up into apoptotic bodies, which are engulfed by 
neighboring cells, leading to cell death without significant inflammatory response [338, 
339]. Controlled delivery of non-thermal plasma may provide a means to kill benign and 
malignant lesions in a defined area, without significant necrosis and subsequent 
inflammation.  Delivery can be achieved by direct treatment of tissue surfaces or 
application of defined media treated with plasma.   
 
Figure 50. DBD plasma produced UV does not does not induce the observed DNA 
damage. Cells overlayed with 100 l of medium were treated with DBD plasma at 1.55 
J/cm
2
 and 4.65 J/cm
2
 with (+) and without (-) placing magnesium fluoride (MgF2) glass 
on the cells during treatment. MgF2 glass blocks all plasma species except UV from 
reaching the surface of the medium covering the cells during treatment. Representative 
immunoblot with -H2AX (upper panel) or -tubulin (lower panel) is shown.   
Plasma-induced DNA damage is likely initiated by neutral species which plasma 
produces in gas phase. As shown in Table 2, Non-thermal atmospheric pressure DBD 
plasmas produce long lived (O3, NO, HO2, H2O2) and short lived (OH, O, electronically 
excited oxygen O) neutral particles and charged particles which include ions and 
electrons [17]). Exclusion of charged particles (ions and electrons) by using a grounded 
mesh did not significantly affect H2AX phosphorylation, indicating that neutral species 
produced in the gas phase and not charged species are responsible for these effects. 
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Moreover, the results of the experiments comparing direct treatment with indirect and 
separated plasma treatment rule out any role of DBD plasma produced UV, temperature 
or electric field. DBD plasma is known to produce very weak UV and it has been shown 
to have no effect on living organisms [20, 28, 446]. Blocking of all plasma species, 
except UV by a magnesium fluoride glass placed on the cells during treatment 
completely blocked the phosphorylation of H2AX after DBD plasma treatment (Figure 
50). This shows that UV does not play a role in DBD plasma induced DNA damage in 
mammalian cells. Further, the results of the experiments comparing direct treatment with 
indirect and separated plasma treatment rule out any role of heating as DBD plasma does 
not directly come in contact with medium and cells. 
Mammalian cells undergo DNA damage as a result of ROS generated from 
endogenous and exogenous sources.  The induction of DNA damage by non-thermal 
plasma is mediated through the formation of ROS. The intracellular ROS scavenger, 
NAC, completely blocked phosphorylation of H2AX after non-thermal plasma treatment 
of MCF10A cells. The role of ROS is further supported by direct measurement of 
intracellular ROS and by the formation of lipid peroxidation products, specifically MDA 
(Figure 42 and Figure 43).   
We have provided several lines of evidence that the formation of intracellular 
ROS as a result of plasma treatment results from formation of organic peroxides in the 
media.  Media separately treated with plasma remains active over extended periods of 
time, which would not be the case with inorganic peroxides (e.g. H2O2) and is consistent 
with published reports on organic peroxides [233].  Additionally, there is a direct 
correlation between the peroxidation efficiency of 11 different amino acids and the 
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amount of DNA damage induced in cells exposed to these amino acid solutions.  Taken 
together, these data strongly support the conclusion that the effects of DBD plasma are 
mediated by the organic peroxides formed in the media, although formation of organic 
peroxides in plasma-treated media should be directly measured.   
ROS–induced DNA damage includes small or bulky modifications to bases and 
sugars, interstrand and intrastrand cross-links, as well as single-strand breaks and double-
strand breaks [62, 447]. Complex molecular networks that rapidly sense and repair DNA 
damage have evolved to maintain genomic stability and ensure cell survival [448]. 
Oxidative stress and IR activate the phosphatidylinositol 3-kinase–related kinases 
(PIKK), including ataxia-telangiectasia mutated (ATM), DNA-PK, and ATM and Rad3-
related kinase (ATR) [445]. The histone variant H2AX is phosphorylated on Ser139 by 
ATM, ATR, and DNA-PK over a large region of chromatin surrounding a DSB [449, 
450]. In this study, we have shown that phosphorylation of H2AX after non-thermal 
plasma treatment of MCF10A cells is primarily through ATR, in contrast to the ATM-
dependent phosphorylation of H2AX after treatment of cells with IR or hydrogen 
peroxide. Our studies suggest that oxidative stress induced by non-thermal plasma 
treatment of cells leads to activation of ATR, suggesting that unlike IR and H2O2, non-
thermal plasma primarily induces bulky lesions and stalled replication forks. 
It has been shown earlier that reactive oxygen species mediate non-thermal 
plasma induced DNA damage in mammalian cells.  Reactive oxygen species also interact 
with cellular membrane leading to lipid peroxidation. We investigated the role of ROS 
produced by non-thermal plasma in inducing lipid peroxidation in mammalian cells. It 
was hypothesized that non-thermal plasma induces DNA damage in mammalian cells via 
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lipid peroxidation. The results indicate that non-thermal plasma indeed leads to lipid 
peroxidation, but non-thermal plasma induced lipid peroxidation by-products is not what 
induces DNA damage. Further investigations are necessary to determine other pathways 
of non-thermal plasma induced DNA damage in mammalian cells, which may include 
reactive oxygen species mediated cellular signaling or uptake of long lived reactive 
oxygen species via active transport. 
 
6.5. Summary 
Clinical application of DBD plasma requires an understanding of its interaction 
with living tissues.  We have shown here that DBD plasma generates ROS in gas phase, 
which can react with organic components such as serum or amino acids to produce long 
living reactive species, mostly likely amino acid and protein hydroperoxides.  The 
amount of intracellular ROS produced by plasma can be controlled by varying the 
frequency and voltage waveform, allowing fine tuning of therapeutic effect, from 
stimulating cell proliferation to inducing apoptosis, essentially by modulating the level of 
ROS produced.  Generation of organic peroxides in solution may provide an alternative 
means of administration.  Understanding the mechanism underlying the effects of plasma 
is an essential first step in applying it to clinical use.  Future work will involve 
investigating the mechanism by which peroxidized amino acids are processed by the cell.  
The only limitation to using DBD plasma for a wide range of clinical applications is 
designing devices for plasma delivery appropriate for the use. The potential clinical 
applications of DBD plasma include treatment of wounds to enhance healing and sterilize 
wound surfaces or controlled ablation of tissue, including benign lesions or cancers.   
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Chapter 7. Concluding Remarks 
This thesis demonstrates that the dose-dependent effects of non-thermal plasma 
on mammalian cells are related to production of reactive oxygen species, which induce a 
variety of effects, ranging from increased cell proliferation to apoptosis depending on 
concentration. Non-thermal plasma offers the potential for therapeutic applications 
ranging from promoting wound healing to treating cancer. In order to utilize non-thermal 
plasma for therapeutic applications, it is essential to understand the mechanism by which 
it can exert these effects.  While the effects of IR and hydrogen peroxide are also 
primarily due to generation or ROS, these agents induce several different types of DNA 
damage, including DNA double strand breaks.  A significant limitation of IR or hydrogen 
peroxide is the lack of precise control over the area and depth of effects required to avoid 
injury to surrounding tissue. Exquisite control of treatment area and dose can be achieved 
with non-thermal plasma, which can be generated with a reasonably portable, compact 
and inexpensive device, in contrast to IR, which requires expensive facilities and highly 
skilled professionals.   
Cell death in response to non-thermal plasma treatment is primarily though 
induction of apoptosis, which is an important therapeutic consideration. Plasma-induced 
DNA damage is likely related to neutral ROS which cannot be attributed to ozone alone. 
Moreover, we have shown that phosphorylation of H2AX after non-thermal plasma 
treatment of mammalian cells is primarily through ATR, in contrast to the ATM-
dependent phosphorylation of H2AX after treatment of cells with IR or hydrogen 
peroxide. Our studies suggest that oxidative stress induced by non-thermal plasma 
treatment of cells leads to activation of ATR, suggesting that unlike IR and H2O2, non-
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thermal plasma primarily induces bulky lesions. Further we also showed that although 
non-thermal plasma induces lipid peroxidation of the plasma membrane, the pathway by 
which plasma generated oxidative stress is transferred across cellular membranes does 
not involve lipid peroxidation by-products. 
Clinical application of DBD plasma requires an understanding of its interaction 
with living tissues.  We have shown here that DBD plasma generates ROS, which can 
react with organic components such as serum or amino acids to produce long living 
reactive amino acid and protein hydroperoxides.  The amount of ROS produced by 
plasma can be tightly controlled by varying the frequency and voltage waveform, 
allowing fine tuning of therapeutic effect, from stimulating cell proliferation to inducing 
apoptosis, essentially by modulating the level of ROS produced.  Generation of organic 
peroxides in solution may provide an alternative means of administration.  Understanding 
the mechanism underlying the effects of plasma is an essential first step in applying it to 
clinical use.   
Future work will involve investigating the mechanisms by which hydroperoxides 
are processed by the cell.  It would be important to establish whether the effects of 
plasma are due to their uptake by active transport mechanisms or activation of 
intracellular signaling pathways due to binding of organic hydroperoxides to receptors on 
the cell membrane. The only limitation to using DBD plasma for a wide range of clinical 
applications is designing devices for plasma delivery appropriate for the use. The 
potential clinical applications of DBD plasma include treatment of wounds to enhance 
healing and sterilize wound surfaces or controlled ablation of tissue, including benign 
lesions or cancers.   
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